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Abstract 
 
Astrocytes are considered a default developmental state in mammalian nervous system 
differentiation. Even though astrocytes are involved in the maturation of the nervous 
system, information regarding their own development is sparse. Evidence has shown that 
astrocyte development (astrocytogenesis) commences after neurogenesis, leading to a 
heterogeneous population of astrocytes within the CNS. However, generating astrocytes 
in vitro has proven to be more challenging than previously thought, where complex use of 
morphogens, long time culture incubation (>180 days), and reduced focus on subtype 
astrocyte generation prevents full understanding of astrocytes. By modifying previous 
methodologies, here we describe a quick and efficient method to generate functional and 
heterogeneous astrocytes from mouse embryonic stem cells (mESC) which contributes 
towards ever growing need towards standardising protocols for in vitro astrocytogenesis. 
Under the cell suspension protocol, mESCs formed embryoid bodies (EBs), which were 
then inducted into a neural lineage using retinoic acid (RA) (DIV 3). At DIV 6 EBs were 
seeded onto laminin coated glass coverslips, in astrocyte differentiation media, containing 
heparin and N2. Cells morphologically resembling astrocytes were observed migrating 
from attached EBs, two days post seeding. Migrating cells stained positive for astrocyte 
markers GFAP, ALDH1L1 and S100β. When astrocytes were stimulated with adenosine 
triphosphate (ATP), intracellular calcium concentration was elevated, as revealed by 
Fluo4. Analysis of P2X and P2Y purinoreceptor pathways, revealed significant 
contributions of each pathways and a functional diversity of the generated astrocytes. 
Furthermore, these generated astrocytes displayed potential to be used as a tool for future 
studies via successful removal from substrate, and rescuing damaged neuron rich 
network. In summary, we describe here the generation of functional astrocytes derived 
from mESCs, which display heterogeneity in form and function that is commonly 
observed in astrocytes in vivo.  
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1. Introduction 
 
The central nervous system (CNS) consists of interconnected networks composed of 
variety of neuronal and non-neuronal glial cells such as macroglia and microglia. 
Microglia originates from different ontogenic sources: hematopoietic system and the 
main embryonic cells from yolk sac (Alliot et al. 1999; Ginhoux et al. 2013). Whereas 
macroglia encompasses cells which originate from the neuronal tube such as: 
oligodendrocytes and astrocytes (Nedergaard et al. 2003). The term glia derives from the 
Greek word for ‘glue’ and the study of glial cells dates back to the 19th century, where 
they were first described and made public by Rudolph Virchow in 1858 (Kettenmann & 
Verkhratsky 2008). Virchow described the works of Remak, Muller, and Bremann, who 
revealed the presence of Muller and Bregmann glia within the CNS, and based on their 
discoveries coined the term neuroglia (nervenkitt) - where glial cells were seen as ‘glue’ 
to support neurons and maintain the vasculature of the CNS, with no clear defined 
function – placing neurons at the centre and sole contributors to cognitive function 
(Virchow 1858; Fields & Stevens-Graham 2002). 
 
Pioneer work conducted by Dieters and Golgi in the mid-19th century on glial 
morphology showed differences and similarities between neurons and glia, and brought 
forward the idea of glial cells as separate cell-type when compared to neurons 
(Kettenmann & Verkhratsky 2008). This led to the conclusion that glial cells share the 
same developmental origin as neurons (Oberheim et al. 2012). Over the next few years, 
work conducted by Santiago Ramon y Cajal, von Lenhossek, William Lloyd Andriezen 
and Rio-Hortega, provided seminal evidence towards glial biology, by introducing 
astrocytes and oligodendrocytes to the field of neuroscience (Araque & Navarrete 2010; 
Verkhratsky et al. 2014).  
 
Astrocytes were first described by von Lenhossek as star shaped cells of the neuroglia, 
which display elaborate morphology (Matyash & Kettenmann 2010; Fields et al. 2015). 
Later Andriezen and Cajal built upon these observations and descriptions, and placed 
astrocytes into different subtypes based on their morphological features and introduced 
the terms fibrous and protoplasmic astrocytes (Eng et al. 1971; Miller & Raff 1984; 
Gleichman & Carmichael 2014). Nevertheless, despite these findings, similar to previous 
conclusions, astrocytes were still relegated to secondary role – providing support to 
neurons (Miller and Raff 1984, Belanger et al 2009). In the last several decades however, 
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this view of astrocytes has changed, and ample of evidence now exists which challenges 
places astrocytes as key players in regulating neural transmission (Hu et al. 2016).  
The functional importance of astrocytes both in development, maintenance, and maturity 
of the CNS has become an area of increasingly intense research (Volterra & Meldolesi 
2005; Clarke & Barres 2013). Evidence has now shown that astrocytes are the most 
abundant type of glial cells within the CNS (Verkhratsky & Butt 2018) and ratio of 
astrocyte to neuron is mainly 1:1 – although shown to be highly variable depending on 
the brain region (Herculano-Houzel 2014). This further challenges the idea neuronal 
dogma, and now ample of studies have now provided evidence towards the active 
involvement of astrocytes in various important processes, such as: providing metabolic 
support to neurons (Bouzier-Sore & Pellerin 2013), buffering of extracellular potassium 
(Bellot-Saez et al. 2017), uptake and recycling of neurotransmitters (Petrelli & Bezzi 
2016), ion distribution (Rose & Chatton 2015), sleep (Rusakov et al. 2014), neurogenesis 
(Kempermann et al. 2015), neurodegeneration (Phatnani & Maniatis 2015), 
synaptogenesis (Tsai et al. 2012), modulating synaptic activity, and more recently 
learning and information processing in the brain (Savtchouk & Volterra 2018).   
 
Until recently, astrocytes have been studied as a homogeneous cell population (Matyash 
& Kettenmann 2010; Farmer & Murai 2017). Since their discovery the classic 
subdivision of astrocytes into protoplasmic and fibrous cell type has dominated the field 
(Miller & Raff 1984; Yong et al. 1990; Oberheim et al. 2012). However, this does not 
account for heterogeneous subpopulations of astrocyte that have been identified in recent 
experiments (Xin & Bonci 2018). The understanding of the diversity of astrocytes lags 
far behind that of neurons - in terms of functionality and morphology (Petravicz et al. 
2010; Farmer & Murai 2017). The invention of usage of stem cells, embryonic stem cells 
(ESCs) and/or induced pluripotent stem cells (iPSCs) opens future prospects for 
understanding astrocytes, given that physiologically functional, cellular model systems 
can be generated from these cells (Kuegler et al. 2012; Santos et al. 2017; Xin & Bonci 
2018). This can allow researchers to begin to unravel the complexity of astrocytes and its 
heterogeneity and help solidify the definition and function of astrocytes within the CNS. 
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1.1. Development of Astrocytes – Astrocytegenesis 
 
During development gliogenesis generally follows neurogenesis in the developing brain 
(Miller & Gauthier 2007; Rowitch & Kriegstein 2010; Peljto et al. 2010).  Neural tissue 
of developing vertebrates is specified from the ectoderm germ layer during 
embryogenesis (Suda et al. 1987; Reubinoff et al. 2000; Sadler 2005). The ectoderm, 
most of which will eventually give rise to the epidermis, contains a subset of 
neuroepithelial cells that will develop into the neural tube, which give rise to the spinal 
cord and the CNS (Sadler 2005). The neural tube is patterned throughout the dorso-
ventral axis by morphogens (SHH, BMPs, and Wnts) (Le Dréau & Martí 2012), which 
regulate the expression of homeodomain transcription factors forming domains leading to 
neurons and glial cells (Fig. 1) (Le Dréau & Martí 2012; Rowitch & Kriegstein 2010). 
Initial evidence displayed astrocyte emerge from the ventral P2 progenitor domain 
(Molofsky & Deneen 2015). Fate mapping of astrocytes by (Tsai et al. 2012), revealed 
astrocytes emerge from all of the domains during development, with the ventral domains 
contributing towards 80% of astrocytes (Fig.4) (Molofsky et al. 2014). Regionally 
specified neural progenitor cells (NPC) – called radial glia, will initially give rise to 
neurons and then eventually give rise to regional astrocyte progenitors. This process is 
called the neural-glial switch (Molofsky & Deneen 2015). Within the developing neural 
tube, the development of astrocytes and the regulation of neural-glial switch is controlled 
by several key transcription factors, such as Neurogenin 1/2, a bHLH transcription factor 
(Sun et al. 2001; Kessaris et al. 2008; Velkey & O’Shea 2015; Bayraktar et al. 2015). 
These factors control and supress astrocytic genes (GFAP, S100β, and ALDH1L1) by 
hypermethylation (Sun et al. 2001; Cahoy et al. 2008; Takouda et al. 2017), and prevent 
the development of astrocytes. Therefore, downregulation of pro-neural genes (such as 
Neurogenin) and upregulation of pro-astrocyte genes (such as Notch, transcriptional 
repressor N-CoR, Nuclear Factor I-A, Sox9) is required to induce astrocytogenesis 
(Velkey & O’Shea 2015; Takouda et al. 2017). For example, Nuclear Factor I-A was 
identified and found to be both necessary and sufficient for astrocytogenesis in 
developing mice (Wilczynska et al. 2009; Kang et al. 2012). Changing the expression of 
NFI family genes altered the neural-glial switch, led to decreased astrocyte numbers 
within the developing brain (Sloan & Barres 2014). 
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Figure 1: Graphical overview of astrocyte development. Interaction of multiple 
transcription factors in the neural tube leads to astrocyte development.  Image adapted 
and reproduced from Molofsky et al 2012 under a Creative Commons 4.0 license.  
 
As the transition towards astrocytogenesis occurs by inhibition of pro-neuronal factors, 
the astrocyte precursors become primed to be induced by cytokines such (Ciliary 
neurotrophic factor) CNTF (Hughes et al. 2010; Yang et al. 2013), (Leukemia inhibitory 
factor) LIF (Asano et al. 2009) and growth factors like (bone morphogenetic proteins) 
BMPs (Kohyama et al. 2010; Le Dréau & Martí 2012) which act to activate signalling 
pathways such as STAT, SMAD or PI3K-Akt pathway necessary for astrocyte 
development and maturity (Fig.5) (Hong & Song 2014; Wang et al. 2014). For example, 
the STAT pathways is one of the key pathways which is required in astrocyteogenesis 
(Hong & Song 2014). The pathway requires combinatorial work by Neurotrophins (NTF) 
and LIF to bind to gp-130, a cell surface co-receptor and leads to dimerization with LIF 
receptors (Nakashima et al. 1999; Hong & Song 2014). Dimerisation of LIFR leads to 
activation of (Janus kinase) JAK/STAT pathway, which causes the activated STAT locate 
from cytoplasm to the nucleus and relaxes the chromatin structure GFAP promoter region 
and triggers transcription of GFAP leading formation, maturity and differentiation of 
astrocytes (Fig.5) (He et al. 2005; Asano et al. 2009; Hong & Song 2014). Several studies 
have shown the necessity of gp-130 activation for astrocytogenesis, for example 
Nakashima et al 1999 shown that gp-130 null mice present reduction in STAT and GFAP 
when compared to control mice, and these mice showed impairment in astrocyte 
induction with significant reduction led to significant neuronal defects which is controlled 
by maturing astrocytes (Nakashima et al 1999).  
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Figure 2: Graphical overview of astrocyte development pathways. Interaction of multiple 
transcription factors in the neural tube leads to astrocyte development.  Image adapted 
and reproduced from Rowitch and Kriegstein 2010, Sloan and Barres 2014 under a 
Creative Commons 4.0 license. 
 
A major limitation of all these studies investigating the gliogenic switch is that, they all 
converge at the expression of GFAP as “the” marker to understand the commitment 
towards astrocytic lineage (Eng et al. 2000; Bayraktar et al. 2015; Molofsky & Deneen 
2015; Hol & Pekny 2015). Therefore, further studies are required to relate the expression 
of other important astrocytic markers like ALDH1L1 and S100ß (Raponi et al. 2007; 
Cahoy et al. 2008; Roybon et al. 2013; Kleiderman et al. 2016). Also, it remains to be 
elucidated whether or not these pathways are working in parallel or one pathway can 
compensate for the lack of the other or whether they exhibit a temporal pattern. Also, 
further investigation is also required to study the relation between these different ways of 
initiating astrocytic differentiation in order to build a better temporal model for 
understanding astrocytogenesis (Sloan & Barres 2014; Xin & Bonci 2018).  
 
1.2. In vitro astrocytogenesis  
	
To gain clearer understanding on astrocytogenesis, in vitro assays have been performed 
ubiquitously using variety of methods and cell types (Mccarthy & Vellis 1980). Majority 
of initial studies have used primary monolayer cultures as a model of studying astrocytes 
in vitro (Mccarthy & Vellis 1980; Schildge et al. 2013). For example, the first human 
astrocytes were cultured from foetal and adult post- mortem tissue (Ennas et al. 1992; 
Schildge et al. 2013) but were often contaminated with microglia and other cell types 
which were difficult to separate during dissections (Crocker et al. 2008). The 
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contamination of other cells raises severe disadvantages when studying astrocytes 
specifically (Crocker et al. 2008; Schildge et al. 2013). Furthermore, as primary 
astrocytes are more committed in terms of region specific roles and gene expression, they 
are not a suitable alternative to fully recapture and unravel role of astrocytes and 
astrocytogenesis (Hewett & Hewett 2012). Moreover, inaccessibility of tissue, mainly 
human, due to ethical concerns and potential health risks also leads to primary sources as 
not a viable option for studying astrocytogenesis (Lange et al. 2012).   
 
In vitro astrocytogenesis using other alternatives methods, such as stem cells or partially 
differentiated cells stem cells (such as glial or neural progenitors) unravel new 
possibilities to investigate development and the complex roles of astrocytes (Kleiderman 
& Kirner 2017; TCW et al. 2017; Li et al. 2018). Stem cells, initially studied by Becker et 
al (1963), are a group of highly specialised cells that have become exceedingly attractive 
for many applications in tissue engineering, pharmaceutical screening and cellular 
therapies (Becker, A.J. McCulloch, E.A. Till 1963; Gardner 2007). Stem cells have 
attracted a large amount of attention in recent years because they are able to provide 
inexhaustible source and a large pool of cells to be used (Ying et al. 2003; Gardner 2007), 
by having the ability of self-renewal and differentiate (Ying et al. 2003).  
 
Stem cells have been broadly categorised into two subtypes, adult and embryonic (Biehl 
& Russell 2009; Chagastelles & Nardi 2011). Adult stem cells are generally tissue and 
region restricted, and their roles and numbers tightly controlled and only used for 
maintenance and when in demand throughout the life of an organism (Chagastelles & 
Nardi 2011; Gao et al. 2017). Stem cells residing in the adult tissues are extremely 
interesting for several reasons, as they are closer to fully specialised cell types and may 
therefore be more readily manipulated  (Biehl & Russell 2009). However, this is also 
their downfall as these cells are unipotent and require significant changes and alteration 
to be differentiated to other cells type (Kleiderman et al. 2016; Gao et al. 2017). For 
example, Gao et al 2017 were able to show de-differentiation of astrocytes towards 
neuronal lineage via expression of pro-neuronal transcription factors, however they were 
not able to create specific neuronal subtypes and lacked expression which matched 
primary cells. Therefore, embryonic stem cells (ESC) have shown to be more favourable 
and have the main focus for future studies (Conley et al. 2004; Kuegler et al. 2012). 
Embryonic stem (ESC) cells are unique in their ability to differentiate into cells from 
each of the three germ layers, ectoderm, endoderm and mesoderm – they can make all the 
tissues of the adult organism (a property termed pluripotency) (Martin 1981; Reubinoff et 
al. 2000). This, together with their ability to multiply in culture without apparent limit, 
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makes and made them an attractive source for the in vitro generation of cell types that 
may be of use to study disease or to provide a limitless source of cells for cell-
replacement therapies (Suda et al. 1987). Using and understanding mechanisms which 
keep ESC in their pluripotent stages in vitro, researchers were able to reverse the process 
and able to derive stem cells, which can be kept in their pluripotent stage, from adult stem 
cells – termed induced pluripotent stem cells (iPSCs) (Stadtfeld et al. 2010). Pioneer 
work by Kazutoshi, Takahashi and Yamanaka, 2006, on mouse lines, they were able to 
show that by using Oct4, KLF4, Sox and cMy, termed Yamanaka factors, adult stem cells 
can be kept in undifferentiated stage and can be formed into of a pool of induced 
pluripotent stem cells (iPSCs) (Stadtfeld et al. 2010). The establishment of an ES like cell 
line from human cells was achieved also achieved using the four Yamanaka factors 
(Takahashi et al. 2006; Liu et al. 2008) or new factor LIN28, allowing for the production 
of human iPSC lines (Takahashi et al. 2006; Liu et al. 2008; Stadtfeld et al. 2010). 
 
To employ in vitro systems for studying and trying to capture astrocytogenesis, it is 
important to mimic in vivo conditions (Nagao et al. 2016; Sloan et al. 2017). With the 
growing use of stem cells, there have been several well defined protocols for their 
differentiation into different subtypes of neurons, but only few protocols exist for the 
generation of towards astrocytes (Falsig et al. 2004; Kuegler et al. 2012; Roybon et al. 
2013; Shaltouki et al. 2013; Chandrasekaran et al. 2016; Li et al. 2018). Also, very few 
protocols exist which utilise ESC, which will fully allow to recapitulate in vivo 
astrocytogenesis  (Kuegler et al. 2012; Kleiderman & Kirner 2017). ESC were first 
isolated in 1981 by Martin Evans, Matthew Kaufman, and Gail R. Martin (Kaufman et al. 
1983). In 1995, Martin Evans and Austin Smith described the culture of mouse ESC with 
LIF, which keeps the cells in their pluripotent, self-renewing state. Human ESC were 
isolated later in 1998 by James Thomson from the inner cell mass (ICM) of residual 
blastocysts of in vitro fertilisations (Ying et al. 2003; Conti et al. 2005). Using and 
understanding mechanisms which keep ESC in their pluripotent stages in vitro, 
researchers were able to induce these ESC into neuronal and glial subtypes. For example, 
Ying et al 2003 described that pure population of neural stem cells can be generated from 
mESC and subsequently provided a platform for generation of glia and neurons which 
was used by Conti et al 2005 to generate neurons, oligodendrocytes and astrocytes (Ying 
et al 2003; Conti et al 2005). However, research into mESC was arrested and the focus 
was shifted towards using human ESC. Although human ESC isolation was defined 
before by (Zhang et al. 2001), where they were able to obtain neural precursors, the usage 
of human ESC gained traction more recently (Zhang et al 2001). For example, Krenick et 
al 2011 displayed differentiation potential of human ESC, and generated functional 
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astrocytes in 160 days (Krencik & Zhang 2011). This was further optimised by Gupta et 
al. 2012 and using functional assays such as glutamate uptake and kinetic assays, they 
showed that the human ESC astrocytes can be used effectively to model neuron– 
astrocyte interactions and investigate their mechanism (Gupta et al. 2012; Santos et al. 
2017). However, the differentiation of human embryonic stem cells to astrocytes is much 
more complicated when compared with mouse systems (Keugler et al. 2012), since 
human development proceeds in a different time scale (Santos et al. 2017). Although 
using human systems would be more desirable, similar to in vivo experimental planning 
and protocols are far more complex that their murine counterparts. Additionally, current 
protocols for the generation of astrocytes require longer incubation period, and are harder 
to maintain (Li et al. 2018). Also, the differentiated astrocytes in most protocols are not 
fully mature and do not fully represent the diversity seen during in vivo astrocytogenesis 
(Roybon et al. 2013). Furthermore, employing human sources of stem cells presents itself 
with its own challenges, such as ethical and availability issues. Thus, for studies, which 
require representative populations of astrocytes to fully unravel their complexity, 
astrocytes generated from murine stem cells are still the best approach. 
 
Since the pioneering studies, there have been assortment of methods which have 
generated functional astrocytes from mouse embryonic stem cells (mESC). However, the 
methodologies used either produced other cell types, such as neurons and 
oligodendrocytes, alongside astrocytes, were large in their timescales or required 
alteration of protocol which deviated from in vivo astrocytogenesis (Kamnasaran et al. 
2008). For example, Kamnasaran et al. 2008 transiently transfected cells, which had 
already been through morphogens which selectively induced gliogenesis in the media. 
Furthermore, alongside morphogen usage, they used a human (h) GFAP: GFP plasmid to 
selectively induce transcription for GFAP, and accelerate the generation of astrocytes. 
This protocol is sufficient for understanding astrocyte function, however it is a protocol 
which was difficult to replicate and does not follow astrocytogenesis principles. In order 
to precisely mimic in vivo astrocytogenesis, Kuegler et al (2012), refined previous 
methodologies from Falsig et al 2004, and generated astrocytes which were GFAP 
negative – displaying heterogeneity in marker expression (Falsig et al. 2004; Kuegler et 
al. 2012). These astrocytes were immunocompetent and expressed majority of astrocyte 
specific markers. Nevertheless, the protocol requires adaptations and further 
specifications to reduce the timeline (Keugler protocol generated astrocytes in 50+ days) 
and requires stringent validation assays to show production of high quality, pure 
astrocytes.  
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Majority of the above studies are limited by the requirement of a long differentiation time 
to attain astrocyte rich cultures. Also, they use of either serum or expensive growth 
factors to recapture developmental principles. But above all, majority of protocols rely 
largely on the expression of GFAP to mark the completion of astrocyte differentiation 
and maturation, and provide reduced data on step by step temporal analysis of developing 
astrocytes (Wang & Bordey 2008; Gupta et al. 2012; Yang et al. 2013). This has resulted 
in overlooking astrocyte heterogeneity and developmental principles while employing in 
vitro methods, thereby highlighting the need for an economical and less time consuming 
method for the generation of different possible subtypes of astrocytes  (Molofsky & 
Deneen 2015). Furthermore, it is important in vitro to develop standardised protocols for 
the in vitro generation of astrocyte subsets with defined maturity status, phenotypic 
properties and which captures developmental principles in a timely and efficient manner.  
 
1.3. Classification of an astrocyte 
	
	
	
	
Figure 3: Original Cajal drawing illustrating the human neuroglia in the pyramidal and 
radiated layers of Ammon's horn with the gold chloride method: A represents thick 
astrocyte wrapping a pyramidal cell; B, sibling astrocytes forming a nest around a cell 
(C), one of them extend two processes to another nest (D); E: cell with autolysis sign'. F: 
Astrocyte close to blood vessels. Image adapted from Cajal Legacy, Instituto Cajal, CSIC 
under a Creative Commons 4.0 license. 
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Since the discovery of astrocytes in the early 19th century (Fig. 3), astrocytes have been 
shown to be a heterogeneous group of cells (Oberheim et al. 2012). Although, due to the 
neuronal dogma taking centre stage, astrocytes have been treated as a homogenous 
groups of cells (Verkhratsky & Butt 2018). The full scope of astrocytic heterogeneity, 
however, has not been realised and it is only now beginning to unravel (Oberheim et al. 
2012; Hu et al. 2016; Farmer & Murai 2017; Xin & Bonci 2018). However, in 
comparison to neuronal diversity, understanding astrocyte heterogeneity still remains 
rudimentary (Farmer et al 2017; Xin et al 2018). This heterogeneity is not only of 
morphological nature, but also phenotypic, functional, regional, and local aspects, which 
are closely linked to each other and the environmental niche they encompass (Okuda 
2018).  
 
Classically, astrocytes have been divided into subgroups based on their morphological 
appearances (Fig. 3). The protoplasmic astrocytes, usually found in the grey matter, and 
the fibrous astrocytes, which are located in the white matter. This classical subdivision, 
although rudimentary, was still one of the most defining means of classifying astrocytes.  
The phenotype of cells can be easily assessed by PCR on mRNA level and by 
immunocytochemistry on protein level. PCR provides an early response to changes in the 
environment, but does not allow single cell analysis. Immunocytochemistry is therefore 
crucial to examine the distribution of marker expression and protein localization in single 
cells of a possibly heterogeneous population. There are several specific astrocyte 
markers, which can be detected by one or both methods. 
 
As seen until now, most of the studies for defining astrocytes and their development 
depend largely on the expression of GFAP (Sofroniew & Vinters 2010; Hol & Pekny 
2015). But with more detailed studies of astrocytes, it is becoming clear that not all 
astrocytes are labelled uniformly with GFAP (Zhang & Barres 2010). Also, the type B 
stem cells in adult SVZ stains positive for GFAP (López-Hidalgo & Schummers 2014). 
In addition, GFAP expression is augmented in reactive astrocytes as well as serum 
derived cultured astrocytes. These findings suggest that the use of GFAP as ‘the 
prototypical’ astrocytic marker is highly disputable. There are several markers in which 
one can distinguish astrocytes. 
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S100β 
 
S100β belongs to the family of Ca2+, Zn2+, Cu2+ binding proteins, and is highly expressed 
in the brain. It has been reported that the initiation of S100β expression (at around E13 in 
mouse) in astrocytes marks the loss of their NSC potential, thereby stabilizing their 
commitment towards the astrocytic lineage (Raponi et al. 2007). Expression of S100β in 
astrocytes is seen in all regions of the brain, occupying both cytoplasmic and nuclear 
location. Although the exact physiological function of S100β is unknown, it has been 
attributed to play a crucial role in cytoskeleton organization, calcium binding, and 
scavenging of toxic substances (Brozzi et al. 2009). Also, intracellular S100β is 
considered to stimulate cell proliferation, migration along with inhibition of apoptosis 
and differentiation (Hachem et al. 2007; Donato et al. 2008). In astrocytes, S100β is also 
known to regulate their response to inflammation in a receptor for advanced glycation 
end products (RAGE) dependent manner (Selinfreund et al. 1991; Hachem et al. 2007). 
 
EAAT/GLAST 
 
The activation of excitatory amino acid transporter 1 (EAAT1 or sodium dependent 
glutamate- aspartate transporter GLAST) promoter overlaps its expression with neuronal 
migration (Shibata et al., 1997. In the murine forebrain, Ullensvang et al 1997 showed 
that the expression of GLAST occurs at the start at the second embryonic week and 
reaches a maximum level by P5. Ullensvang et al 1997 also showed that the expression 
was mainly present in glial cells in both young and adult animals (Ullensvang et al. 
1997). Excitatory amino acid transporter 2 (EAAT2 or Glutamate transporter 1) is the 
second most dominant glutamate transporter expressed by astrocytes performing a similar 
function in glutamate clearance as described for EAAT1 (Yang et al. 2011). EAAT2 
expression begins late in development and increases in a region based manner till 
development (Desilva et al. 2012). Also, DeSilva et al 2012 showed that by performing 
western blots, EAAT2 undergoes glycosylation and this increases during development 
(DeSilva et al. 2012). 
 
ALDH1L1 
 
Aldehyde dehydrogenase 1 light chain 1 (ALDH1L1, as known as 10- formyl 
tetrahydrofolate dehydrogenase (FDH)) is a folate metabolizing enzyme, first shown to be 
expressed in rodent astrocytes, making them an important site for folate metabolism 
(Anthony & Heintz 2007). Later, using P0 mouse, it was reported that ALDH1L1 labels 
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all astrocytes throughout the brain, whereas GFAP was predominantly expressed in the 
white matter. Also, it does not co- stain with neuronal or oligodendrocyte markers, 
thereby promoting the use of ALDH1L1 as a highly specific, ‘pan’ astrocytic marker 
which could be employed for preparation of pure astrocytic cultures by performing FACS 
(C(Vasiliou & Nebert 2005; Foo & Dougherty 2013; Molofsky et al. 2013). By means of 
GLT1+, ALDH1L1+ reporter mice; another study has reported a decrease in the 
expression of ALDH1L1 with maturation of spinal cord astrocytes (Yang et al. 2011).  
 
GFAP 
 
Glial fibrillary acidic protein (GFAP) has been widely used as “the” mature astrocytic 
marker to identify them both in vivo and in vitro and also to elucidate the signalling 
cascade for their differentiation (Eng et al. 2000). However as mentioned before, a deeper 
analysis of the expression of GFAP has revealed that not all the astrocytes express GFAP, 
its level being higher in white matter, fibrous astrocytes and almost insignificant in grey 
matter, protoplasmic ones (Kimelberg 2010). Protoplasmic astrocytes can however be 
identified by the presence of other pan astrocyte markers like ALDH1L1, GS and 
functional marker like EAAT2. In addition, glia limitans (astrocyte foot processes) and 
another subtype of astrocytes called interlaminar astrocytes also express GFAP. Its 
expression has been observed to start at E16 in mouse and at 23 gestational weeks in 
humans and peaks till E18 and 41 post conception week in mouse and humans 
respectively (Desilva et al. 2012; Mamber et al. 2012). Protoplasmic astrocytes when 
turned reactive upon inflammatory insult, retain the ability to exhibit GFAP expression. 
GFAP ICC does not sufficiently reveal astrocyte morphology. Using dye filling 
experiments it has been illustrated that in vivo astrocytes possess far more processes than 
those observed with GFAP immunostaining, and GFAP represents only 15% of the total 
cell volume (Oberheim et al. 2012).  
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1.4. Roles and functions of Astrocytes  
	
Alongside astrocyte morphology, recent observations of astrocyte functions have also 
revealed heterogeneity. For example, Martin et al 2015 show Circuit-specific signalling 
in astrocyte-neuron networks in basal ganglia pathways, where each subpopulations of 
astrocytes selectively responded to specific neuronal activity (Martin et al. 2015; Okuda 
2018).   
	
The brain is one of the most energy demanding organ in the body, and since the discovery 
of astrocytes, the conclusions have been that sole purpose of these cells is to provide 
nutrients and support to neurons (Raichle & Gusnard 2002). Based on our recent 
understanding of astrocytes, we now know that these cells perform many other complex 
functions such as regulation of neural activity and transmission, neuroprotection (Fields 
& Stevens-Graham 2002; Agulhon et al. 2008) regulation of memory (Lee et al. 2014), 
sleep (Rusakov et al 2014), contribute towards formation of the blood-brain barrier 
(Nedergaard et al. 2003), guidance during migration and many more other functions 
which are outline below. However, the initial observations were correct, and astrocytes 
do provide metabolic and physical support to neurons and this is indeed one of their key 
roles within the CNS (Fields and Graham 2002). 
 
Evidence has shown that astrocytes are involved in providing energy to neurons (Dienel 
2015) under basal and energy demanding conditions, via the astrocyte-neuron lactate 
shuttle (Suzuki et al. 2011; Jakoby et al. 2014). Using fluorescent glucose probes Jakopy 
et al 2014, showed that astrocytes show preferential transport and metabolism of glucose 
when compared to neurons from primary hippocampal and cortical cultures. This glucose 
via glycolysis gets converted into Adenosine Triphosphate (ATP) and pyruvate, however 
due to high uptake of glucose by astrocytes excess pyruvate is produced. This excess 
pyruvate gets converted into lactate for neurons to use and directly produce ATP for their 
function. This lactate shuttle provides evidence of astrocyte supporting neurons in 
performing their functions (Suzuki et al. 2011; Dienel 2015).  
 
Further evidence of neuronal support is astrocyte involvement in preventing runaway 
excitation via uptake of glutamate from extracellular space (Petrelli et al 2016). 
Glutamate is one of the primary neurotransmitter alongside ATP within the CNS. Excess 
glutamate can lead to glutamate excitotoxicity – where neuronal firing rates increases 
leading neuronal loss  (Schousboe & Waagepetersen 2005; Risher et al. 2014). Because 
astrocytes are overburdened with excess glutamate, astrocyte metabolise glutamate in 
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many ways. Mainly, glutamate is converted to glutamine through the action of glutamine 
synthase and shuttled to neurons for further signalling purposes or recycled (Zou et al. 
2011). Zou et al that effecting glutamine synthase activity was inhibited by applying an 
antagonist or cytokines, it significantly reduced GS expression and inhibited glutamate-
induced GS activation resulting in increased excitotoxicity to neurons – shown via 
glutamate uptake assay (Zou et al. 2011). 
 
1.4.1 Non-conventional roles of Astrocytes 
 
Due to astrocyte ability to interact with neurons in a support manner, researchers began to 
unravel further roles of astrocytes which challenged the dogma and showed that 
astrocytes are more than just support cells. One of these functions was the identification 
of the tripartite synapse – where astrocytes survey, prune and form, influence and for a 
network that influences the neural activity that is occurring between pre-and post-
synapses (Araque et al. 1999; Clarke & Barres 2013; Chung et al. 2015). 
 
Evidence from Halassa et al 2007 led to identification of extent to which a single 
astrocyte can interact neurons. Using mouse cortex, Halassa et al 2007 quantified the 
number of synapses which are in contact with a single astrocyte, and found that 100,000 
synaptic connections were formed by a single astrocytes (Michael M Halassa et al. 2007; 
Farhy-Tselnicker & Allen 2018). This showed that astrocytes can influence and modify 
the working of neural circuitry and signalling in a more direct way.  
 
One of the most direct way that an astrocyte can influence neural activity is through the 
release of transmitters (Savtchouk & Volterra 2018). The transmitter which are released 
from astrocytes are termed gliotransmitters and astrocytes have been shown release all of 
the transmitter which are released by neurons (Zorec et al. 2012; Petrelli & Bezzi 2016; 
Zorec et al. 2015; Savtchouk & Volterra 2018). This places astrocyte right at the centre of 
mediating activity in the brain. Astrocytes membrane currents are passive and they 
display no ability to generate action potentials (Dallérac et al. 2013). Given these 
findings, the majority stance was that astrocytes were silent support elements in the brain. 
As astrocytes are incapable of generating action potentials, their excitation cannot be 
revealed via conventional methods such as, electrophysiology (Dallérac et al. 2013). 
Several key observations in the early 90's, provided evidence that calcium, rather than 
electrical signalling is a substrate for astrocyte excitability. When activated by internal or 
external signals, calcium waves were observed (Henneberger et al. 2010) (Hennebereger 
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et al 2000) and these waves led to the release transmitters (gliotransmission) (Araque et al 
1999). 
 
Calcium signalling and generation of calcium wave is important for astrocytes, as it is an 
important method of communication (intercellular) and influencing the environment 
around them (intracellular) (Navarrete et al. 2013; Bazargani & Attwell 2016). The 
complexity and mechanisms of astrocyte calcium signalling are only recently beginning 
to unravel, however full comprehension of its nature compared to neuronal signalling is 
still in its infancy (Volterra et al. 2015; Bazargani & Attwell 2016; Savtchouk & Volterra 
2018). Calcium waves have been observed in cultured astrocytes after stimulation by 
various methods, including application of glutamate (Innocenti et al. 2000), ATP (Guthrie 
et al. 1999), endothelin-1 (Venance et al. 1997), noradrenaline (Tordjmann et al. 1997), 
and mechanical stimulation by poking with a pipette tip (Lee et al. 2015). The mechanism 
of calcium wave propagation from the stimulated cell to adjacent regions has generally 
been identified to be from two potential pathways: 1) the autocrine/paracrine activation of 
metabotropic P2 purinergic receptors (Pascual et al. 2005), and/or 2) through the 
diffusion of inositol 1, 4, 5-trisphosphate (IP3) through open gap junctions and ionotropic 
P2 purinergic that connect adjacent astrocytes (Kaja et al. 2014) (Yamane et al. 2002). 
The exact interplay between the two mechanisms seems to depend on culture conditions 
and the ostimulating event (Scemes & Giaume 2007). For example, Salter and Hicks 
1995, provided evidence of extracellular ATP activating metabotropic or ionotropic 
purinergic receptors, causing an elevation of intracellular calcium in astrocytes. Using 
whole patch clamp recording on wistar rat cultures, they showed that application of ATP 
led to an elevation of intracellular calcium, and release of gliotransmitters (Salter & Hicks 
1995).  
 
1.5. ATP and Purinergic receptors 
  
A greater appreciation has been developing for the importance of ATP signalling in 
physiological and pathological brain function. As mentioned above, extracellular ATP 
activates the P2 purinergic family of receptors  (Burnstock et al. 2010). There are two 
major groups of P2 receptors: P2X, which are ion channels, and P2Y, which are 
metabotropic G-protein coupled receptors (Bernstein et al. 1998; Burnstock et al. 2010; 
Pascual et al. 2016). P2X receptors are ionotropic with two transmembrane domains. 
There are seven cloned P2X subtypes; P2X1-7, which all respond to ATP as their 
endogenous agonist. P2X receptors act as cation channels and upon activation by ATP, 
allow the flow of sodium, potassium and calcium. This causes depolarization of the cell 
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membrane, which in turn can open calcium channels (Vizi et al. 2006; Suadicani et al. 
2009). P2X1-6 are all very similar in structure while P2X7 has an elongated intracellular 
peptide sequence. When exposed to ATP it initially functions as the other P2X receptors, 
however if the ATP exposure is prolonged its pore enlarges and larger molecules can 
flow through. 
 
P2Y receptors are G-coupled with seven transmembrane spanning domains. There are 
eight P2Y receptor subtypes that have been cloned; P2Y1, P2Y2, P2Y4, P2Y6 and 
P2Y11 through P2Y14 (Fam et al. 2003; Gallagher & Salter 2003; Puchałowicz et al. 
2015). P2Y receptors respond to a more varied array of endogenous agonists, including 
ATP, ADP and even uridine nucleotides UTP and UDP. The strength of response to these 
agonists varies by receptor subtype, which is sometimes used for subtype identification. 
For instance, if a cell exhibits a physiological response to ATP and UTP, but not ADP 
then the responsible receptor is likely either P2Y2 or P2Y4. G-proteins utilized by P2Y 
receptors are Gi, Go, Gs, Gq/G11, G/G12 and Gi/Go (Centemeri et al. 1997; Gallagher & 
Salter 2003). Some P2Y receptor subtypes have specific G-proteins they associate with, 
but many can associate with multiple. For example, the P2Y2 receptor can activate Go, 
Gq/G11 and G12. Stimulation of these G-proteins by recombinant P2Y receptors can 
either activate phospholipase C (PLC) or adenylate cyclase, causing intracellular calcium 
release or changes in cAMP levels, respectively (Venance et al. 1997).  
  
Extracellular ATP can activate calcium responses from astrocytes and is the primary 
signalling molecule in astrocyte communication (Guthrie et al. 1999; Anderson et al. 
2004). In addition, ATP is involved in mediating the release of neurotransmitters through 
several different signalling mechanisms (Centemeri et al. 1997; Tang et al. 2015). ATP 
activation of P2X7 receptors, which are found in large numbers on astrocytes, can lead to 
the release of glutamate (Fellin 2009; Kang & Othmer 2009). In addition, the activation 
of several P2Y receptors, and, specifically, the P2Y1 receptor, can cause the release of 
glutamate from astrocytic vesicles in a PLC-mediated calcium-dependent manner 
(Burnstock et al. 2010). ATP activation on astrocytes can also cause the release of 
addition ATP, as mentioned above (Anderson et al. 2004). In this way, astrocyte 
activation can have a direct effect on the environment they encompass (Hashioka et al. 
2014). 
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2. Aims of the study	
	
The in vitro generation of astrocytes stem cells has reached a state where the cells can be 
considered for clinical applications. However, remaining research needs to work toward 
protocols that provide standardised sets of cells which capture the process of 
astrocytogenesis in vitro. To do this, the cell population will need to be characterised for: 
(a) Excess of positive and negative markers (b) for maturity - by using markers, and gene 
expression profiling which measure astrocyte at different stages of development (c) 
function - by functional assays like looking at calcium dynamics or receptor specific 
dynamics. To our knowledge, the field still lacks sufficient standardisation of the 
available protocols. The available protocols have drawbacks such as: (a) some of the 
protocols do not provide sufficient detail for reproduction, or deviate away from 
capturing astrocytogenesis (b) astrocyte purity and maturity is not comparable to that 
obtained with primary or in vivo astrocytes (c) there are technical issues that prohibit 
widespread use, even though the protocol may be suitable (e.g., long-term induction, or 
long term generation >100 days of astrocytes) and (d) the emerging astrocytes are often 
poorly characterised (e.g., are only stained GFAP), but hardly for maturity markers, 
regional identity, negative markers and additional astrocyte functional characterisation. 
For this reason, there was no protocol when this study was being conducted that was the 
gold standard for astrocytogenesis. As depicted in Table. 1 plethora of studies (16 at the 
time of the literature review) utilised ESC’s, and verified the need for further protocol 
optimisation and for better characterisation and standardisation of the resultant cell types.  
The present work aims to contribute and reduce the time taken towards generation of 
astrocytes from stem cells. By using mouse embryonic stem cells (mESC), the 
developmental transition of astrocytes, similar to what is seen during gliogenensis in vivo, 
can be fully captured and assessed. Therefore, initially the work will focus on the 
question of how to generate astrocytes from embryonic stem cells. These generated cells 
will be characterised with respect to their phenotypic and genetic features. Subsequently, 
once characterised these generated astrocytes will be subjected to functional analysis via 
assessing their ability to generate calcium dynamics – observed via calcium imaging. 
Furthermore, the main pathway/s in which the generated astrocytes influence and govern 
calcium activity will also be tested across the developmental day in vitro (DIVs). Lastly, 
once characterised the generated astrocytes will be subjected to multiple isolation 
protocols, and characterised again post isolation. This is essential for future storage 
(creating a cell bank) and testing integration ability of the generated astrocytes in multiple 
cell assays.  
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3. Generation of astrocytes from embryonic stem cells  
 
3.1. Introduction  
 
Neurons have been for long the major neural cell type differentiated from stem cells. 
Plethora of developmental pathway based protocols have been put utilised to generate 
several functional neuronal subtypes ranging from cortical dopaminergic, cholinergic, 
GABAergic, glutamergic neurons, cerebellar purkinje neurons to spinal motor neurons 
(Peljto et al. 2010). The generation of subtypes of astrocytes from stem cells has been 
greatly limited due to lack of our understanding about their specification and consistent 
markers (Bayraktar et al. 2015). Also, there are no well described markers or assays to 
differentiate the subtypes of astrocytes (Imura et al. 2006; Bayraktar et al. 2015). 
Additionally, most of the studies reporting the generation of astrocytes rely on the 
expression of GFAP which is not ubiquitously expressed in all astrocytes (Eng et al. 
2000). Studies done for establishing differentiation of stem cells towards astrocytes show 
a long culture time required for their acquisition of gliogenic potential (Krencik et al., 
2011, Roybon et al., 2013, TCW et al. 2017). Although, these protocols have successfully 
generated astrocytes which closely resemble the in vitro counterparts, till date there is no 
well-defined and commodious protocol for the generation of well characterised astrocytes 
and their subtypes in a quick and efficient manner.  
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Table 1: Studies which use stem cells to derive and differentiate astrocytes. The arrow 
indicates starting of the study to contribute towards standardisation of protocols. 
 
3.1.1. EB’s and spontaneous emergence of astrocytes  
 
To mimic the in vivo mechanisms governing early neurogenesis, two major classes of 
protocols are utilised: an EB-based technique and a single cell monolayer-based method. 
The 3D aggregation system is thought to better maintain the “stemness” of stem cells and 
to allow better cell-to-cell and cell-to-matrix interactions (Sloan et al. 2017). Other vital 
considerations for improved neural cultures are media composition, exogenous growth 
factors or small molecules, and most importantly the timing of the procedure itself 
(Molofsky & Deneen 2015). Zhang et al 2001 was the first to develop a novel technique 
to isolate and culture human astrocytes in serum-free conditions, thus recapitulating the 
resting, non-reactive state normally observed in healthy astrocytes in vivo. The group 
differentiated 3D spheres, now known as Embryoid Bodies (EBs), in chemically defined 
medium containing FGF-2, which later form neural rosettes. By day 7, almost all EBs 
expressed neural progenitor cells and neural stem cells markers, confirmed by the 
expression of neural markers nestin. Subsequently the prolonged culture of the protocol 
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led to the development of GFAP positive astrocytes. Later other EB based differentiation 
studies were published (Reubinoff et al. 2000; Carpenter et al. 2001). In one of the 
protocols by Carpenter et al 2001, EBs were differentiated into neuronal progenitors in 
the presence of retinoic acid (RA) along with selective morphogens (Carpenter et al., 
2001). All of the studies obtained populations with a wide panel of morphological 
characteristics, positive for neuronal and astrocyte progenitors and led to the usage of EB 
culture system in vitro to model developmentally relevant culture system to generate 
neuronal and astrocyte subtypes (Tabata 2015). 
 
Astrocytes can also emerge spontaneously in cultures by the “spontaneous emergence 
approach”. For example, human iPSC-derived NPCs have been differentiated toward 
various neuronal lineages such as cortical neurons  (Shi et al. 2012; Chandrasekaran et al. 
2016), and spinal MNs, where astrocytes and oligodendrocytes frequently appear as 
secondary by-products in these preparations, however, the efficiency is low and not 
reliable. A recent study showed the emergence of endogenous astrocytes from neuronal 
cultures via increased expression of the glial fibrillary acidic protein (GFAP), at day 100, 
with confirmation through the NanoString platform (Muratore et al. 2014). Other groups 
have also confirmed the emergence of astrocytes with long-term differentiation of 
hiPSCs-derived neural progenitors and primary stem cells (Shi et al. 2012; Espuny-
Camacho et al. 2013). However, all of these protocols are complex in methodology 
replication and astrocytes that are produce have fewer functional properties such as: being 
immunoreactive (Roybon et al. 2013), reduced ability to form synapses (Boehler et al. 
2008; Tyzack et al. 2016) than their in vivo counterparts.  
 
3.1.2. Generation of astrocytes from stem cells  
 
Recent advances in understanding the complex molecules involved in astrocytogenesis 
has enabled in vitro protocols to produce astrocytes efficiently from stem cells. Several 
studies have utilised embryonic and neural stem cells from a variety of species, ranging 
from human to mice, to mimic and confirm in vivo astrocytogenesis (Table 4) (Roybon et 
al 2017, TCW et al 2017). Nevertheless, replication of astrocytogenesis in vitro has 
shown to be more challenging than previously thought (Rajan & McKay 1998; Reubinoff 
et al. 2000; Zhang et al. 2001; Barberi et al. 2003; Tabar et al. 2005). The current 
challenge is to further clarify the developmental mechanisms of astrocyte generation and 
establish simple and efficient protocols to unravel complexity in astrocytes (Uzzaman et 
al. 2005; Johnson et al. 2007; Emdad et al. 2012; Juopperi et al. 2012). As differentiation 
of human embryonic stem cells to astrocytes is much more complicated compared with 
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mouse systems and current protocols for the generation of astrocytes require long-term 
cultures (Palm et al. 2015; Li et al. 2018). Thus, for studies and considering the limited 
time available to dully unravel the complex process of astrocytogenesis, astrocytes 
generated from murine stem cells are still the best approach. Here, we describe the 
derivation of astrocytes from mouse embryonic stem cells mESC to produce a protocol 
which contributes towards standardisation of protocols to generate astrocytes. 	
 
The derived protocol combines and alters two existing protocols from Peljto et al 2010 
and Keugler et al 2012 to accelerate astrocytogenesis. The rationale behind using and 
coalescing these two protocols are the following: both protocols utilise mESCs and do not 
use and transgenic manipulation, Peljto et al 2010 does not use excessive morphogens – 
to induce semi-spontaneous emergence of desired cells, and neuralises (directs cells into 
neurons) mESCs in short timeframe compared to other published protocols using mESCs 
(Ban et al 2001), and Keugler et al 2012 protocol uses 3D aggregation method which 
closely mimics in vivo astrocyte development. Further to this, both protocols use key 
factors (morphogens) such as retinoic acid (RA), heparin and N2, at crucial time points to 
develop desired cells. In addition to all of the above, Keugler et al 2012 develops 
astrocytes which are also GFAP negative in expression. Therefore, for the acceleration of 
neurogenesis and development of heterogeneous population of astrocytes, these two 
protocols were altered and used. 
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3.2 Method and Materials  
 
3.2.1. Materials 
 
Table 2: Materials used for generation of mESCDA 
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3.2.1. Maintenance of murine embryonic stem cell line 
 
The murine embryonic stem cell (mESC) (line derived from Mus musculus, strain 129) 
were used for all of the experiments.  
 
Media Recipe 
 
mESC media 
 
• DMEM 
• 10% Foetal bovine serum (FBS)  
• 1% Penicillin/Streptomycin  
• 1% L-glutamine  
• 100uM 2- Mercaptoethanol  
• 1000units/mL - Leukaemia Inhibitory Factor  
 
Step by Step method for maintenance and passaging 
 
1. T-25 flasks were coated with 0.1 geltain (diluted in PBS) 2 hours before 
experimentation  
2. Gelatin coated flasks were rinsed with 5mL of PBS twice  
3. When the mESC reached confluence, 2mL of Trypsin/EDTA was added and cells 
were gently agitated the cells until they formed a suspension 
4. After 2 minutes, 3 mL of mESC media was added to neutralise the trypsin 
5. Cells were transferred to a 15mL falcon and centrifuged for 5 minutes at 180 Rcf 
and acceleration of 4.  
6. Supernatant was aspirated and mESC were resuspend in the pellet in an 
appropriate volume for the split ratio of 1:8  
7. An even suspension was ensured by gently pippeting up and down, five or six 
times 
8. Media was changed every other day and flask assessed every day for confluency  
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3.2.2. Incubation and generation of embryoid bodies – a push towards neural lineage 
 
Cultures of mESC were used when they reached 80% confluency, with a serum based 
media containing DMEM and FBS with 1uM of LIF to prevent spontaneous 
differentiation. 
 
Media Recipe 
 
Aggregation Medium (ADFNK) 
 
• Advanced DMEM/F12 – Neurobasal (1:1) 
• 10% Knockout Serum Replacement 
• 1% Penicillin/Streptomycin   
• 1% L-Glutamine 
• 100uM 2-Mercaptoethanol 
•  
Step by step method 
 
1. Confluent flask of mESC cells (around 80%) was taken and medium aspirated 
from the flask. 
2. The flask was then washed in 5 ml PBS. 
3. PBS was aspirated and cells in flask were exposed to 2 mL Trypsin/EDTA for 2 
minutes 
4. Flask was gently agitatated until top layer of mESC cells were detached 
5. Trypsin/EDTA was inactivated with 3 mL mESC media (See above) and the 
lifted cells were transferred to a 20mL universal tube. 
6. Cells were centrifuged for 5 minutes at 180g 
7. Supernatant aspirated and cells were resuspend cells in 2mL ADFNK medium 
8. Cells counted haemocytometer 
9. Cells were seeded in mESC cells in ADFNK medium, at a density from 2 x 104 
to 2.5 x 105, (recommended 50,000 cells/mL) in either non-tissue culture treated 
6-well plates or petri dishes. For a petri dish, 500,000 cells per 10 mL is 
sufficient. 
10. Cells were incubated at 37°C for 2 days, by which time aggregates were formed 
and found to be floating in the medium. 
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11. After 2 days EBs were exposed to fresh ADFNK media containing either 
containing retinoic acid (RA) at 1uM or no retinoic acid (depending on the 
methodology required and tested, see results). Media was also changed to remove 
non-EB formed cells and any debris 
12. At day five, if RA was added it was removed and fresh ADFNK media was 
added by transferring medium containing EBs to a 15 mL centrifuge tube. The 
EBs were allowed settle under gravity.  
13. The supernatant was aspirated and EBs were gently re-suspend in fresh ADFNK 
media and transferred to petri dish for further incubation  
14. At DIV 6 EBs were ready for further experimentation  
 
3.2.3. Differentiation of mESC into Astrocytes (mESCDA) – single cell and EB based 
methods 
 
The process of differentiation tried to recapture astrocytogenesis. For differentiation of 
astrocytes, both a single cell monolayer and EB based technique was used (Chandrasekan 
et al 2016). Both methodologies, employed an altered astrocyte differentiation media 
(Keugler et al. 2012).  
 
Media Recipe  
 
mESCDA media 
 
• ADMEM/F12 
• 2% FBS 
• 1% N2 (x100) 
• 1% L-glutamine 
• 1% Pen/Strep 
• 100uM β-mercaptoethanol  
• 50ug/mL heparin  
 
Step by step single cell method   
 
1. Laminin coated glass coverslips for 12/24 well plates were prepared by adding 
2µg/cm2 laminin in PBS for 2 h at 37°C  
2. After 2 hours, coverslips were washed 2x with PBS and coverslips incubated 
overnight 
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3. Generated DIV 6 EBs were removed from plates and suspended onto 15mL 
falcon.  
4. Media was aspirated and EBs were suspended in Trypsin/EDTA and incubated 
for 60 seconds to allow EBs to dissociate   
5. To neutralise the trypsin, cells were suspended in mESCDA media 
6. Cells were the passed through 70 µm cell strainer to ensure efficient removal of 
EBs which were not properly dissociated  
7. Cells were centrifuged at 180 Rcf for 5 minutes  
8. Supernatant was removed and cells were re-suspended in mESCDA media 
9. The incubated coverslips were washed 2x with PBS 
10. Cells were plated at a density of 50,000 cells/cm2 in 12/24 plates coated with 
2µg/cm2 laminin  
 
Step by step EB based method   
 
1. Similar to above, laminin coated glass coverslips for 12/24 well plates were 
prepared by adding 2µg/cm2 laminin in PBS for 2 h at 37°C  
2. After 2 hours, coverslips were washed 2x with PBS and coverslips incubated 
overnight 
3. Generated DIV 6 EBs were removed from plates and suspended onto 15mL 
falcon.  
4. Media was aspirated and EBs were re-suspended in mESCDA media    
5. 10-20 intact EB’s were directly plated in 12/24 plates coated with 2µg/cm2 
laminin  
 
 
3.2.4. Immunocytochemistry and image acquisition  
 
Images were taken using an Axio Imager microscope (Zeiss, Germany). 
Separate digital images (red 568nm, green 468nm, blue 350nm - RGB) of astrocyte stains 
(green and red light) and DNA (Hoechst 33342) were captured with a ×20 objective 
(1040x1388 pixels) from the same nine non-overlapping microscopic fields per well 
AxioCam CCD digital camera (Carl Zeiss) mounted to an inverted AxioVert 135 Carl 
Zeiss epifluorescence microscope. Focus was adjusted for each new field, but fluorescent 
illumination and exposure were kept constant to improve consistency during analysis. 
Scale bars were calibrated using AxioVision software (release 4.6.3; Carl Zeiss). Files 
were saved in tagged image file format (.tif) and JPEG (.jpeg). 
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Table 3: Antibodies and their concentrations used for immunohistochemistry 
 
Primary antibody process 
 
1. Remove the media in which cells were incubated in and wash coverslips with 
PBS x 3 
2. Coverslips were incubated with 1 ml of paraformaldehyde (PFA) and left to 
incubate at room temperature for 30 mins  
3. Coverslips were washed again three times with PBS 
4. Once washed 400ul of Triton was added. (Note that Triton is x100 concentrated 
(we need around 0.02% of triton - therefore add 200ul of triton in 10ml of PBS) 
5. Samples were placed on the rocker for 10 mins and washed again with PBS three 
times. 
6. 10% Goat serum was prepared. (2.5ml of goat serum in 25ml of PBS) and 
coverslips were incubated for 2 hours.  
7. Desired antibodies (Table 2) in 10% goat serum 
8. Petri dishes were prepared. Briefly: cut out a circle of tissue and place it inside 
the petri dish. Slightly wet the circle of tissue; to keep it stabilised in the Petri 
dish, and cover the circle of tissue with parafilm to create a hydrophobic later. 
Label the petri dish. 
9. The antibodies were made at the desired concentrations (Table 2)  
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10. Using fine tip forceps, coverslips were removed from the well plate and placed it 
on the earlier prepared petri dish 
11. Antibodies was directly applied on the coverslip - add around 150ul.  
12. Samples were incubated overnight in the fridge.  
 
Secondary antibody process 
 
1. Fresh 10% goat serum was prepared   
2. Petri dishes with primary incubated coverslips were washed with PBS  
3. Once washed 150ul of secondary antibodies (Table 2) was added onto the 
coverslips 
4. The coverslips were incubated secondary antibody for 2 hours at room 
temperature - the samples are wrapped in foil to prevent any light coming in 
5. Hoechst was prepared at the concentration of 1:1000  
6. After secondary incubation, coverslips were washed 3 times with PBS.  
7. After washings, Hoechst was added and coverslips incubated for 1 mins and 
washing process was repeated  
8. Microscope slides were washed with 70% ethanol to clean and remove debris  
9. Once microscope slides were cleaned, a small drop (10ul) of mounting media 
was added in the middle of microscope slide 
10. Coverslips were removed with fine tip forceps and placed onto the 
microscope slide  
11. Coverslips were left to dry - nail polish around the coverslip was added to 
prevent the coverslips from moving around 
12. Samples were stored in slide box in the fridge in the dark for analysis 
 
3.2.5 Image analysis for quantification and co-localisation of cell body and nuclei  
 
All of the image analysis was initially performed manually, utilising ImageJ (NIH - 
National Institutes of Health), and later were performed on bespoke algorithms using 
MATLAB. For analysis of cell body and nuclei, images were split into individual 
channels from RGB (red 568 nm and green – cell body 488 nm, Blue – Nuclei (Hoescht). 
To analyse these images, we developed a workflow (See appendix). Initially, the images 
were thresholded utilising the Otsu method of thresholding (Vala & Baxi 2013) to 
remove any potential uneven illumination. Additionally, debris and unwanted cellular 
artefacts were also removed. Finally, original image was overlaid on top of the altered 
image and Pearson’s correlation analysis was performed to assess its distance to the 
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original image. The altered image was then analysed for astrocyte stain positive cells and 
percentage area covered by astrocyte positive cells (see Appendix). Co-localisation 
analysis was performed on co-localised astrocyte positive stains manual counting. 
Percentage co-localised cells was assessed by measuring the number of co-localised 
cells/number of total cells multiplied by 100.  
 
3.2.6. Reverse Transcription Polymerase Chain Reaction  
 
Total RNA was isolated using the QIAGEN RNeasy Kit according to the manufacturer’s 
instructions (see step by step below). Eluted RNA was measured in a spectrophotometer 
and purity ensured by 260/280 nm ratio of greater than 1.95 for all samples. Each RNA 
sample was treated with DNase I from the RNeasy Kit, to eliminate any genomic 
contamination. The QIAGEN QuantiTect Reverse Transcription Kit was used to 
transcribe 1µg of RNA to cDNA. PCR was conducted with the DreamTaq Green PCR 
Master Mix (ThermoFisher). The protocol consisted of an initial denaturation step at 
95°C for 2 min and 35 cycles of: i) denaturation step 30 s at 95°C, ii) annealing step 30 s 
at 55°C and iii) extension step 1 min at 72°C. A final extension step of 5 min at 72°C was 
conducted at the end. Separation of PCR products was performed in a 1% agarose gel via 
electrophoresis and visualization was done with SYBR safe DNA gel stain 
(ThermoFisher). Digital photographs of the gels were taken with the Syngene U Genius 3 
System (SLS) and cDNA levels relative to the housekeeping gene Gapdh were calculated 
using PCR band densitometry (See Appendix).  
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Table 4: RT-PCR: Primers used for each tested gene 
 
Primer design and optimisation 
 
Genes were chosen for validation from categories that were enriched in both the 
symptomatic and the late-stage time-points. Primers were designed for genes of interest 
using the Primer Blast tool from NCBI (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) 
(Table 3).  Primers were designed to produce amplicons of 50- 150bp in length and to 
overlap an exon boundary. If an exon boundary could not be overlapped controls were 
used which had received no reverse transcriptase enzyme during cDNA synthesis, thus 
checking for the presence of genomic DNA. Primers were ordered from Sigma Aldrich at 
a synthesis scale of 0.025µmol and desalt purification and were kept at a stock 
concentration of 100µM at -20°C according to manufacturer’s instructions.  
 
 
Purification of Total RNA from Animal Cells using Spin Technology 
 
1. Buffer RPE is supplied as a concentrate. Before using for the first time, 4 
volumes of 100% ethanol was added as indicated to obtain a working solution  
2. Cells were harvested via cell scraping (see chapter 4)  
3. Cells were disrupted by adding 600 µl of supplied Buffer RLT to lyse the cells 
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4. Lysate was pippeted directly into a QIAshredder spin column (supplied) and 
centrifuge for 2 min at full speed at a table top centrifuge 
5. 600mL of ethanol was added to the lysate and mixed well by pippeting  
6. 700µl of the sample, including any precipitate that may have formed, was 
collected to an RNeasy spin column placed in a 2 ml collection tube (supplied).  
7. Lid was closed gently, and the spin column was centrifuged for 15 s at ≥8000 x g 
(≥10,000 rpm). Flow-through was discarded post centrifuge.  
8. Post centrifuge, the column was collected and 700µl Buffer RWI was added and 
centrifuged at 15 s at ≥8000 x g (≥10,000 rpm) 
9. After centrifugation, spin column was removed from the collection tube and new 
collection tube was used 
10. 500µl of Buffer RPE was added to RNeasy spin column and centrifuged for 15 s 
at ≥8000 x g (≥10,000 rpm) – this was repeated again 
11. The RNeasy spin column was placed in a new 1.5 ml collection tube (supplied).  
12. 30–50 µl RNase-free water directly added to the spin column membrane and 
centrifuge for 1 min at ≥8000 x g (≥10,000 rpm) to elute the RNA   
13. Eluted RNA was measured by NanoDrop™ 2000/2000c Spectrophotometer 
(Thermo) 
 
Reverse Transcription with Elimination of Genomic DNA for PCR  
 
1. Genomic DNA elimination reaction was prepared by mixing 2µl of supplied 
gDNA Wipeout Buffer, with 1µg of RNA and RNAse free water with total 
volume of 14µl 
2. The reaction was incubated for 2 min at 42°C. Then place immediately on ice 
3. Reverse-transcription reaction components were prepared by combining supplied 
1µl Quantiscript Reverse Transcriptase, 4µl Quantiscript RT Buffer, 1µl RT 
Primer Mix  
4.  Template RNA from step 1 (14 µl) was added to component transcription master 
mix 
5.  Using a thermal cycler, the cDNA was made by incubating the prepared sample 
for 15 min at 42°C   
6. Then the thermal cycler was switched to 95°C for 3 min at to inactivate 
Quantiscript Reverse Transcriptase reaction   
7. Samples were stored at –20°C for further experiments  
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Preparation of PCR mixture 
 
1. Thermo ScientificTM DreamTaqTM Green PCR Master Mix (2X) was used to 
prepare PCR mixture 
2. 25µl of Green PCR Master Mix was added with 1µl of forward primer, 1µl  of 
reverse primer, 10µl of template DNA and nucleus free water to make up final 
solution of 50µl   
3. Sample was gently vortexed and PCR was performed on a thermal cycler for 
denaturing, primer annealing, extension and final extension steps 
• Initial denaturation step for 3 minutes at 95°C with 1 cycle  
• Denaturing step for 30 seconds at 95°C 
• Annealing step for 30 seconds for primer melting temperature of 65°C 
• Extension step for 30 seconds at 72°C   
• These steps were performed at 35 cycles  
• Final extension step for 15 minutes at 72°C 
 
Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used for the separation of DNA fragments according to 
their size in an agarose gel matrix. This method was employed to confirm the specificity 
of amplified PCR products as well as for restriction analysis of expression and reporter 
DNA constructs.  
 
1. Agarose gel density of 1-2% agarose was prepared by melting agarose in 100 ml 
of TBE buffer  
2. 5 µl (0.5 µg/ml) of ethidium bromide was added to the agarose to stain the DNA 
fragments.  
3. The resultant solution was poured in an electrophoresis chamber. 
4. Samples (PCR products and DNA ladder) were loaded into the gel pocket 
5. Electrophoresis was carried out at 100 V for approximately 1 hour.  
6. The Invitrogen DNA ladder (Invitrogen) was used to verify the size of the 
separated DNA fragments. 
7. DNA samples were visualised using Syngene U Genius 3 System (SLS) and 
cDNA levels relative to the housekeeping gene Gapdh were calculated using 
PCR band densitometry 
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2.2.7 Statistical Analysis  
 
Experiments with immunofluorescent labelling and PCR were performed in triplicates. In 
each experiment 3 glass coverslips for each timepoint (7, 14, 21 and 28 DIV) were 
cultured and fixed and 9 images were collected from each glass coverslip (27 images 
were analysed per timepoint per experiment). Immunofluorescence and gel analysis was 
performed using bespoke MATLAB algorithms (see appendix) and published algorithms 
via Image J. Furthermore, to confirm algorithm specificity gel densomitary for gel 
electrophoresis, and cell profiler for immunocytochemistry was used (Livak et al., 2001). 
Data are presented as means +/- SEM and the statistical differences were tested by 
Unpaired T-Tests, ANOVA with Bonferroni’s Multiple Comparison post-hoc or Mann-
Whitney tests where appropriate, using GraphPad Prism 6.0 (Graphpad Software, La 
Jolla, CA). Statistical significance was assumed when P<0.05, and was indicated by an 
asterisk on the respective data point in figure. Two asterisks indicated P<0.01 and three 
P<0.001.  
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3.3. Results 
 
3.3.1 Critical conditions for the development of astrocytes from mouse embryonic 
stem cells 
 
The conditions for generating and culturing stem cells to develop astrocytes in vitro show 
a high degree of variability. Limitations such as growth factor concentration and 
combination, incubation period, and type of surface substrate used are all factors 
influencing the development of cells (Falsig et al. 2004; Krencik & Zhang 2011). These 
limitations could be overcome by identifying optimal methods which best mimic 
astrocyte development occurring in vivo (Molofsky & Deneen 2015; Tabata 2015). 
Derived mouse embryonic stem cells (mESC) were initially subjected to different culture 
conditions: spontaneous emergence, semi-directed, 3D aggregation, or mono-layer 
methodologies, to identify the best approach for generating astrocytes (mESCDA) 
(Carpenter et al. 2001; Chandrasekaran et al. 2016). 
 
Figure 4: Monolayer methodology for astrocyte development. (A) Single cell seeding of 
mESC for astrocyte development failed to form clusters required. (B) Nestin stain was 
used for cell immaturity and immunoflouresence show attached cells are nestin postive 
(C) GFAP was used to confirm astrocyte presence and GFAP positive cells are seen - 
however they sparsely labelled. C: Analysis reveals attached cells unclustered cells are 
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significantly postive for nestin instead of GFAP. Cultures have been counterstained for 
cell nuclei marker H- 33342 (blue stain). Scale bar = 20µm. All data are expressed as 
mean ± SEM from three separate experiments, *P < 0.05, **P < 0.01, ***P < 0.001) from 
Unpaired T statistical test.  
 
Each method tested used a reformed version of established protocols from Peljto et al 
2010, and Keugler et al 2012 (Peljto et al. 2010; Keugler et al. 2012). The expression 
level of astrocyte marker GFAP, via immunofluorescence, was used to observe the 
emergence of astrocytes and also used to confirm the endpoint for each method 
(Carpenter et al. 2001). Firstly, the mono- layer method was implemented (Fig.4). The 
mono-layer method followed 2:3:1 neuralisation protocol, which generated spherical 
embryoid bodies (EB) (Asano et al. 2012; Peljto et al. 2010). 650,000 cells/ml were 
dissociated (via trypsin) from generated EB’s and plated onto laminin- coated coverslips - 
which contained heparin rich astrocyte media altered from Keugler et al 2012. 
Assessment of cultures at DIV 28 revealed poor attachment of neuralised mESC to the 
coverslips (Fig.4A - white arrow). The single cell suspension failed to form clusters 
required for astrocyte emergence and development (Rujano et al. 2004). Almost all cells 
expressed high levels of the neural stem cell marker nestin (Fig.4B-4D <65.77% ± 
4.31%, p<0.05) and held neurogenic potential, this was further confirmed lower than the 
expected expression of GFAP (Fig.4B-4D <10% ± 1.03%) (Conti et al. 2005). This 
subsequently led to using 3D aggregation methodology (direct seeding of EBs) for 
subsequent experiments (Santos et al. 2017).  
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Figure 5: Semi Directed approach leads to mESCDA. Brightfield (A) and GFAP stained 
image (B) of plated Embryoid Body (EB’s). The protrusion and extension of its processes 
and abdication of cells astrocytes from EBs can be seen. (C) Comparison between RA 
treated and non-RA treated reveals a significant increase in GFAP positive cells in RA 
treated cells. Cultures have been counterstained for cell nuclei marker H- 33342 (blue 
stain). Scale bar = 50µm. All data are expressed as mean ± SEM from three separate 
experiments, *P < 0.05, **P < 0.01, ***P < 0.001) from ANOVA with Bonferroni’s 
Multiple Comparison post-hoc or Mann-Whitney tests.  
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The 3D aggregation method contained 2 conditions: 1) following 2:3:1 neuralisation 
protocol, which contained retinoic acid (RA) – semi-directed approach (Fig.5) (Shi et al. 
2012; Peljto et al. 2010) and 2) removal of retinoic acid (RA) from neuralisation protocol 
– spontaneous emergence approach (Fig.5) (Carpenter et al. 2001; Reubinoff et al. 2001; 
Peljto et al 2010). Both conditions generated spherical embryoid bodies (EB), which were 
directly seeded onto laminin-coated coverslips (Fig.5A). The generated EBs attached to 
the surface and extended protrusions in each condition (Fig.5A). These protrusions 
formed a scaffold which allowed EBs to anchor (Goh et al 2013). Immunostaining at 
DIV28 showed GFAP positive astrocytes to emerge from EBs (Fig.5B). The semi-
directed approach, which contained RA, produced significantly more GFAP positive cells 
(Fig.5C. 71.22% ± 8.11% p<0.05) compared to the spontaneous approach (Fig.5C 
21.42% ± 6.21%). Based on these results, all of the experiments performed later for this 
study were carried out using direct EBs seeding method in heparin rich astrocyte media. 
Next, it was essential to determine the suitable number of EBs which would allow the 
successful and accelerated generation of mESCDA (Keugler et al 2012). Low (0-10), 
medium (10-20) and high (20-50) density of EBs were plated onto laminin-coated 
coverslips. Assessment of GFAP positive stain at DIV 28 revealed high-density EBs lead 
to a significantly reduced number of GFAP positive cells (Fig.5D 30.12% ± 4.41% 
p<0.001) when compared to low (0-10) and medium density (10-20). No significant 
difference was observed between low (Fig.5D 77.11% ± 1.13%) and medium (Fig.5D 
79.01% ± 1.85%) EB numbers. Therefore, to maximize astrocyte development and 
provide uniformity in methodology, subsequent experiments were performed on medium 
density EBs, as it provided a slightly higher number of GFAP positive cells.  
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3.3.2. Rapid generation of mESCDA and genetic analysis of differentiated cells  
	
After having established the protocol necessary for mESCDA (Fig.5A), temporal mRNA 
marker expression patterns in cell populations were analysed by reverse transcriptase-
PCR. Migrating cells on the laminin-coated coverslips were harvested via cell scraping 
methodology (see chapter 4) and total RNA was extracted and screened for the genetic 
expression of markers was assessed temporally (DIVs 7-28) post seeding (Cahoy et al. 
2012) (Table 1). Firstly, stem cell pluripotency gene, Nanog was assessed. Nanog 
expression was at its highest at DIV 7 (Fig.5C 13.92% ± 1.86%, N=3), with a significant 
downregulation at DIV 28 (Fig.5C 2.77% ± 2.6%, N=3), indicating the limited presence 
of stem cells amongst the generated astrocyte population as the cultures progress 
temporally. Additionally, there was absence of neural progenitor gene Nestin (Cho et al. 
2013), microglial marker IBA1 (Hopperton et al. 2018) and oligodendrocyte gene Olig-2 
(Zhou & Anderson 2002) at DIV 7 or later, suggesting absence or non-detectable 
presence of neural progenitors, and macroglial cells during the EB seeding/astrocyte 
induction phase of protocol.  
 
 
Figure 6: Rapid generation of non-proliferating, mature astrocytes from mESC. (A) 
Heterogeneous populations of mESCDA were generated from murine embryonic stem 
cells (mESC) in the presence of RA. EBs were generated and plated in the presence of 
RA, N2 and Heprain on laminin coated coverslips produced heteregenous populations of 
astrocytes. (B,C) Expression of genes of mESCDA across DIVs (from DIV 7-28) 
measured by PCR. Data are given in percent expression relative to the housekeeping gene 
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Gapdh. (C) Nestin, Olig2 (oligodendrocyte lineage transcription factor; neuroectodermal 
marker), IBA1 and Nanog were used as other cell markers (B) GFAP (glial fibrillary 
acidic protein), S100β (S100beta), AQP4 (aquaporin), EAAT2 (Slc1A2, glutamate 
transporter), and ALDH1L1 (aldehyde dehydrogenase) were used as astrocyte markers. 
All data are expressed as mean ± SEM from three separate experiments, *P < 0.05, **P < 
0.01, ***P < 0.001) ANOVA with Bonferroni’s Multiple Comparison post-hoc tests.  
 
Astrocytic markers, GFAP (Eng et al 2000), S100β (Pinto et al 2000), ALDH1L1 (Cahoy 
et al. 2008), and AQP-4 (Szu & Binder 2016), were also investigated. ALDH1L1 is a 
pan-astrocytic marker and an early marker of astrocyte maturation (Eng et al 2001). 
Analysis revealed a significant (p<0.05) upregulation of ALDH1L1 from DIV 7 (Fig. 6B 
67.5% ± 3.6%, N=3) to DIV28 (Fig.6B 120.7% ± 27.5%, N=3,). GFAP, an established 
astrocytic marker, was also upregulated between DIV 7 (Fig.6B 53% ± 11.9%, N=3) and 
DIV 28 (Fig.6B 102.9% ± 28.2%, N=3). In contrast, S100β (Fig. 6B) and AQP-4 (Fig. 
6B) exhibited aberrant expression patterns, with the highest expression at DIV 28. 
Analysis of S100β revealed the characteristic downregulation of the gene at DIV 14, as 
its main role switches from a GFAP conformation regulator to a calcium-binding protein 
(Fig.6B from 32.3% ± 2.04% to 65.9% ± 3.78%, N=3). AQP-4, a water channel protein, 
analysis revealed early expression at DIV 7 (Fig.6B 21.62% ± 2.9%, N=3), with a 
significant downregulation at DIV 21 (Fig.6B 12.04% ± 2.1%, N=3),, and a significant 
upregulation at DIV 28 (Fig.6B 22.73% ± 3.1%, N=3), similar to what is reported in vivo 
(Fallier-Becker et al 2014).  
 
Purinergic receptor specific markers P2YR1, P2X7, endogenous calcium mediating 
receptor marker IP3R2 (Hamilton et al. 2008) and connexing - Cx30 (GJB6) (Pannasch & 
Rouach 2013) were also examined. Expression of these genes was upregulated 
throughout temproally. Differences between DIV 7/DIV14 and DIV 28 were statistically 
significant between of: P2YR1: (At DIV 7 Fig.6B 36.81% ± 3.01%, N=3 - DIV 28 
Fig.6B 176.27% ± 13.11%, N=3, p<0.05) P2X7: (Fig.6B At DIV 7 Fig. 2.27% ± 0.88%, 
N=3 - DIV 28 Fig.6B 27.93% ± 4.12%, N=3, p<0.001) IP3R2: (At DIV 14 Fig.6B 1.38% 
± 0.38%, N=3 - DIV 28 Fig.6B 9.39% ± 1.91%, N=3, p<0.05) and GJB6: (At DIV 7 Fig. 
6B 3.40% ± 1.21%, N=3 - DIV 28 Fig.6B 51.16% ± 10.29%, N=3, p<0.05).  
 
 
 
 
	- 40 - 
3.3.3. Immunocytochemical phenotyping of mESCDA 
 
A time course study of the expression of established astrocytic proteins, using 
immunocytochemistry was also performed. Since a single positive marker, such as 
GFAP, is not sufficient to characterise the extent of astrocyte differentiation, select 
astrocytic markers were used: GFAP (Fig.7), S100β (Fig.11) and ALDH1L1 (Fig.13) and 
astrocyte negative marker Pan-neuronal was used (Fig. 8).  
 
 
 
Figure 7: Immunocytochemical phenotyping of mESCDA. (A) DIV 7-28 fluorescent 
images of astrocytes RA inducted from mESC, labelled for established astrocytic marker 
GFAP. Cultures have been counterstained for cell nuclei marker H- 33342 (blue stain). 
Scale bar = 20µm. 
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Figure 8: Cells negative for neurons: Cells were immunostained at DIV 28 for neuronal 
markers. No neurons were visible when cells were stained for pan-neuronal (A) (left 
panel) and nestin (B) (right panel). (C) Experiment performed on a neuronal protocol 
from Peljto et al. 2010 positively stained for pan-neuronal (mature neurons). Nuclei were 
counterstained with Hoechst (Blue) with H-33342. Scale bar = 50µm.  
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Figure 9: Quantification of GFAP marker expression. (A) Absolute number of marker 
positive cells per mm2. (B) Percent (%) area covered by marker positive cells. (C) 
Percent (%) of marker positive cells. (D) Percent of area covered by an average marker 
positive cell. All data are expressed as mean ± SEM from three separate experiments, *P 
< 0.05, **P < 0.01, ***P < 0.001) ANOVA with Bonferroni’s Multiple Comparison post-
hoc tests.  
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Figure 10: Heterogeneity in morphology of mESCDA. Cultures immunostained for the 
astrocytic marker GFAP, alongside counterstained for cell nuclei marker (blue) with H- 
33342. Scale bar = 20µm. (A) Reveals typical dinnerplate morphology. (B) Displays 
more elaborate morphology with extended protrusions of processes – revealing 
heterogeneity in morphology expression in mESCDA 
	
At DIV 14 approximately half of the cell population was GFAP positive (Fig.9B 52.93% 
± 14.94%, n=9) and exhibited typical astrocytic morphology (Fig.10). This percentage 
significantly increased during the following weeks and plateaued at DIV 28 (Fig.9B 
73.68% ± 9.03%, n=9). Assessment of the relative surface area covered by GFAP 
positive cells revealed a statistically significant increase (p< 0.05) from less than 5% 
surface coverage at DIV7 (Fig.9C 3.88% ± 1.060%, n=9) to more than 40% at DIV28 
(Fig.9C 44.23% ± 5.268%, n=9). The area covered by the average individual GFAP 
positive cell was also analysed at different DIVs (Fig.9D). There was a significant 
(p<0.05) doubling in GFAP positive cell size from DIV 7 (Fig.9D 0.054% ± 0.0057%, 
n=9) to DIV28 (Fig.9D 0.284% ± 0.088%, n=9). Furthermore, heterogeneous 
morphology was also observed within the cultures, morphology ranged from a “dinner 
plate” morphology to an enlarged complex morphology with elongated processes 
(typically seen in primary astrocytes) across all DIVs (Fig.10).  
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Figure 11: Immunocytochemical phenotyping of mESCDA. (A) DIV 7-28 fluorescent 
images of astrocytes RA inducted from mESC, labelled for established astrocytic marker 
S100β. Cultures have been counterstained for cell nuclei marker H- 33342 (blue stain). 
Scale bar = 20µm. 
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Figure 12: Quantification of S100β marker expression. (A) Absolute number of marker 
positive cells per mm2. (B) Percent (%) area covered by marker positive cells. (C) 
Percent (%) of marker positive cells. (D) Percent of area covered by an average marker 
positive cell. All data are expressed as mean ± SEM from three separate experiments, *P 
< 0.05, **P < 0.01, ***P < 0.001) ANOVA with Bonferroni’s Multiple Comparison post-
hoc tests   
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Further to above examination, there was significant decrease in S100β positive cells 
(P<0.05) between DIV 7 (Fig.12B 32.82% ± 4.61%, n=9) and DIV 14 (Fig.12B14.52% ± 
3.29%, n=9). At DIV 28, S100β positive cells recovered and plateaued and maximal 
expression was achieved (Fig.12B 25.04% ± 4.67%, n=9). The relative surface area 
covered by S100β positive cells was highest at DIV 7 (Fig. 12C 13.56% ± 1.55%, n=9), 
with a statistically significant reduction (p<0.05) at DIV 14 (Fig. 12C 7.01% ± 1.78%, 
n=9), which coincided with the decrease in the percentage of S100β positive cells. At 
later DIVs (DIV 21 and 28), cell coverage plateaued. Analysis of area coverage of an 
average individual S100β positive cell showed no significant differences across DIVs and 
was stable at approximately 0.08% (Fig.12D).  
 
 
 
 
Figure 13: Immunocytochemical phenotyping of mESCDA. (A) DIV 7-28 fluorescent 
images of astrocytes RA inducted from mESC, labelled for established astrocytic marker 
ALDH1L1. Cultures have been counterstained for cell nuclei marker H-33342. Scale bar 
= 20µm 
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Figure 14: Quantification of ALDH1L1 marker expression. (A) Absolute number of 
marker positive cells per mm2. (B) Percent (%) area covered by marker positive cells. (C) 
Percent (%) of marker positive cells. (D) Percent of area covered by an average marker 
positive cell. All data are expressed as mean ± SEM from three separate experiments, *P 
< 0.05, **P < 0.01, ***P < 0.001). ANOVA with Bonferroni’s Multiple Comparison 
post-hoc tests 
 
Analysis of ALDH1L1 immunolabelled cultures revealed no significant difference in the 
percentage of ALDH1L1 positive cells from DIV 7 to DIV 28 (Fig.14A-B stable at 
approximately 40%). A non- significant upwards trend was observable on the relative 
surface area coverage (Fig.14C) from DIV 7 to DIV 28, whereas relative area coverage of 
an average ALDH1L1 positive cell remained stable at approximately 0.07% (Fig.14D).  
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3.3.4. Co-localisation of astrocytic markers within mESCDA 
 
 
 
Figure 15: Co-localisation of astrocytic markers (GFAP, ALDH1L1 and S100β). (A and 
B) Cultures co- immunostained for the astrocytic marker proteins GFAP (red), S100β 
(green), and ALDH1L1 (green) counterstained for cell nuclei marker with H- 33342 
(blue). (A) Culture example at DIV 28 of astrocytes co-expressing GFAP (red) and 
ALDH1L1 (green) (red arrow) or expressing only ALDH1L1 (yellow arrow). (B) Culture 
example at DIV 28 of astrocytes co-expressing GFAP (red) and S100β (green) (red 
arrow) or expressing only S100β (yellow arrow). Scale bar = 20µm. (C-D) Analysis of 
co-localisation across different days in vitro reveals heterogeneity of differentiated 
astrocytes in protein expression. Percent differences in staining where (C) 
GFAP/ALDH1L1 and (D) GFAP/S100β stains from DIV 7 to DIV 28. ANOVA with 
Bonferroni’s Multiple Comparison post-hoc tests 
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Astrocytes generated in vitro are not as homogenous in marker expression as previously 
assumed (Matyash and Kettenman 2010). To highlight the existence of subpopulations of 
astrocytes, we performed double-immunolabelling of GFAP with either ALDH1L1 
(Fig.15A) or S100β (Fig.15B) temporally across DIVs (DIV 7-DIV 28). In figures, 15A 
and 15B yellow arrows point to cells expressing only one protein ALDH1L1 or S100β, 
while red arrows point to cells expressing both proteins, in DIV 28 cultures. 
Quantification revealed that not all cells express all astrocytic markers simultaneously, 
illustrating the existence of astrocytic sub-populations (heterogeneity in marker 
expression). Analysis of ALDH1L1 and GFAP co-staining revealed a significant positive 
increase in number of colocalised cells, which was significantly increasing towards the 
late time-points (Fig 15C. DIV 7 14.3% n=9 and DIV 28 42.4% 0.04 n=9, P<0.01). 
S100β and GFAP stains were not significantly different throughout the culture (Fig. 15D 
DIV7 22.51% n=9 and DIV 28 25.31% n=9).  
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3.4. Discussion 
	
	
The study of astrocytes, in their resting state or in different defined activation scenarios, 
faces a number of challenges: 1) measurements in vivo require a distinction of astrocytes 
from sur- rounding cells for the analytical endpoints chosen; 2) ex vivo studies, for 
example using purified adult astrocytes, suffer from a compromised viability of the 
obtained cells, and from undefined activation states, when put in culture; 3) in vitro 
studies mainly rely on studies of mixed populations, prepared from relatively immature 
cells. They may also contain precursor cells, reactive astrocytes and other cell types, such 
as microglia and oligodendrocytes. Additional approaches would thus be desirable to 
further explore astrocyte biology. Here, the result provides an alternative strategy via 
using stem cells, which allows generation of a pure population of non-proliferative, non-
activated astrocytes.  
 
Although stem cell derived astrocyte generation is not a relatively unexplored field, as 
recently new methods of astrocyte generation have been described (Table 4) (Shaltouki et 
al. 2013; Roybon et al. 2013; Zhang et al. 2016, Chandrasekaran et al. 2016; Kleiderman 
et al. 2016, TCW et al. 2017, Xi et al 2018 – see Table), there lacks uniformity in all of 
the protocols. The majority of current protocols are time-consuming, rely on variety of 
morphogens, lack granularity in astrocytic subtype generation and often are not as 
efficient as for example neural induction methods (Ban et al. 2007; Kamnasaran et al. 
2008; Peljto et al. 2010). Therefore, for efficient development of heterogeneous 
astrocytes, there was an effort to improve the established protocols by 1) reducing the 
time frame for astrocytogenesis; 2) preventing excessive use of morphogens and direction 
towards a lineage to produce physiologically relevant astrocytes, and 3) characterise and 
provide evidence of subtype (heterogeneous) generation.  
 
2.4.1 Reduction of timeframe via a semi-directed approach  
 
Two major classes of protocols are usually utilised to mimic the in vivo mechanisms 
governing astrocytogenesis: an EB-based 3D aggregation technique and a single cell 
monolayer-based method (Shi et al. 2012; Chandrasekaran et al. 2016). Here a semi-
directed spontaneous emergence based approach for differentiation of mESC towards 
astrocytes was optimised and developed. Most studies follow a distinct lineage direction 
pattern where from stem cells, exogenous lineage specific morphogens are used to 
develop neural stem cells, and then glial progenitor cells and finally astrocytes (Table 4). 
Here, two established protocols from Pjelto et al 2010 and Keugler et al 2012, were 
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combined and altered, to minimise morphogen application, accelerate astrocyte 
development and contribute towards a standardisation of protocols that exists within the 
literature. The altered protocol led to the generation of heterogeneous populations of 
astrocytes from different time points.  
 
During development, the regional identity (anterior-posterior, dorsal-ventral) of 
astrocytes is determined when neural stem cells are patterned to regional progenitors by 
morphogens such as retinoic acid. The regionalised progenitors first give rise to 
subclasses of neurons and then, during gliogenesis, generate regional-specific astrocytes 
with functionally distinct characteristics (Nakashima et al. 1999; Muroyama et al. 2005). 
Therefore, a combination of extrinsic cues and epigenetic factors contribute to fate 
specification during development. The idea that extrinsic signals are required for 
astrocytogenesis in vitro first arose from the observation that embryonic cortical 
precursors produce neurons when cultured on embryonic cortical slices, but astrocytes 
when cultured on postnatal cortical slices (Morrow et al. 2001). Therefore, by mimicking 
endogenous signalling pathways in vitro is necessary towards an accelerated production 
of astrocytes. 
 
Peljto et al 2010 protocol was essential in the generation of astrocytes, as it provided 
endogenous signalling induced by retinoic acid (RA) that direct the generation of 
specialised cell subtypes with properties that match those of counterpart cells generated in 
vivo. The protocol was initially used for directed generation of motor neuronal subtype 
via the aid of only RA, and no transgenic manipulation (Fig. 8). Therefore, to induce and 
accelerate astrocyte development Keugler et al 2012 protocol was used. By using RA 
alongside heparin and N2 within the cultures, the results showed the accelerated 
emergence of GFAP positive astrocytes from EBs (71% at DIV 28), when compared to 
non-RA treated EBs (from 21% at DIV28) (Fig.5). The findings indicate neuralisation of 
the protocol is essential and RA is a key regulator in inducing astrocyte differentiation 
within the EB (Fig.5).  
 
Retinoic acid performs its actions by activating endogenous signalling pathways and 
creating a feed- back loop to allow endogenous production of RA in an autocrine manner 
(He et al 2005). Pathways such as Bone morphogenetic proteins (BMP) and ciliary 
neurotrophic factor CNTF that suppresses the potential for neural differentiation are 
activated during RA application (Rajan & McKay 1998; Miller & Gauthier 2007; Okada 
et al. 2004) (see literature review chapter 1). BMPs form a complex between the BMP-
downstream transcription factor Smad1 and STATs, bridged by the transcription 
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coactivator p300/CREB-binding protein (CBP), and ciliary neurotrophic factor CNTF 
suppress the potential for neural differentiation by activating (JAK) signal transducer and 
activator of transcription (STAT) (gp130-JAK-STAT) pathway (Hong & Song 2014) all 
of which lead to astrocytogenesis (Asano et al. 2012). This evidence of RA leading to 
these intracellular pathway changes is shown by expression of IL-6 within the cultures. 
IL-6 pathway is a family of cytokines which share membrane glycoprotein gp130 as a 
critical receptor component for activation JAK-STAT pathway required for 
astrocytogenesis (Yanagisawa et al. 2001; Brown et al. 2014). Evidence by Yanagiswa et 
al 2001 show IL-6 expression is elevated to induce astrocyte differentiation. Using 
neuroepithelial cells from mice, the study displayed that IL-6 expression coincided with 
astrocytogenesis, and this increase in expression is necessary to allow formation of BMP-
IL6 complex to induce activation of GFAP promotor leading astrocytogenesis. This is 
shown within the generated mESCDA, where at DIV 7/14 there is increase in IL-6 
expression, and at later DIVs (DIV 21/28) this expression non-existent (Yanagisawa et al. 
2001). The reduced expression of nestin and high expression of IL-6, provides evidence 
towards lineage specification and accelerated astrocyte development by RA application at 
the neurilisation steps (Fig.6). 
 
Alongside, RA Hepran sulphate and its highly sulphated analogue heparin promote neural 
and glial phenotypes  (Pickford et al. 2011). Several studies have demonstrated the proof 
of concept of using heparin to enhance the maintenance of ESCs as well as to stimulate 
their differentiation into therapeutically relevant cell types (Furue et al. 2008; Pickford et 
al. 2011). Given that physiological heparins modulates important cell signalling pathways 
and cell fate, exogenously supplemented heparins have shown to manipulate cell 
signalling and direct cell fate choices of cells during development towards astrocytes 
(Nagayasu et al. 2005). Therefore, to accelerate astrocytogenesis within the cultures, 
heparin rich media obtained from Keugler et al. 2012 was used to develop astrocytes 
from neuralised mESC. This strategy is now widely employed (TCW et al. 2017), 
however during the establishment of protocol Heparin usage for astrocytogenesis was a 
novel route, subsequently preventing the use of further morphogens to direct astrocyte 
differentiation. This semi-directed approach via combination and alteration of two 
established protocols led to generation of astrocyte within 13 days within the cultures, 
confirmed via immunocytochemistry and RT-PCR (Fig.6-14), contributing towards a 
growing need to 1) reduce the time frame for astrocytogenesis and 2) prevent excessive 
use of morphogens and direction towards a lineage to produce physiologically relevant 
astrocytes.  
 
	- 53 - 
2.4.2 Characterisation and evidence of subtype (heterogeneous) generation of 
mESCDA  
 
Heterogeneity of astrocytes derived from rodent brains or from stem cells has been 
underestimated. Astrocyte are a heterogeneous group of cells within the CNS. There 
exists genetic, protein, functional, morphological, and regional heterogeneity (Farmer et 
al. 2017; Xin et al. 2018). In in vitro astrocytogenesis, it has been common in the field to 
strongly rely on a few single markers, such as GFAP (Namihira et al. 2009; Kamphuis et 
al. 2012). Also, morphologically cells are homogeneous cells are mainly developed and 
show a single ‘dinner plate’ morphology (Fig.10) (Olude et al. 2015). Nevertheless, most 
of the published protocols for differentiation of astrocytes from stem cells (independent 
of the use of serum or culture duration) judge differentiation maturity, efficiency and 
subtype generation exclusively via by the expression of GFAP (Krencik & Zhang 2011; 
Palm et al. 2015; Kleiderman 2016). Therefore, for comparison, it was essential to 
perform GFAP analysis on the generated protocol.  
 
GFAP is a type III intermediate filament protein and an important component of the 
astrocyte cytoskeleton (Eng et al. 2000). Here immunocytochemical and PCR analysis 
revealed a significant increase in GFAP positive cells across time (from DIV7 to DIV 
28), which plateaued at DIV 21 (Fig 6). This temporal expression reflects in vivo changes 
seen in GFAP expression. Temporal analysis performed on mouse GFAP mRNA by Riol 
et al 1992 revealed significant increase and a plateau in expression of GFAP during 
development and this GFAP increase coincides with appearance of astrocytes. This 
expression of GFAP mRNA is significantly high at birth and continues to increase, 
donating a period of astrocytic proliferation. Subsequently, during maturation the 
expression of GFAP was shown to be decreased, coinciding with arrest in astrocyte 
population - donating a period of astrocytic morphological differentiation (Riol et al. 
1992). This has also been observed in human by Rezaie et al 2003, where there is 
extensive distribution and presence of GFAP-Positive astrocytes in the human foetal 
brain at 19–20 gestational weeks onwards, which arrests as the brain matures (Rezaie et 
al. 2003). These temporal changes in expression observed here subsequently suggest 
temporal maturity of generated mESCDA, and provide direct evidence of astrocyte which 
are comparable to their in vivo counterparts (Freeman 2010). This temporal analysis of 
GFAP expression has not been performed in recent stem cell derived astrocyte studies, 
therefore the evidence presented here provides an excellent opportunity to revisit GFAP 
expression and assess it with an alternative angle.    
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Additionally, within the cultures heterogeneous morphological populations of GFAP 
positive cells were also observed across DIVs, i.e. at DIV 21 and 28 – where there was 
presence of elaborate star shape morphology alongside reduced protrusions and ‘dinner 
plate’ morphology observed in vitro (Freeman 2010; Olude et al. 2015). However, as a 
general rule, post DIV 14, as GFAP expression started to plateau, GFAP cells began to 
lose their radial and ‘dinner plate’ morphology and adopted a more spongiform/stellate 
phenotype with extended fine protrusions (Fig.6-10), while doubling in size. These 
changes in morphology donates to cell maturity, and dictates presence of subpopulations 
of mature and immature cells present together within the culture (Freeman 2010). 
Additionally, this double in morphology could dictate the presence of reactive astrocytes 
(Kamphuis et al. 2012). Using primary astrocyte cell culture, Kamphuis et al. 2012, 
suggest that an increase in astrocyte cell size and cell morphology and suggests an 
increased in astrocytes activation. Nevertheless, within the generated mESCDA it is safe 
to rule out astrocyte activation due to limited/reduced presence of iNOS and IL-6, 
markers for neuroinflammation and activation, at later DIVs when GFAP expression is at 
its highest.  The assessment here verifies generated mESCDA capability to display 
complex morphologies which are comparable with in vivo and primary astrocytes.  
 
However, expression or absence of single markers cannot sufficiently describe cell 
populations and therefore other approaches had to be developed. GFAP has been proved 
not to be “the marker’ for all types of astrocytes, as it shows weak expression in grey 
matter protoplasmic astrocytes (Tabata 2015), which are the major type of astrocytes in 
the brain, and occupies only which represent ~15% of the total volume of the astrocyte 
(Farmer 2010). Although GFAP is an important endpoint marker to identify mature 
astrocytes, astrocytes can also be identified by the expression of calcium-binding protein 
S100β, ALDH1L1, AQP- 4, ALDH1L1 and additional markers proposed based on 
microarray gene expression profiles  Furthermore, expressions of these markers, as well 
as astrocyte morphologies, vary considerably amongst cortical regions and at different 
time points during development (Emsley & Macklis 2006; Bradley & A 2018), 
suggesting that during in vitro astrocytogenesis, temporal analysis of other astrocyte 
markers is also essential in the identification of astrocyte subtypes.  
 
Developmental studies have shown that the sequence of marker appearance during the 
initial, embryonic phase of gliogenesis is ALDH1L1 > S100β > GFAP with AQP4 and 
EAAT1/2 labelling perivascular membranes and mature astrocytes respectively. 
Therefore, to reliably test the efficiency of protocol in the generation of astrocytes, other 
well defined markers were used for a better characterisation of astrocytes and its 
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developmental journey in vitro. Within the protocol, mESCDA reliably expressed GFAP 
negative astrocytic genes (S100β, ADH1L1, AQP4, and receptor-specific genes), 
revealing heterogeneity of marker expression as observed in vivo.  
 
Concerning the problem related to astrocyte identity, several studies have been done to 
discover pan-astrocyte markers and also to understand the molecular differences in a 
region specific manner (Yang et al. 2011; Tsai et al. 2012). A couple of studies have 
described ALDH1L1, a folate metabolizing enzyme, to be expressed specifically in 
astrocytes in murine brain, making it one of the most widely accepted pan-astrocyte 
marker and an early astrocyte marker, reliably labelling all subtypes of astrocytes: 
protoplasmic and fibrous (Cahoy et al. 2008; Tsai et al. 2012).  Analysis of ALDH1L1 
markers showed that in contrast to GFAP, expression of ALDH1L1 in generated 
mESCDA produced by the protocol remains stable across different DIVs - when looking 
at both genetic and immunocytochemical assessments (Fig.14). Evidence by Yang et al 
2011 and Roybon et al 2013 show ALDH1L1 expression occurring before GFAP in the 
sequence of astrocytic markers. Inspection of the data supports this observation, where 
immunocytochemical expression of ALDH1L1 at DIV 7 (Fig.14) is higher than GFAP 
(Fig.7). Furthermore, Roybon et al 2013 show that in iPSC derived astrocytes the 
increase in ALDH1L1 expression correlates with decreased astrocyte proliferation 
(Roybon et al. 2013). The presence of stability of ALDH1L1 expression across all time 
points therefore dictates presence of proliferative cells alongside mature cells, across the 
DIVs within the mESCDA. Furthermore, analysis of cell size and coverage also displays 
presence of stability in expression. At the time of the study, these analyses of ALDH1L1 
positive staining have not been displayed previously and provide novel evidence towards 
ALDH1L1 expression. This stability in expression of ALDH1L1 in stem cell derived 
astrocytes has not been reported before, and grants access to highly proliferative 
population of cells– further confirming subpopulation (heterogeneous) generation of 
astrocytes. 
 
Additionally, studies claim the expression of ALDH1L1 does not particularly map to the 
mature astrocyte phenotype (Roybon et al. 2013). The results partly corroborate this 
claim, as there is sparse co-labelling of GFAP positive and ALDH1L1 positive cells in 
the cultures, at later developmental stages (DIV 21 and DIV 28) (Fig.15). Nevertheless, 
this claim warrants further investigation, as within our cultures there are ALDH1L1 
positive cells that do not express GFAP (Fig.15A). This indicates the presence of either 
immature astrocytes or mature astrocytes that lack GFAP expression (Keugler et al 2012, 
Molofsky et al 2013).  
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Likewise, S100β is a useful astrocyte marker. S100β is involved in a plethora of 
intracellular processes within astrocytes, such as cell proliferation, calcium binding, and 
activity, microtubule stability, cell cycle, and development. The role of S100β in 
developmental stages has shown to be extremely important. When analysing S100β, there 
was an existence of GFAP negative cells (Fig.15) (Keugler et al. 2012). Evidence has 
shown that its expression coincides with GFAP in vitro (Brozzi et al. 2009). In generated 
cultures, there was a presence of S100β at DIV7, with a significant reduction in 
expression occurring at DIV14 (Fig.12). This reduction has been previously linked to 
astrocyte maturation and is also involved in the shift of S100β role during development 
and corroborates with literature, suggesting S100β contribute towards the migratory 
capacity of undifferentiated astrocytes and that S100β expression needs to be repressed 
for mature astrocytes to appear (Hachem et al. 2007; Patro et al. 2015). Nevertheless, 
Patro et al. 2015 using Sprague dawley rats display that once astrocytes lose their 
potential for proliferation, the S100β expression is repressed (Patro et al. 2015). However 
once astrocytes reach maturity, S100β expression reappears – making S100β a dual 
marker for astrocytes. Here, the effects of S100β expression suggest that S100β might 
contribute to astrocyte development as well as to the maintenance of an undifferentiated 
phenotype in astrocytic cells by interacting with GFAP as shown by co-localisation 
analysis. Double- immunolabelling of GFAP positive cells with S100β positive cells at 
different DIVs performed (Fig.15D), revealed a stability in the expression of both 
labelled cells, indicating GFAP and S100β are mostly co-expressed together and they are 
tightly regulated together in determining astrocyte fate.  
 
2.4.3. Study improvements and future directions  
 
Comparatively to other protocols (Table 4) the differentiation of mESCDA is fast and 
robust, and all steps are easily accessible at every stage. Hence it offers the possibility to 
investigate assess astrocyte development at every stage. The quick reproducibility and 
generation of heterogeneous (subtypes) of astrocytes would allow these cells to be used in 
studies which allow probing of the astrocytes. Although the study does provide a 
platform for future studies, assessment of further developmental markers along the way 
would sufficiently benefit the obtained results, and would further allow characterisation 
of the generated mESCDA. For example, Sun et al 2017 recently used SOX-9 to 
determine the number of astrocytes in the adult brain outside the neurogenic regions. 
SOX-9 is an early developmental transcription factor involved in fate switching of 
astrocytes (Kang et al. 2012; Sun et al. 2017), and using SOX-9 immunolabeling and 
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isotropic fractionator techniques, Sun et al 2017 were able to quantify astrocytes. Similar 
staining and technique could be applied in generated mESCDA, and would sufficiently 
show presence of mature/immature astrocytes.  
 
Furthermore, alongside immunostaining and morphological analysis, western blot 
analysis would further solidify the results. Although the technique is not short of its 
pitfalls, and would provide similar semi-quantitative analysis performed above, it would 
provide confirmation of results seen above. Additionally, the response of mESCDA 
towards cytokines might help to get new insights into astrocyte behaviour during 
inflammatory conditions, which occur in most neurodegenerative diseases.  
Furthermore, a comparison of mESCDA could be performed with iPSC cells, to analyse 
which is the best methodology which can offer offers new possibilities to investigate the 
involvement of astrocytes in processes within the CNS.  
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4. Calcium dynamics of generated mouse embryonic stem cell derived astrocytes 
(mESCDA)  
 
4.1. Introduction  
 
Astrocytes have emerged as key players in the regulation of synaptic physiology. They 
display complex and heterogeneous morphological structures and are able to sense and 
respond to environmental signals, modulate neuronal activity, synaptic transmission, and 
vascular function (Perea et al. 2014; Petrelli & Bezzi 2016). Synaptic activity is 
integrated into astrocytes (Perea & Araque 2010) and might result in intracellular calcium 
(Ca2+) elevations with specific spatial and temporal properties. These might appear as 
global and local responses within the astrocytic complex morphology. It is yet unclear if 
global Ca2+ elevations are more representative of an integrative response or if they are the 
result of a summation of Ca2+ fluctuations or inositol 1,4,5-trisphosphate (IP3) levels; 
nevertheless, these have been used as a hallmark of astrocytic function (Khakh & 
McCarthy 2015). These calcium elevations may appear spontaneously or may be 
triggered by endogenous or exogenous stimuli - such as the release of transmitters from 
adjacent cells such as neurons, or mechanical stimulation and exogenous pharmacological 
applications (Zorec et al. 2012). 
 
Astrocytes are theorised to modulate synaptic activity through the release of 
gliotransmitters including glutamate, ATP (which is broken down to adenosine) and D-
serine. These transmitters are released from astrocytes in a Ca2+ dependent manner in 
response to either electrical or pharmacological stimulation (Agulhon et al. 2008). In the 
hippocampus, ATP-evoked astrocyte Ca2+ was shown to promote glutamate release, 
which consequently facilitating synaptic transmission via activation of mGluRs (Perea et 
al. 2014; Panatier & Robitaille 2015). Nevertheless, attempts from multiple studies have 
shown that astrocyte calcium signalling has failed to affect the neurogenic niche it 
surrounds. These studies have used readouts of synaptic transmission and plasticity in the 
hippocampus using a variety of mouse models such as MrgA1 and IP3R2 KO (Petravicz 
et al. 2010; Li et al. 2013) to show astrocytes play a minimal role in mediating neuronal 
response. However, these studies are limited in terms of their arguments. Multiple pieces 
of evidence for plethora of studies have shown that there are astrocytes are majorly 
involved in regulating neural networks. For example, Henneberger et al 2010 show a tight 
modulation of astrocytic intracellular Ca2+ is crucial for D-serine-dependent long-term 
potentiation (LTP) of hippocampal CA1 pyramidal cells (Henneberger et al. 2010). 
Accordingly, a recent study has shown that acute blockade of Ca2+ dependent IP3 
mechanisms impairs LTP, but that this can be rescued by exogenous D-serine. 
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The primary mechanism for the elevation of intracellular Ca2+ levels in astrocytes is 
through the Gq-GPCR-PLC-IP3 pathway (Fiacco & Mccarthy 2004; Michael M. Halassa 
et al. 2007; Lalo et al. 2011). As astrocytes in the central nervous system possess a full 
complement of membrane receptors and ion channels (Bernstein et al. 1998; Lalo et al. 
2011), this allows them to respond to intercellular signals from both other astrocytes and 
from neurons on a millisecond timescale (Scemes & Giaume 2007). First shown in 
culture, the principal mechanism of long-distance signalling in astrocyte networks are 
intercellular calcium waves mediated by the extracellular diffusion of adenosine 5’-
triphosphate (ATP) and related purines interacting with the P2Y family of membrane 
receptors (James & Butt 2001). This causes a rise in intracellular calcium levels, which is 
part of a cascade that can result in the vesicular release of gliotransmitters, in particular, 
ATP, which can signal other downstream astrocytes; thereby causing a propagation of 
calcium waves (Guthrie et al. 1999; Miller 2010; Kuga et al. 2011; Rusakov et al. 2014). 
Recently, calcium waves have been shown to occur in situ in brain slices and in vivo in 
the rat neocortex shown via two-photon microscopy (Wang et al. 2012). Although the 
physiological and pathophysiological roles of calcium wave in vivo are not clearly 
understood and are very much an area of active research. A particularly intriguing and 
clinically important function may be the augmentation of calcium wave following disease 
or injury, for instance, during ischemic insults or seizures, essentially acting as a 
pathological signalling mechanism that may augment reactive gliosis and secondary 
injury processes (Delekate et al. 2014).  
 
The functional extent of any physiological or pathophysiological contributions of calcium 
waves will depend on the dynamics of signal propagation through the network, which 
will, in turn, depend on the molecular mechanisms that underlie the dynamics. For 
example, the ability of extracellular ATP in binding to purinoreceptors and causing a 
cascade of intracellular signalling - inositol 1,4,5-trisphosphate - IP3 mediated signalling 
leading to astrocyte environmental niche control. Therefore, analysis of specific receptor 
pathways mediating and contributing to calcium dynamics is essential.  
 
4.1.1. Purinergic receptor and its components  
 
One of the most important discoveries in the field of purinergic transmission in recent 
years was the role of ATP as the transmitter mediating intercellular communication in the 
brain. In astrocytes derived from rat cortex, the generation of a calcium wave was shown 
to depend most crucially by the activation of either ligand-gated P2X or G-protein-
coupled P2Y purinergic receptors (Ceruti & Abbracchio 2006). 
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The metabotropic P2YR1 and pore-forming P2X7 receptors are regarded as one of the 
main receptors for astrocyte transmission (gliotransmission) within the CNS. P2YR1 
receptors are coupled primarily through the Gαq/11-signalling pathway (Burnstock et al. 
2010). The conventional Gαq/11-signalling pathway involves activation of the 
heterotrimeric G protein and the subsequent dissociation of αq and ßγ subunits. The αq 
subunit activates PLC, which catalyses the hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2) into IP3 and diacylglycerol (DAG). IP3 then binds to IP3 receptors on 
the endoplasmic reticulum, triggering a release of intracellular calcium. Therefore, the 
primary mechanism for the elevation of intracellular calcium levels in astrocytes is 
through the Gq-GPCR-PLC-IP3 pathway (Haydon 2001; Fiacco & Mccarthy 2004; Fellin 
2009; Sherwood et al. 2017). Although current models of receptor-activated calcium 
entry focus on this cascade mechanism, there is increasing evidence that this pathway is 
not the only one whereby calcium elevation occurs (Sherwood et al. 2017).  
 
Recently, ionotropic P2 purinoceptors (P2X7) permeable to calcium have been 
functionally characterised in astrocytes (Burnstock et al. 2010). Hence, because of the 
complexity of the P2 purinoceptor mediated calcium signalling, dissecting the relative 
contribution of the different calcium elevating pathways in each cellular context is of 
crucial importance in the attempt to determine the biological significance of the 
mechanisms regulating the intracellular calcium homeostasis (James & Butt 2001). P2X 
receptors are ligand-gated ion channels conveying the ionotropic actions of extracellular 
ATP. Until now, seven different subunits of this receptor family have been identified 
which form functional receptor ion channel complexes in homo/ hetero oligomeric 
assemblies. Within the P2X receptor family, the P2X7 receptor has a distinguished role in 
astrocyte calcium activity (Nobile et al. 2003; Vizi et al. 2006). The long intracellular C- 
terminal domain has been shown to be instrumental for the pore-forming property of 
P2X7 receptors, which has been involved in calcium influx and has shown to contribute 
towards store-operated calcium entry and elevation in intracellular calcium and 
contributing to calcium increase and signalling (Verkhratsky & Parpura 2014).  
 
The identification of mechanisms mediating transmitter release from astrocytes is 
relevant not only for normal physiological processes but also for pathological states of the 
central nervous system (CNS). For instance, during ischemic insults and seizures, 
reduction of calcium concentrations in the extracellular environment may trigger the 
release of transmitters from astrocytes (Hamilton & Attwell 2010; Ding 2014). The 
function of the different subtypes of purinoreceptors on astrocytes is not well understood. 
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Important unresolved questions from previous studies such as, whether calcium signalling 
occurs in all populations of astrocytes, and which subtypes of purinoreceptors 
predominantly mediated the response to ATP. Here, the studies aim to show that in 
developed mESCDA, ATP evokes increased cytosolic calcium via metabotropic P2Y 
purinoceptors and ionotropic P2X purinoreceptors, which are activated at micromolar 
concentrations of ATP. Additionally, the study will aim to identify the predominant 
pathway which leads to changes in calcium dynamics via the application of several 
receptor specific compounds impeding calcium signalling. Additionally, astrocytic Ca2+ 
signals exhibit critical spatiotemporal features that need to be fully understood to allow 
for the careful assessment of their functional implications. Among them: fast vs. slow 
elevations; single vs. multiple astrocytes; receptor-dependent mechanisms. The 
complementary application of existing tools, as well as the development of accurate 
models to tackle its unique features, will allow the study to provide novel insights into 
receptor specific actions and consequences. Therefore, the study here will aim to further 
the field and contribute to understanding the complexity of astrocyte signalling - 
particularly in stem cell derived astrocytes.  
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4.2. Materials and Method 
4.2.1 Materials  
 
Table 5: Materials used for assessment of mESCDA calcium dynamics  
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4.2.2. Generation of mESCDA for calcium imaging  
 
The EB based technique was utilised for calcium experiments as it resulted in successful 
generated of mESCDA (see chapter 2). 20 intact EB’s were seeded directly onto laminin 
coated 13mm coverslips containing astrocyte differentiation media (ADMEM/F12, 2% 
FBS, N2, 1% L-glutamine, 1% Pen/Strep, 100µM β-mercaptoethanol and 50µg/mL 
heparin (Robertson and Goldstein 1988; Nagayasu et al. 2005) (Sigma Aldrich, Poole, 
UK), were grown from DIV 7- DIV 28 for calcium imaging assessment.  
 
4.2.3. Immunofluorescence and genetic analysis of purinoreceptors 
 
 
 
Table 6: Antibodies used for immunofluorescence  
 
Immunofluorescence was performed with same methodology as in previous chapter (see 
chapter 2). Cells were washed with PBS, at 7, 14, 21 and 28 DIV, fixed with 3.7% 
formaldehyde in PBS for 30 minutes, and permeabilised with 0.02% Triton X-100 diluted 
in 10% goat serum for 10 minutes. Subsequently, cells were washed with PBS and 10% 
goat serum was added to block against non-specific binding for 2 hours. Cells were then 
stained with anti- rabbit polyclonal P2YR1 (APR-009) and anti- rabbit polyclonal PX27R 
(APR-004) P2X7 at 1:250 concentrations, and counterstained with anti-rabbit 488 
polyclonal secondary antibodies (Table 6). Nuclei were counterstained with H-33342 
(Hoechst dye). Images were taken using an Axio Imager microscope (Zeiss, Germany). 
 
Polymerase chain reaction was performed as per previous conditioned described in 
chapter 2. The forward and reverse primer (see primer list) and template DNA was added, 
alongside nuclease-free water to make 50ul reaction for gel electrophoresis. 
Electrophorese was run on ethidium bromide agarose based gel at 100V for 40 min. 20µl 
of diluted markers/ladders was ran alongside, 20µl of sample per well. Data gel analysis 
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was performed using bespoke MATLAB algorithms (see appendix) and published 
algorithms via Image J. Furthermore, to confirm algorithm specificity gel densomitary for 
gel electrophoresis was performed.  
 
4.2.4. Calcium Imaging of mESCDA 
 
 
Figure 16: Fluo-4 AM is taken up by the cells and hydrolysed by endogenous esterases 
thereby rendering the dye fluorescent and sensitive to calcium. ECM= Extracellular 
medium, CM= Cell membrane. 1 - Astrocyte Medium, 2 - Fluo4 Calcium medium, 3 - 
HBBS buffer minus Fluo-4.  Image adapted from 
https://www.embl.de/eamnet/html/calcium/dyes/fluorescentdyes3.htm 
 
Calcium imaging was performed using Fluo-4 acetoxymethyl ester dye as it is easily 
taken up by the cells in the presence of Ca2+ and Mg2+ and exhibits high fluorescence 
with a Kd of 335 nM. Once inside the cell, the ester is hydrolysed by endogenous 
esterases, thereby making it fluorescent and sensitive to calcium (Fig. 16). 
 
Prior to recording, coverslips from different DIVs were loaded with Fluo-4/AM (2.5 µM) 
within 1M HEPES Buffer, 1M CaCl2, 2mM Bovine Serum Albumin (BSA) and double 
distilled water (ddH2O) for 30 minutes 37°C, 5% CO2 (Molecular Probes) (Neary et al. 
1999; Lock et al. 2015). Subsequently, post 30 minutes, cells were thoroughly rinsed with 
Hank’s Balanced Salt Solution (HBSS) to remove extracellular traces of the dye and to 
complete de-esterification and incubated again for 30 minutes 37°C, 5% CO2. Coverslips 
were then moved to the recording chamber and all fluorescence measurements were made 
at 37°C (Warner Instruments) with no CO2 control for 5 minutes – 300 Seconds. 
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Excitation and emission wavelengths were 494 nm and 516 nm respectively. Changes in 
calcium were detected with an inverted Nikon Eclipse TE2000-S microscope (Nikon) 
equipped with a xenon arc lamp (Sutter Instruments). Imaging Workbench 6.0 (INDEC 
Bio- Systems) was used to control a Lambda 10-2 shutter system (Sutter Instruments).  
 
4.2.5. Applications of compounds  
 
Suramin hexasodium salt (suramin 100 µM) – General P2 anatgonist, N6-methyl-20-
dexyadenosine-30,50- bisphosphate, tetraammonium salt (MRS 2179002050 µM) – 
P2YR1 antagonist, Brilliant Blue-G (BBG 50 µM) – P2X7 antagonist and U73122 PLC 
blocker were obtained from Tocris Biosciences. ATP (50 µM), and Ionomycin (100 µM) 
were obtained from Sigma. Compounds were prepared as stock solutions as per 
manufactures guidelines and frozen in aliquots. When required, compounds were made 
up in HBBS. Post Fluo-4/AM, coverslips were incubated with the compounds for 30 
minutes pre-recording and then washed three times with HBBS. The concertation of 
compounds ATP, and Suramin concentration were chosen from Hamilton et al 2008, 
whereas concentration of other compound concentrations were chosen based on previous 
experiments performed in the laboratory.  
 
4.2.6. Data Analysis  
 
 
 
Figure 17: Breakdown of wave components for analysis of ATP evoked calcium 
dynamics.    
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Unless otherwise stated, ATP was applied after 30 seconds of background recording (to 
acquire baseline average fluorescence) at 50µM and was applied post incubation with 
compounds. Cells with unstable resting calcium in the baseline condition (i.e. fluctuations 
unlike normally observed calcium transients or a constantly rising baseline) were 
discarded. Astrocytes were identified at 488 nm excitation, and cell bodies within a single 
plane of focus were selected as regions of interest (ROI); several ROI were 
simultaneously recorded from in each experiment. The relative changes in calcium 
response to all stimulation were quantified as fold increase over baseline and was 
calculated for each trace and reported as ∆F/F0 (Macleod 2012). The signal was filtered 
using low pass filtering (Otsu et al. 2014). Area under curve (the area under the curve 
from the application of agonist till the end of experiment), rise time (10%-90% rise of 
curve), decay tau (peak maximum till decay curve was fit with the following equation 𝑓 𝑡 = 𝑎 ∗ exp(−𝑡/𝑡𝑎𝑢) and latency were analysed from each ROI and compared across 
astrocytes which had been treated with ATP (Kang & Othmer 2009; Okada et al. 2012; 
Hashioka et al. 2014) (Fig. 17). For compound treatment analysis, the fluorescent 
dynamics were compared against ATP application and peak differences between ATP 
agonist and purinoreceptors antagonists were measured. The peak response of an 
antagonist was expressed as a percentage of the response to ATP (denoted % peak 
change). Number of responding vs non-responding cells were also characterised.  
 
All data analysis was performed offline and data assessed with Clampfit 10, WinFlour 
software packages (Strathclyde University) and modified MATLAB algorithms (see 
appendix). Experiments were performed in triplicates and for each of 7, 14, 21 and 28 
DIVs. Multiple ROI (cell somata) were analysed n = 30 astrocytes per DIVs with the 
experimental n=4. Data are presented as means +/- SEM and the statistical differences 
were tested by ANOVA with Bonferroni’s Multiple Comparison Test post-hoc test, or 
Mann-Whitney tests, where appropriate, using GraphPad Prism 6.0 (Graphpad Software, 
La Jolla, CA). Statistical significance was assumed when P<0.05) 
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4.3. Results  
4.3.1 Expression of purinergic receptors in mESCDA  
	
Calcium oscillations and waves in astrocytes are one of the most well-studied 
mechanisms for the cells to respond to various stimuli and a mode of intra as well as 
intercellular signalling (Fiacco & Mccarthy 2004; Rusakov et al. 2014). After having 
established a methodology to generate mESCDA, it was essential to assess whether 
mESCDA are functionally mature and are able to respond to the environmental cues as 
expected. This was done via assessing their calcium dynamics through Adenosine 
triphosphate (ATP - 50 µM) stimulation of Fluo-4 loaded mESCDA. Prior to calcium 
dynamics assessment, it was essential to evaluate purinergic receptor expression within 
the mESCDA. During protocol establishment, purinergic receptors P2YR1 and P2X7 
were temporally examined (from DIV7-28) via reverse transcriptase-PCR (see chapter 2). 
Expression of these genes was up-regulated throughout temporally. Differences between 
DIV 7/DIV14 and DIV 28 were statistically significant between of: P2YR1: (At DIV 7 
Fig 18. 36.81%±3.01%, N=3 - DIV 28, Fig 18. 176.27% ± 13.11%, N=3, p<0.05) P2X7: 
(Fig18. At DIV 7 Fig 14. 2.27%±0.88%, N=3 - DIV 28 Fig 18. 27.93%±4.12%, N=3, 
p<0.001).  
 
Figure 18: Generation of and development of purinergic receptors in mESCDA. Data are 
given in percent expression relative to the housekeeping gene Gapdh. (A) P2YR1 
expression (B) P2X7 expression across DIVs. All data are expressed as mean ± SEM 
from three separate experiments, *P < 0.05, **P < 0.01, ***P < 0.001) ANOVA with 
Bonferroni’s Multiple Comparison post-hoc tests 
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In addition to genetic assessment, it was essential to elucidate protein expression and 
localisation of the receptors within mESCDA. Temporal immunostaining (DIV 7-28) for 
both P2YR1 and P2X7 receptors revealed mESCDA reliably expressing both purinergic 
receptors, confirming genetic analysis (Fig 18-21). The upregulation of receptor was 
visible in fluorescence images acquired, moreover, looking at co-localisation staining 
revealed both receptors are expressed in regions occupied by GFAP positive staining 
(Fig. 19-21). Although, some receptors staining is also visible outside of GFAP positive 
stains, signifying purinergic receptor expression occurring in GFAP negative mESCDA 
(Fig 18 -21). 
 
 
 
 
Figure 19: Immunocytochemical phenotyping of purinergic receptors. P2YR1 receptors 
at DIV 28, immunofluorescent labelled for established astrocytic marker P2YR - green 
and GFAP – red. Cultures have been counterstained for cell nuclei marker H- 33342 (blue 
stain). Scale bar = 20µm, image acquired at x20 magnification. 
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Figure 20: Immunocytochemical phenotyping of for purinergic receptors. P2X7 receptors 
at DIV 28, immunofluorescent labelled for established astrocytic marker P2X7 - green 
and GFAP – red. Cultures have been counterstained for cell nuclei marker H- 33342 (blue 
stain). Scale bar = 20µm, image acquired at x20 magnification. 
 
 
Figure 21: Immunocytochemical images of DIV 28 astrocytes at x40 magnification for 
(A) P2YR1 receptors –(B) P2X7 receptors - green and GFAP - red. Cultures have been 
counterstained for cell nuclei marker H- 33342 (blue stain). 
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4.3.2. Application of ATP leads to calcium transients in mESCDA  
 
A time-lapse sequence of a 5-minute recording is illustrated in figure 22, where calcium 
concentration in multiple regions of interest (e.g. middle right and middle left) increases 
(from 30 to 60 seconds) and returns to initial levels (from 90 to 300 seconds). 
Furthermore, heatmap also revealed that evoked activity travels in a wave-like manner 
across the regions of interests (ROI) (Fig. 22). Evoked calcium transients displayed a 
temporal rise, a peak and decay phase post peak, which was expected due to responses 
seen in vivo, a hallmark of astrocyte function (Bazargani & Attwell 2016; Shigetomi et al. 
2016). This kinetics varied across DIVs (Fig 24), Indicating this variety and 
heterogeneity in response can be linked to heterogeneity in expression of purinergic 
receptors (Fig. 18), and may also linked to increase in response of these cells – indicated 
by the significant decrease in number of cells responding across the DIVs (Fig. 19-21) 
(DIV 7 – 20% to DIV 28 – 5%).  
 
 
Figure 22: Calcium waves of ATP evoked mESCDA. (A) Heatmap of Fluo4 treated, 
activated astrocytes when evoked via ATP, starting with pre-stimulus, ending with 300 
seconds- end of experiment.  
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Figure 23: Activation of purinergic pathways within mESCDA. Schematic representation 
of intracellular processes within astrocytes (B) when purinergic receptors are activated. 
(B) Number of responsive v/s nonresponsive cells increasing across DIVs. Analysis 
performed by ANOVA with Bonferroni’s Multiple Comparison post-hoc statistical tests.  
 
Heatmap observation revealed cells which do not respond to the exogenous application of 
ATP, therefore it was essential to assess the number of responsive and non- responsive 
cells temporally across the cultures. Quantification of the percentage of astrocytes 
displaying Ca2+ transients showed a significant decrease in percent (%) of non-responding 
cells as we progressed through the DIVs, from approximately 20% at DIV 7 to 
approximately 5% at DIV 28 (Fig. 19C), revealing temporal changes lead to changes 
maximal affinity of purinergic receptors (Kuntz et al 1999). 
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Figure 24: Representative ATP evoked responses of mESCDA. Purinergic response 
calcium waves from evoked ATP across different DIVs (DIV 7-28) reveal differences in 
calcium dynamics, the transients are mono and bi-phasic in nature (black arrow at DIV 7 
showing bi-phasic response).  
 
Evoked calcium transients displayed a temporal rise, a peak and decay phase post peak, 
which was expected due to responses seen in vivo, a hallmark of astrocyte function 
(Bazargani and Attwell 2016; Shigetomi et al. 2016). This kinetics varied across DIVs 
(Fig 24), Indicating this variety and heterogeneity in response can be linked to 
heterogeneity in expression of purinergic receptors (Fig. 18), and may also linked to 
increase in response of these cells – indicated by the significant decrease in number of 
cells responding across the DIVs (Fig. 23) (DIV 7 – 20% to DIV 28 – 5%).  
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4.3.3 Characterisation of intracellular calcium pool  
 
 
 
 
 
Figure 25: All or nothing response from mESCDA. Application of Ionomycin at the end 
of the experiment 300 seconds (DIV 28) reveals intracellular stores responsible for 
evoked calcium transients.  
  
The role of intracellular calcium dynamics being responsible for the observed calcium 
wave was further confirmed by the application of Ionomycin – a calcium ionophore 
(Muller et al 2013). Application of 100 µM triggered a phasic increase in cytosolic 
calcium post ATP evoked calcium transient (Fig. 25). Post application there was a peak 
which was significantly different from ATP evoked calcium transients. This indicated an 
all or nothing response and this has occurred due to release of calcium within the 
intracellular (cytosolic) stores – via IP3 mediated release (Sherwood et al 2017). The 
results here confirming involvement of intracellular calcium in the observed ATP induced 
calcium dynamics (Fig 22).  
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4.3.4 Temporal analysis of calcium transients  
	
After solidifying that the evoked calcium dynamics occurred mainly due to changes in 
cytosolic calcium, and were not noise, the Ca2+ waveform was decomposed into different 
components: decay tau, area under the curve (AUC), and rise time (RT). The latency 
between the application of ATP and the rise in intracellular Ca2+ concentration was also 
assessed (Bernstein et al. 1998). 
 
 
Figure 26: Components of ATP evoked calcium dynamics. Analysis of individual 
components in ATP evoked calcium transients. From left to right - (A) Area under curve 
(AUC), (B) decay tau (Tau), (C) rise time (RT), and (D) latency of n = 30 astrocytes 
reveals heterogeneity in response. All data are means ± SEM from three experiments. 
n.s., no significant difference (P > 0.05); *P < 0.05, **P < 0.001 ANOVA with 
Bonferroni’s Multiple Comparison post-hoc tests 
 
There was a significant (p<0.05) increase in rise time of DIV 7 (Fig. 26C: 3.75s ± 0.202s, 
n=3) astrocytes when compared to DIV 21 (Fig. 26C: 5.81 ± 0.73s, n=3) and DIV28 (Fig. 
26C: 6.04s ± 0.56s, n=3), alongside significant increase when comparing DIV 14 (Fig. 
26C: 4.01 ± 0.61s, n=3) to DIV 28 (Fig. 26C: 6.04s ± 0.56s, n=3). Area under the curve 
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revealed a significant reduction in response of DIV 21 (Fig. 26A: 54.38 ± 2.56s, n=3) and 
DIV 28 (Fig. 26A: 62.08 ± 4.51s, n=3) when compared to DIV 7 (Fig. 26A: 70.76 ± 
5.11s, n=3), revealing a change in number of calcium trafficked in and out of the cell as 
the cultures matures. The ability to clear the amount of calcium measured via decay tau 
significantly decreases at DIV21 (Fig. 26B: 65.42 ± 13.56s, n=3) when comparing DIV 7 
(Fig. 26B: 82.95 ± 11.16s, n=3) and DIV 14 (Fig. 26B: 80.66 ± 22.21s, n=3) with a 
decreasing trend at DIV 28. The latency of response of ATP remains the same across 
DIVs (around 22 Seconds) (Fig. 26D). These temporal changes in astrocyte components 
show that there is heterogeneity in the response similar to heterogeneity in receptor 
expression and marker expression seen previously.  
 
 
 
Figure 27: Individual components responsible for calcium dynamics in mESCDA. 
Principle component analysis (PCA) reveals the major contributors in calcium waves. 
AUC and Tau are linked with similar directionality, whereas RT is an individual 
component with its own directionality.  
 
In addition to the above, to further understand which of these different components con- 
tribute majorly towards calcium dynamics, principal component analysis (PCA) was 
performed (Fig. 27). PCA displayed 2 major components: where AUC and decay tau 
contributing towards one component (around 49.23% contribution together), and RT 
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contributing towards the second component (around 29.95% contribution alone) 
demonstrating the involvement of each component towards the calcium wave. Previous 
evidence has displayed P2YR1, and P2X7 contribute towards RT and Decay tau 
respectively (Hamilton et al. 2008), therefore to further clarify which receptor is the 
major contributor towards evoked calcium response, receptor-specific antagonists are 
required.  
 
4.3.5 Phasic responses in calcium transients dictate the involvement of different 
purinergic receptors  
	
The evoked calcium transients due to activation of purinergic receptors display either 
monophasic (Fig. 28A, average traces) or biphasic (Fig. 28B, average traces) response in 
the decay phase depending on whether there was a sustained response after the half-
amplitude of peak response. The percentage of monophasic and biphasic responses varied 
across different days in vitro. Temporal analysis revealed that majority of responding 
mESCDA display responses, with a slight decrease at DIV 21 from >90% at DIV 7, to 
>65% at DIV 21 (Fig. 29).  
 
Figure 28: Mono and bi-phasic responses of mESCDA. Average calcium dynamics of 
ATP evoked calcium transients across DIVs (DIV 7-28) where (A) displays monophasic 
and (B) displays bi- phasic calcium response. 
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Figure 29: Percentage of monophasic v/s biphasic cells across DIVs 
 
4.3.6 Identification of principle purinergic pathway involved in calcium transient 
	
	
To identify the principle pathway/s involved in the generation of evoking calcium 
transient, it was essential to utilise compounds which were selective for specific receptors 
and pathways (Petravicz et al. 2008). Since ATP is a non-selective P2 purinoceptor 
agonist, initially non-selective antagonists were utilised. Prolonged bath application of 
the broad-spectrum P2 antagonist suramin (at 100 µM) reduced evoked calcium 
transients. 
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Figure 30: Suramin reveals involvement of purinergic receptors in mESCDA calcium 
dynamics. Bath incubation of mESCDA with suramin reveal stunted calcium dynamics 
across DIVs (DIV 7-28) confirming involvement of intracellular dynamics and purinergic 
receptors in mESCDA calcium dynamics. Red trace – suramin treated dynamics, blue 
trace – non suramin treated dynamics of representative traces.  
 
Although the signal profile of the evoked calcium responses was similar (Fig. 30), the 
signal responses were stunted, at DIV 21 and DIV 28 (Fig. 30). This was further 
confirmed via peak difference analysis, where the peak of ATP was compared to the peak 
of suramin. The peak differences showed a stepwise reduction in peaks, with a significant 
reduction mainly at DIV 21 (Fig. 30: 50.02 ±2.71 n=4, p<0.05) and DIV 28 (Fig. 30: 
58.8± 3.15 n=4, p<0.05). when compared to ATP. There was a 50% reduction in signal at 
DIV 21, with a slight return at DIV 28.  
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Figure 31: Suramin treated mESCDA. (A) Percentage peak differences was measured 
between suramin and non suramin treated mESCDA. Assessment show significant 
difference across DIVs (mainly later DIVs) when compared to control. (B) Rise time 
(RT) of n = 30 astrocytes from 3 separate experiments. All data are means ± SEM from 
three experiments. n.s., no significant difference (P > 0.05); *P < 0.05, **P < 0.001 
ANOVA with Bonferroni’s Multiple Comparison post-hoc tests. 
 
 
There was a significant (p<0.05) increase in rise time of DIV 7 (Fig. 30B: 6.71s ± 0.192s, 
n=3) astrocytes when compared to DIV 21 (Fig. 30B: 1.43 ± 0.73s, n=3) and DIV28 (Fig. 
30B: 11.88s ± 2.06s, n=3), alongside significant increase when comparing DIV 14 (Fig. 
30B: 8.33 ± 2.11s, n=3) to DIV 28 (Fig. 30B: 11.88s ± 2.06s, n=3). Collectively, these 
results add support to the tenet that in mESCDA ATP induced transient calcium elevation 
and the calcium decay are dependent on the activation of different subtypes of P2 
purinoceptors and suggest that the sustained calcium signalling is mediated by activation 
of calcium-permeable P2X7-like receptors.  
 
 
 
 
 
 
 
 
 
A	 B	
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4.3.7. P2X7 provides minor contribution to purinergic calcium dynamics 
	
Having established that purinergic receptor mechanisms in the generated mESCDA 
contribute to the calcium dynamics, receptor-specific antagonists to block the signalling 
pathways were used. Initially, contributions of the P2X7 receptor were assessed. Bath 
incubation of mESCDA with the P2X7 antagonist, BBG (50 µM), revealed no significant 
changes in evoked ATP calcium transients (Fig. 32).  
 
 
 
 
 
Figure 32: BBG reveals involvement of P2X7 receptors in calcium dynamics. Bath 
incubation of mESCDA with BBG reveals attenuated calcium dynamics across DIVs 
(DIV 7-28). Red trace – BBG treated dynamics, blue trace – non BBG treated dynamics 
of representative traces.  
 
  
A	 B	
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Figure 33: BBG treated mESCDA. (A) Percentage peak differences was measured 
between BBG and non BBG treated mESCDA. Assessment show significant difference at 
DIV 7 when compared to control. (B) Rise time (RT) of n = 30 astrocytes from 3 separate 
experiments. All data are means ± SEM from three experiments. n.s., no significant 
difference (P > 0.05); *P < 0.05, **P < 0.001 ANOVA with Bonferroni’s Multiple 
Comparison post-hoc tests 
 
 
A temporal inspection revealed a reduction in baseline and an attenuated response (Fig. 
32), however, the reduction in signal was less pronounced when compared to suramin. 
There was no difference in rise time, where peak difference analysis of BBG treated cells 
revealed a significant reduction in the peak at DIV7 (Fig. 33: 53.11 ± 2.11 n=4), when 
compared to ATP, with an increase in peaks comparable to control at later DIVs (DIV 14-
28). Further to this, a closer examination of the calcium kinetics revealed changes in 
decay tau when compared to ATP responses, but these could be due to noise or artificial 
signals due to summation of many signals in figure (Fig. 32). The results here show some 
involvement of the P2X7 receptor in calcium dynamics and involvement of P2X7 receptor 
involvement in calcium response of mECSDA. 
 
4.3.8. P2YR1 contributes majorly towards mESCDA calcium transients 
  
P2YR1 plays a prominent role in the rise time component in calcium kinetics (Zhu & 
Kimelberg2 2001; James & Butt 2001). Furthermore, metabotropic signalling and 
downstream pathways have been majorly linked with astrocyte calcium dynamics and 
further changes brought to the CNS via astrocyte calcium signalling (Martin et al. 2015). 
Therefore, it was essential to assess whether generated mESCDA responded to ATP via 
the activation of P2YR1 and the subsequent pathway. To test this, MRS2179: P2YR1 
antagonist was used to selectively inhibit receptor specific response.  
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Figure 34:  MRS2179 reveals involvement of purinergic receptors in mESCDA calcium 
dynamics. Bath incubation of mESCDA with MRS2179 reveals stunted calcium 
dynamics across DIVs (DIV 7-28). Red trace – MRS2179 treated dynamics, blue trace – 
non MRS2179 treated dynamics of representative traces.  
 
 
  
Figure 35: MRS2179 treated mESCDA. Percentage peak differences was measured 
between MRS2179 and non MRS2179 treated mESCDA. Assessment show significant 
difference at across DIVs (DIV 7-28) compared to control. All data are means ± SEM 
from three experiments. n.s., no significant difference (P > 0.05); *P < 0.05, **P < 0.001 
ANOVA with Bonferroni’s Multiple Comparison post-hoc tests 
 
A	 B	
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Figure 36:  Inhibition of downstream PLC reveals involvement Gq-GPCR/PLC/IP3 
signalling in mESCDA calcium dynamics. Bath incubation of mESCDA with U73122 
reveals stunted calcium dynamics at DIV 28. Purple trace – U73122 treated dynamics, 
blue trace – non U73122 treated dynamics.  
  
The response to ATP was significantly and reversibly inhibited by the P2Y1 receptor 
antagonist MRS2179. Observing the calcium kinetics across the DIVs, there were a 
significant attenuation and dampening of the response – similar to the effect of suramin 
responses. There was a significant (p<0.05) increase in rise time of DIV 7 (Fig. 35B: 
7.46s ± 1.10s, n=3) astrocytes when compared to DIV 21 (Fig. 35B: 12.06 ± 2.13s, n=3) 
and DIV28 (Fig. 35B: 11.84s ± 2.56s, n=3), alongside significant increase when 
comparing DIV 14 (Fig. 35B: 9.14 ± 1.92s, n=3) to DIV 21 (Fig. 35B: 11.84s ± 2.11s, 
n=3). Comparison of peak differences revealed a significant difference across the DIVs 
(Fig.33A). There was a significant decrease in peaks across all of the DIVs, DIV 7 (Fig. 
35A: 53.02 ± 1.33 n=4, p<0.05), DIV 14 (Fig. 35A: 64.66 ± 2.01 n=4, p<0.05), DIV 21 
(Fig. 35A: 63.66 ± 1.13 n=4, p<0.05) and DIV 28 (Fig35A. 33: 65.01 ± 3.15 n=4, 
p<0.05), with majority of the significant difference occurring at DIV 7 (Fig. 35: 53.02 ± 
1.33 n=4, p<0.05). The results revealed P2YR1 as a major contributor towards evoked 
ATP signalling observed within mESCDA.  
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4.4. Discussion  
 
In the brain, astrocytes are associated intimately with neurons and surround synapses. 
Due to their close proximity to synaptic clefts, astrocytes are in a prime location for 
receiving synaptic information from released neurotransmitters. Evidence in vitro and in 
vivo has shown that astrocytes express all of the neurotransmitter receptors and respond 
to neuronal transmitter release by further releasing their own transmitters – termed 
gliotransmitters (Michael M. Halassa et al. 2007; Volterra et al. 2015). As astrocytes are 
electrically passive cells, they mediate the changes and response via elevating their 
intracellular calcium levels (Khakh et al. 2015). Therefore, it was essential to test whether 
the generated mESCDA a) possessed the necessary receptors (mainly purinergic) b) 
possessed the ability to respond to the environmental niche via responding to exogenous 
transmitters c) possessed the ability to display calcium transients d) whether these 
transients were due to response to their environment. 
 
The purinergic signalling system is, arguably, one of the main extracellular signalling 
system that integrates neuronal-glial and glial–glial circuits in the nervous system 
(Pascual et al. 2005). Adenosine 5’-triphosphate (ATP), which is the principal purinergic 
signaller, is released from cells by several mechanisms, such as exocytosis, diffusion 
through plasmalemmal channels and transporters mediated release. In addition, ATP is 
released also released from pathological astrocytes, as an immunocompromised signal 
response. Evidence has shown that purinergic signalling mediates reciprocative signalling 
between neurons and astrocytes (Fields & Stevens-Graham 2002). For example, 
Hassinger et al 1996 displayed extracellular ATP being involved in mediating calcium 
waves which propagate in situ, showing purines and pyrimidines provide for multiple 
signalling pathways within the astrocytic network, and are responsible for mediating 
calcium waves (Burnstock 1978; Hassinger et al. 1996; Hamilton et al. 2008). The family 
of purinoceptors is coupled with numerous dowsntream signalling cascades such as 
calcium or metabolites pathways which governing astrocytes physiological and 
pathological responses, therefore purinergic signalling was chosen to be scrutinised 
within the generated mESCDA.  
 
The functional ATP responses that hinted at several receptor classes were recognized 
rather early. Burnstock & Kennedy (1978) proposed the first clear subdivision of P2 
purinoceptors into P2X purinoceptors and P2Y purinoceptors (Burnstock 1978) Recent 
accumulation of evidence has indicated that ATP mediated calcium changes within 
astrocytes are brought about mainly via P2YR1 and P2X7 receptors (Scemes & Giaume 
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2007; Suadicani et al. 2009). Furthermore, based on evidence from pioneering studies 
from Centimeri et al 1997, James and Butt 2001, and Sudacani et al 2009, these two main 
subtypes of purinoreceptors are responsible for the majority of purinergic signalling 
occurring within astrocytes (Centemeri et al. 1997; James & Butt 2001; Suadicani et al. 
2009). 
 
Genetic assessment on P2YR1 and P2X7 revealed temporal changes in expression, where 
both P2YR1 and P2X7 expression mainly increased across DIVs (Fig.18). This observed 
increase in receptor expression may be due to the result of increased proliferation and 
differentiation of astrocytes as observed within mESCDA (see chapter 2). Further to this, 
purinergic receptor expression is also visible in GFAP negative cells (Fig. 15-17). This 
further confirms ubiquitous expression of the receptors in generated mESCDA. Chick 
and murine assessments of purinergic receptors show expression of receptor P2X7 at E18 
and P2YR1 at E10 and this subsequently increases until adulthood where it reaches a 
plateau (Majumder et al. 2007; Burnstock et al. 2010). Furthermore, in vitro studies have 
shown increased expression of each receptor as the culture matures, as each receptor 
performs its functions such as proliferation, cell growth and mitogenic signalling leading 
to accelerated differentiation (Burnstock et al. 2010). For example, Tsao et al 2013 show 
upregulation of P2 receptors during development of mice, and their involvement in 
neurogenesis and gliogenesis via intracellular signalling cascades (Tsao et al. 2013). The 
results here agree with the literature and show purinergic receptor expression increases 
during development. However, on closer inspection, the P2YR1 receptor expression 
display a dip in expression at DIV 14. This may be due to culture conditions such as 
changes in developmental regulation, changes in glucose and energy metabolism, or 
changes in differentiation patterns to match the demands of the culture, as observed 
previously via S100B expression. However, this has not been reported elsewhere. Further 
to this, the P2YR1 expression comparatively was more that P2X7 expression – 
comparatively across DIVs (Fig.21). The reduced in expression in P2X7 shows that 
developed mESCDA are not reactive in nature. Evidence has shown that increased 
expression of P2X7 has shown to occur mainly in pathological conditions and cause the 
release of proinflammatory cytokines and nitric oxide leading to diseases such as multiple 
sclerosis (Zou et al. 2011; Amadio et al. 2017). This genetic assessment was further 
confirmed via immunostaining, and these results here showed receptors are indeed 
expressed during development. Both P2YR1 and P2X7 showed reliable staining and also 
showed co-localisation with astrocytes – shown via GFAP positive staining (Fig. 17). The 
results provided here display novelty in terms of receptor expression in stem cell derived 
astrocytes. The temporal assessment of these receptors within stem cell derived astrocytes 
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(mainly mouse) has not been performed. Although studies do provide a detailed genetic 
profile of stem cells derived astrocytes (Krenick et al. 2011; Zhang et al. 2016), they only 
utilise one time point and set this as a basis of future studies. Therefore, a detailed 
temporal analysis of receptors, is needed when trying to set out any future functional 
studies.  
 
4.4.1. Purinergic assessment of mESCDA 
 
Developed astrocytes were successfully loaded using Fluo-4 AM and agreement with the 
previous literature (Parri et al. 2001), the majority of the Fluo-4-loaded cells exhibited 
astrocytic morphology – extensive branching and elaborate morphology (Fig. 20). 
Astrocytes display both spontaneous and evoked intracellular calcium increases. Evoked 
calcium responses have been extensively studied using a variety of stimulation protocols 
such as mechanical and evoked (pharmacological) (Venance et al. 1997; Hamilton et al. 
2008). Therefore, for comparative analysis here the developed mESCDA were tested for 
their ability to display evoked (pharmacological) calcium transient via ATP application.  
 
Application of ATP displayed clear transients across the DIVs (Fig. 22). These transients 
had a rise phase, a peak response and a decay phase. These responses were analogous to 
primary (Fig. 48) (Nobile et al. 2003; Hamilton et al. 2008) and other stem derived 
astrocytes (Zhang et al. 2016; Lundin et al. 2018) in which they also showed a clear rise 
and decay phase, showing the mESCDA are functional and readily respond to their 
environment. The temporal assessment showed that the number of astrocytes which did 
not respond decreased significantly, indicating that temporal maturity in culture leads to 
increased functionality (Khakh et al. 2015). This increased in functionality could be due 
to developmental maturity of the cultures, as astrocytes begin to stably express the 
majority of the astrocyte specific genes (see chapter 2) which are involved in mediating 
astrocyte function (IP3R2, GJB6), or increased number of receptors subsequently 
increased binding sites for ATP (Fig. 21B). Additionally, the intracellular machinery of 
astrocytes, such as downstream pathways which lead to elevation of calcium from 
intracellular stores also gains complexity and intricacy, and these reasons could be related 
to increased responses in astrocytes across the DIVs. 
 
Although no direct evidence exists which displays and compares temporal changes in the 
functional response of purified astrocyte cultures from stem cells, co-culture studies have 
shown that developmentally increased numbers of astrocytes have shown to respond as 
culture matures. For example, Shtrahman et al 2017 showed that astrocytes began to 
	- 87 - 
show increased calcium activity when cultured with neurons and this activity increases as 
the cultured matured (Shtrahman et al. 2018). Furthermore, this increased in functionality 
across DIVs may be occurring due to stimulation mitogen-activated protein kinases 
which lead to increased ‘readiness’ in astrocytes to respond to external stimuli(Lundin et 
al. 2018) .  
 
Closer inspection of the calcium transients reveal the ATP induced kinetics to be similar 
across the DIVs - therefore showing that mainly purinergic responses are involved in 
providing calcium dynamics due to ATP stimulation (Nobile et al. 2003). Each DIV 
provides a clear rise and decay phase, therefore analysis of modalities of calcium 
signalling mediated by purinoreceptor activation may offer insight in determining 
astrocyte intracellular machinery (Centemeri et al. 1997; Nobile et al. 2003). Recently, 
when developing astrocytes from stem cells, a number of studies have performed calcium 
imaging as a method of functional assessment (Santos et al. 2017; Lundin et al. 2018). 
However, none have shown the breakdown of calcium dynamics into individual 
components, and the present study is the first to do so, especially mESC derived 
astrocytes. Although it is not clear why the component breakdown of purinergic mediated 
activity in stem cell derived astrocytes have not previously been reported.  It may be 
partly attributed towards a narrow focus adopted by studies, where quicker generation of 
cells is more important than providing a robust characterisation, hence overlooking the 
necessity of individual component assessment. Assessment of individual components in 
primary astrocytes is based on the universally observed characteristics that the astrocytic 
calcium changes exhibit slower kinetics and higher amplitude rises. Rise time is 
universally defined as the time required for the transient to increase from 10% to 90% of 
its maximal amplitude, and data here shows that there were statistically significant 
increases – almost double when comparing DIV 7 to DIV 28, in mESCDA.  
 
For simplicity, the majority of researchers use the peak calcium response (Hamilton et al 
2008, Bernardinelli et al 2011), but alongside rise time, the entire calcium transient can 
also be quantified using area under the curve (AUC) and rate of calcium exit from cell i.e. 
decay tau (DT) (James et al. 2011). Assessment of area under the curve (AUC) and decay 
tau (DT) displayed significant differences between earlier and later DIVs. Both 
parameters displayed a reduction in response where there was significance mainly 
occurring between DIV 7 and DIV21/28. This suggests that cellular ability to display 
calcium dynamics levels out as the culture matures, as there is increased capacity of the 
cell to hold and diffuse calcium through changes in its expression of receptors and 
complexity in pathways (Volterra et al 2014; Shigetomi et al 2016). Similar to rise time, 
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there is no data which measures changes AUC and DT in stem cell derived astrocytes, 
subsequently providing novelty in temporal parameter assessment of purinergic mediated 
calcium response. Although direct comparisons between DIVs and studies cannot be 
performed, observation and comparison of results with primary cell cultures reveal 
mESCDA display similar decay and AUC properties (Centimeri et al. 1997; James et al. 
2011; Hashioka et a.l 2014). For example, rat primary cultures display decay tau kinetics 
similar to mESCDA – shown by Centimeri et al. 1997 and James et al. 2014. The decay 
phase of ATP stimulated rat cortical astrocytes lasted >60 seconds similar to mESCDA 
and showed a time dependent decline.  
 
Isolation of another robust parameter(s) apart from peak calcium response would allow 
researchers to better isolate and understand calcium mechanics in a more robust manner 
(Charlton and Vaquelin 2010). Furthermore, as the datasets for calcium dynamics are 
quite large, individual cellular or temporal identity may be lost (Mukamel et al. 2009). 
Here Principle components analysis (PCA) at DIV 28 was performed to understand 
which parameter is best for isolating and characterising astrocyte response. The results 
indicated that RT alone is sufficient in isolating and measuring astrocytic response, as it 
was shown to be one of the main components. As RT and DT made up more than 40% of 
mESCDA picked up, more than 26% of mESCDA are able to be reliably be picked up by 
PCA. The results here show that alongside peak response, rise time should be used in 
characterising and identifying astrocytes functionally. At this point, this detailed 
breakdown of purinergic calcium dynamics shown here has not been performed.  
 
Biological “noise” in expression levels of the calcium signalling apparatus overwhelms 
any difference observed when the individuals’ components are analysed. The hypothesis 
that calcium signal shape allows discrimination between stimuli is therefore almost 
certainly plausible, however assessing this hypothesis in a quantitative way has provided 
some issues. One of these challenges is the presence of noise and biphasic signals within 
the cultures. Although noise can be filtered out, biphasic calcium dynamics may require 
further analysis (Nobile et al 2001). Biphasic responses are characterised by calcium 
dynamics which contain a prolonged component during the decay phase, which is 
reported to be due to the influx of calcium from extracellular niche via store-operated 
channels (SOCE) or due to pore enlargement ionotropic receptors (e.g. P2XR7) 
(Hashioka et al. 2014). Within the culture, when biphasic responses were analysed across 
DIVs, there was an increase in average biphasic calcium dynamics - mainly in later DIVs 
(Fig. 28 and Fig. 29). Although the number of cells which had an increase in bipasic 
responses were negligible, this required further probing to fully elucidate the calcium 
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dynamics. Hence, receptor-specific assessments, such as pharmacological inhibition of 
receptors, to decouple metabotropic and ionotropic receptor contributions to the cellular 
calcium dynamics offer valuable insight into the differences in the responses seen of the 
generated mESCDA. 
 
4.4.2. Intracellular dynamics are responsible for ATP mediated signalling 
 
Analysis of receptor specific pathways was determined by using receptor specific 
antagonists. However, before receptor specific assessment, it was vital to understand 
whether ATP evoked calcium dynamics were a) not noise and b) were due to the rise of 
endogenous calcium and subsequent activation of further astrocytes. After having 
established that exogenous ATP application leads to calcium signalling in mESCDA via 
purinergic receptor stimulation, it was necessary to elucidate the significance of 
endogenous calcium in bringing about the characteristic calcium wave dynamics. 
Ionomycin– a calcium ionophore (Muller et al 2013) was used as a positive control. 
Application of 100 µM triggered a phasic increase in cytosolic calcium post ATP evoked 
calcium transient (Fig. 25). Post application there was a peak which was significantly 
different from ATP evoked calcium transients. This indicated an all or nothing response 
and this has occurred due to release of calcium within the intracellular (cytosolic) stores – 
via IP3 mediated release (Sherwood et al 2017). The results here confirmed intracellular 
machinery present in mediating and releasing intracellular calcium and disclosed the 
involvement of intracellular calcium in the observed ATP induced calcium dynamics (Fig 
22). 
 
4.4.3. Purinergic receptors mediate ATP evoked calcium response 
 
Once it was established that the ATP evoked responses were indeed due intracellular 
calcium and signalling cascades, the non-selective purinergic antagonist was used to 
confirm purinergic involvement in mediating calcium transients. Initially, application of 
non-selective antagonist suramin was used. Bath application of suramin significantly 
downregulated calcium dynamics across DIVs (Fig. 30). Peak analysis of the signals 
revealed a significant difference in DIVs 21/DIV28, with non-significant but reduced 
peak differences at earlier DIVs – 7/14, when compared non-treated cells (Fig. 31). This 
indicates an involvement of P2 receptors in calcium dynamics evoked by ATP. 
Additionally, the increase in potency of suramin leading to a stunted response may also 
be correlated due to increase receptors that it can bind to - as shown by PCR and 
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immunocytochemistry, leading to an increased ability of the antagonist to prevent 
calcium dynamics  (Ceruti & Abbracchio 2006). Similar to the component breakdown of 
ATP mediated responses, there is a lack of data on temporal dynamics of antagonist 
treated cells. Although, sufficient data lacks on stem cell derived astrocytes, recently 
Mizuno et al 2018 measured spontaneous calcium activity of human Down syndrome 
iPSC model of astrocytes. The study bath applied suramin after DIV 120 differentiation 
of astrocytes and measured spontaneous calcium dynamics, and saw a significant 
reduction in amplitude (around 2 fold). Similarly using P15 mice, analysis of white 
matter tract astrocytes Hamilton et al 2008 observed a similar reduction in ATP evoked 
suramin astrocytes. They observed 40% reductions in calcium response when compared 
to control ATP responses, comparable to what is observed at mESCDA at DIV 21. This 
subsequently confirmed and provided novelty in that the purinergic receptors were 
involved in mediating ATP evoked calcium dynamics in mESCDA, and these responses 
differed temporally. Furthermore, since PCA analysis displayed RT to be a significant 
parameter, subsequent analysis of RT dynamics displayed significant differences across 
DIVs. This novel analysis revealed inhibition of ATP receptors leads to longer time spent 
getting to peak maxima (Burnstock et al. 2014) 
 
Suramin results indicate the involvement of P2YR1 receptors in calcium dynamics 
evoked by ATP, as the Gq-GPCR-PLC-IP3 cascade is blocked, leading to reduced 
uncaging of calcium - showing intracellular cascade is necessary for calcium elevation 
observed. To further solidify P2YR1 involvement in mediating evoked calcium response, 
receptor specific antagonist MRS2719 was applied. The antagonist stunted the ATP 
evoked a response, and there was a significant decrease in activity in all of the DIVs 
when compared to ATP evoked transients (50% decrease when compared to ATP). This 
solidified the role of P2YR1 in mediating calcium dynamics that are visible with the 
mESCDA. These significant stunted responses have not been previously reported in stem 
cell derived astrocytes and were comparable to primary astrocytes. Studies conducted by 
Hamilton et al 2008, and Monar et al 2011 revealed similar truncation in responses . 
Hamilton et al 2008 saw a 50% reduction in responses, similar to what is observed in 
mESCDA at DIV 7. These stunted responses were similar to mESCDA observed at all 
the DIVs. This provided novel evidence of P2YR1 being involved in mediating calcium 
dynamics in stem cell derived astrocytes. Furthermore, these comparable observations 
were also observed in vivo, where Delekate et al 2014 report normalisation of astrocyte 
hyperactivity by blocking P2YR1 receptor on astrocytes (Delekate et al. 2014).  
 
	- 91 - 
4.4.4. Ionotropic receptor contributes rather than dictates calcium dynamics  
 
An alternative pathway involved in calcium transient is provided by activation of 
inotropic P2X7 (Nobile et al. 2003; Bartlett et al. 2014). Astrocytes can express a range of 
ionotropic P2X receptor subtypes, principally P2X1, P2X2, P2X3, P2X4, P2X6, and P2X7 
with the exception of P2X5 (Kukley et al., 2001), however, P2X7 has shown to be, to 
some extent, involved in calcium signalling (James and Butt 2002, Pascual et al. 2005). 
Immunostaining and genetic analysis revealed P2X7 existence and variability across the 
DIVs (Fig…). P2X7 displays a significant permeability to calcium in astrocytes (North 
2002; Pascual et al. 2005). Therefore, to fully elucidate the role of P2X7 in mESCDA, 
BBG was added and calcium transients observed. The addition of P2X7 selective 
antagonist BBG revealed negligible involvement of the receptor in calcium transients. 
There were no significant changes observed in calcium dynamics at later DIVs, however 
at DIV7 there was a significantly weakened response. This was further confirmed during 
the qualitative assessment of the waves, where alongside reduction in peak differences 
and changes in resting calcium, there was no presence of bi-phasic transients (Hashioka et 
al. 2014). The abolishment of bi-phasic response may show involvement of P2X7 in the 
decay phase, although this is yet to be fully shown by other studies. Nevertheless, due to 
no significant quantitative changes observed, it is essential to rule these changes out as an 
artefact or saturation in signal after ATP simulation. Furthermore, as there is no 
conclusive evidence of P2X7 involvement in other components such as rise time, this 
shows P2X7 as an auxiliary receptor, rather than dictating calcium responses within 
mESCDA (James and Butt 2002, Burnstock et al. 2010; Puchałowicz et al. 2015).  
 
Thus, in mESCDA P2YR1 provide major and comparable components to calcium 
signalling at the application of agonist ATP. Activation of P2Y1 receptors results in a 
rapid but transient release of calcium from intracellular stores and, this is followed by a 
slower and prolonged influx of calcium through P2X7 receptors and other store operated 
calcium entry (SOCE) machinery, which continues long after the application of the 
agonist. The results are consistent with the proposed principal role of P2YR1 receptors in 
physiological signalling and an accompanying supplementary role for P2X7 (James and 
Butt 2002). The expression of multiple P2 receptors with different affinities for ATP, 
different sources of calcium, and different kinetics of the calcium signal provides a 
mechanism for a graded astrocyte response that depends on the extracellular level of ATP 
which further needs to be considered. 
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4.4.5. Study improvements and future directions  
 
The evidence here shows ATP caused an increase in of calcium dynamics from generated 
mESCDA, and these changes are mediated by involvements of purinergic receptors. The 
concentration of ATP used was decided by extensive literature review, however the study 
here could benefit from a dose dependent assessment of the mESCDA. For example, 
Azzic & Nedeljkovic 2018 show there are changes in calcium dynamics in terms of peak 
differences when ATP at different concentration is applied onto astrocytes isolated from 
mice (Adzic & Nedeljkovic 2018). Nevertheless, regardless of the concentration, there is 
a clear rise and decay which is seen and therefore justifies the usage of one specific 
concentration of ATP to confirm the presence of calcium dynamics (Hamilton et al. 
2008). Nevertheless, in vivo, the dynamic interplay between neurons and astrocytes 
would lead to different concentration of ATP (Adzic & Nedeljkovic 2018), and this 
would be essential to fully test the role of mESCDA within co-cultures. Additionally, 
alongside testing different concentrations of ATP, one could also test augmenting 
receptor specific responses. For example, (Zeng et al. 2008) selectively activated P2YR1 
by applying ADPbetaS, and observed a significant increase in calcium dynamics. 
Therefore, alongside antagonist responses, mESCDA ability to attenuate a response 
should also be measured (Zeng et al 2008).  
 
Astrocytic Gq-GPCR/PLC/IP3 signalling pathway has been extensively studied in vivo 
and in vitro (Sherwood et al 2017). Available evidence indicates that astrocytes release 
gliotransmitters and mediate their calcium dynamics in a Gq G-protein-coupled receptor 
(GPCR)/IP3R-mediated calcium dependent manner (Pasti et al. 1997; Jeremic et al. 2001; 
Tang et al. 2016). Three IP3R subtypes have been identified, IPR1, 2, and 3, and majority 
of evidence pointed towards heavy IP3R2 involvement in astrocyte calcium dynamics 
(Petravicz et al. 2008; Sherwood et al. 2017). Analysis of IP3R2 in generated mESCDA 
revealed extensive expression of IP3R2 across all DIVs in generated mESCDA (Fig. 6). 
Furthermore, as P2YR1 is a Gq-GPCR, the activation Gq-GPCR/PLC/IP3 signalling 
mediated signalling should be assessed using receptor specific blockers for IP3R2. 
However, during the assessment of calcium dynamics, study from Petravicz et al 2014 
reported an unexpected finding that ablation of IP3R2 in GFAP positive astrocytes leads 
to no detectable alteration behaviour and neuronal activity in mice (Petravicz et al 2014). 
Although evidence has now criticised, where Sherwood et al 2017 show involvement of 
astrocyte IP3R2 in long term potentiation (LTP) in mouse hippocampus. More recently, 
evidence on the involvement of IP3R3 has now also been brought forward (Sherwood et 
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al 2017), where it has been postulated that IP3R2 and IP3R3 work in tandem to mediate 
calcium response. Therefore, due to the scope of the study, and also due to reduce 
availability of highly selective IP3 blockers (Saleem et al. 2014), IP3 mediated receptor 
specific antagonism was not pursued. Therefore, in light of recent evidence and 
significant interest of the field, the generated mESCDA could benefit from performing 
this analysis.  Nevertheless, as a proof of principle and to fully elucidate the involvement 
of P2YR1 receptor and the downstream pathways involved in rise in calcium dynamics, 
phosphate PLC was selectively blocked via application of U73122 (Fig.36). DIV 28 
mESCDA revealed a significant reduction in calcium kinetics when compared to ATP 
mediated signals. However, the result is performed on n=1 and on DIV 28 mESCDA. 
Subsequent increase in n numbers and further analysis on the rest of the DIVs would 
beneficial.  
 
Similarly, the role of P2X7 could also be tested by applying an agonist such as Bz-ATP 
(Nobile et al 2003). The evidence of biphasic and monophonic responses that are 
mediated by P2X7 receptors (Hashioka et al. 2014) could also be assessed by applying 
P2X7 agonists. By application of Bz-ATP Nobile et al 2003 evoked a small peak post 
maximal peak at the plateau phase on rat cortical astrocytes, similar to what is observed 
here in some of the mESCDA across the DIVs. 
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5. Integration and isolation ability of mESCDA 
 
5.1. Introduction  
 
Cell culture (in vitro) models have an advantage of virtually unlimited availability and 
quick reproducible results which allow rapid screening for diseases and drug candidates 
(Hanna & Hubel 2009). In vitro models offer advantages over in vivo models in multiple 
aspects. For example, in vitro models have an advantage of providing unlimited 
availability of cell type of interest via creating a cell bank (Stacey 2012). Subsequently 
providing a model for quick and reproducible results which allow rapid screening for 
plethora of assays such as measurement of disease pathogenesis in neurodegenerative 
diseases or assessment of drug candidates for pharmacological assays (Stacey 2012). 
Furthermore, these in vitro models prevent the need of ubiquitous use of animals. 
Nevertheless, the majority of the in vitro models used do not represent the conditions 
seen in vivo. Most culture conditions have cellular homogeneity, where one cell type 
which of interest is grown (Altschuler & Wu 2010). For example, when unravelling the 
complexity of neurodegenerative and neurodevelopment disorders, experiments are 
mainly performed on neurons rich cultures. Despite the fact that neuronal monocultures 
are extensively used extensively to recapture CNS niche, these cultures represent 
unnatural environmental conditions, since in vivo neurons are heavily surrounded by glial 
cells such as astrocytes (Ullian et al. 2001; Boehler et al. 2008). In the past, astrocytes 
have traditionally been considered as passive elements, providing a metabolic support for 
neurons and regulating the extracellular homeostasis (MacVicar et al 2017). However, 
evidence in the last decade has revealed that astrocytes are also actively involved in the 
control of neuronal functions and neuronal survival (Fellin 2009; Covelo & Araque 
2015). Therefore, to mimic in vivo environmental niche, and since neurons in the brain 
are embedded in a complex interaction network together with astrocytes, a co-culture 
model of both cell types are currently being adopted (Farhy-Tselnicker et al. 2018).  
 
The most used method for obtaining astrocytes is isolation from murine resources 
(Schildge et al. 2013). These methods are hampered by inter-laboratory variability and 
contamination with a high amount of microglia, oligodendrocytes, neurons, and 
endothelial cells (Martin 1981; Schwartz & Wilson 1992; Schildge et al. 2013). 
Therefore, the newly generated pure astrocytes cell lines have received much attention. 
The mESCDA generated here (chapter 2) provide a suitable model to develop a co-
culture system, as they are heterogeneous group of astrocytes which display characterises 
in form and function similar to the in vivo counterparts.  
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5.1.1. Isolation techniques  
 
Efficient isolation protocols have been established and can be usually broken down into 
two main groups, mechanical and enzymatic (Jager et al. 2016). Mechanical dissociation 
methods may involve a combination of, cell scraping, usage of filters, use of devices such 
as homogenisers, and various other approaches. Enzymatic dissociation methods include 
the application of proteolytic enzymes such as Trypsin/EDTA, Accutase, alone or in 
combination. One of the most ubiquitous enzymes used is Trypsin/EDTA (Pan et al. 
2014; Fong et al. 2017). Trypsin is a pancreatic serine protease which cleaves to peptide 
bonds involving the carboxyl group amino acids. Purified trypsin alone is usually 
ineffective for tissue dissociation since it shows little selectivity for extracellular proteins 
(Hui et al. 2015). Combinations of purified trypsin and other enzymes such as EDTA 
(disodium ethylenediaminetetraacetic acid) which chelates the divalent cations (Ca2+, 
Mg2+), allows trypsin to work effectively and efficient removal of cells (Beers et al. 
2013). Evidence has shown that Trypsin/EDTA is a harsh enzyme which causes cell lysis 
and changes in cellular function, and reduces the ability to replace and reuse cells for 
future  (Li et al. 2014). Additionally, when working with stem cells, trypsin doesn’t 
effectively break up the large clusters and leads to increased cellular clumping (Cowan et 
al. 2004). Therefore, more recently less harmful enzymes such as accutase are used. 
Accutase does not contain EDTA and is a marine-origin enzyme with proteolytic and 
collagenolytic activity, leading to effective breaking down of cells (Bajpai et al. 2008). 
Accutase has mainly been used when cultivating cells such as stem cells, and has shown 
to be more effective leading to increased cell viability, and increased plating efficiency 
(TCW et al 2017).  
 
However, aspects of enzymatic dissociation such as an understanding of the mechanisms 
regulating adhesion and incorporation into tissue, the time required for effective and 
increased cell removal and the right type of enzyme for the right type of cell are not well 
understood (Jager et al. 2016). There has been no comprehensive study of the impact of 
different methods of detachment of cells on the functionality, viability and structural 
ability of the cells. Moreover, there is also no comprehensive study on stem cell derived 
astrocytes, which shows effective removal of cells from a substrate, and which measures 
removed cells functional and structural ability. Therefore, the study here aims to assess 
first the efficient method of removal of generated mESCDA. Once an efficient method 
was chosen, the study aims to assess whether these isolated mESCDA are able to have 
similar functional and expression ability as the generated mESCDA and primary 
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astrocytes. Finally, the isolated mESCDA will be tested for their integration ability into a 
neuron rich culture and will be tested for their ability to rescue neurons, this will aim to 
contribute towards in vitro model which can be used for co-culture studies to test for 
neurodevelopment and neurodegenerative studies.  
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5.2. Materials and Method 
 
5.2.1 Materials 
 
 
 
Table 7: Materials used for isolation and integration of mESCDA  
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5.2.2. Generation of mESCDA for mechanical assessment  
 
The EB based isolation of mESCDA was for these experiments (see chapter 3). Briefuly, 
20 intact EB’s were seeded directly onto laminin-coated 13mm coverslips containing 
astrocyte differentiation media (ADMEM/F12, 2% FBS, N2, 1% L-glutamine, 1% 
Pen/Strep, 100uM β-mercaptoethanol and 50ug/mL heparin (Robertson and Goldstein 
1988; Nagayasu et al. 2005) (Sigma Aldrich, Poole, UK), were grown for 28 DIVs.  
 
5.2.3. Generation of neuron-rich culture for integration  
	
Cultures of mESC were used when they reached 80% confluency, with a serum based 
media containing DMEM and FBS with 1uM of LIF to prevent spontaneous 
differentiation. 
 
Media Recipe 
 
Aggregation Medium (ADFNK) 
 
• Advanced DMEM/F12 – Neurobasal (1:1) 
• 10% Knockout Serum Replacement 
• 1% Penicillin/Streptomycin   
• 1% L-Glutamine 
• 100uM 2-Mercaptoethanol 
 
Neuronal Medium (ADFNB) 
 
• Advanced DMEM/F-12 -  Neurobasal medium (1:1)  
• B-27 supplement  
• 1% L- Glutamine  
• 100uM β-mercaptoethanol  
• 1% Pen/Strep  
 
Step by step method 
 
1. Confluent flask of mESC cells (around 80%) was taken and medium aspirated 
from the flask. 
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2. The flask was then washed in 5 ml PBS. 
3. PBS was aspirated and cells in flask were exposed to 2 mL Trypsin/EDTA for 2 
minutes 
4. Flask was gently agitatated until top layer of mESC cells were detached 
5. Trypsin/EDTA was inactivated with 3 mL mESC media (See above) and the 
lifted cells were transferred to a 20mL universal tube. 
6. Cells were centrifuged for 5 minutes at 180g 
7. Supernatant aspirated and cells were resuspend cells in 2mL ADFNK medium 
8. Cells counted haemocytometer 
9. Cells were seeded in mESC cells in ADFNK medium, at a density from 2 x 104 
to 2.5 x 105, (recommended 50,000 cells/mL) in either non-tissue culture treated 
6-well plates or petri dishes. For a petri dish, 500,000 cells per 10 mL is 
sufficient. 
10. Cells were incubated at 37°C for 2 days, by which time aggregates were formed 
and found to be floating in the medium. 
11. After 2 days EBs were exposed to fresh ADFNK media containing either 
containing retinoic acid (RA) at 1uM or no retinoic acid (depending on the 
methodology required and tested, see results). Media was also changed to remove 
non-EB formed cells and any debris 
12. At day five, if RA was added it was removed and fresh ADFNK media was 
added by transferring medium containing EBs to a 15 mL centrifuge tube. The 
EBs were allowed settle under gravity.  
13. The supernatatnt was aspirated and EBs were gently resuspend in fresh ADFNK 
media and transfered to petri dish for further incubation  
14. At DIV 6 EBs were treated with 0.05% trypsin for 60 seconds, re- suspended in 
ADFNB medium  
15. Cells were passed through 70 µm cell strainer and centrifuged at 500g for 5 min  
16. Cells were resuspended in ADFNB medium  
17. Cells were plated at a density of 50,000 cells/cm2 in 12/24 plates coated with 
2µg/cm2 laminin  
18. The cells were assessed via bright field microscopy every day and differentiated 
for up to 7 days with the media changed every other day and assessed via bright 
field microscopy every day and differentiated for up to 7 days.  
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5.2.4. Primary astrocyte rich cultures 
 
E18 mouse cortex was obtained from BrainBits (BrainBits UK). Tissues were 
dissasociated in 2mg/ml papain containing Hibernate E and GlutaMax (Sigma Aldrich, 
Poole, UK) for 10 minutes at 37C. Tissue was triturated using silanised pasture pipette 
for 1 minute, at a gentle speed, to avoid air bubbles and the cell was left to settle for 60 
seconds. The cells were then centrifuged at 1100 rpm for 60 seconds and the supernatant 
discarded. Cells were then resuspended in nbAstro medium (Neurobasal, 10% Fetal 
Bovine Serum (FBS) and Glutamax (Thermo Fisher). Suspended cells were counted, with 
the aid of Neubauer chamber (Sigma Aldrich, Poole, UK) and cells were plated at the 
density of 7,500 cells/cm2 in laminin-coated coverslips and grown for 6 DIVs and stained 
to assess the growth of astrocytes.  
 
5.2.5. mESC derived astrocyte and neuronal co-cultures 
 
Primary astrocyte rich cultures  
 
E18 mouse cortex was obtained from BrainBits (BrainBits UK). 
 
Media Recipe  
 
Dissociating media  
 
• Hibernate E  
• 1% GlutaMax  
• 2mg/ml papain  
 
Primary astrocyte medium  
 
• Neurobasal,  
• 10% Fetal Bovine Serum (FBS)  
• 1% Glutamax 
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1. Tissues were disassociated in dissociating media for 10 minutes at 37°C, 5% CO2 
2. Tissue was triturated using salinized pasture pipette for 1 minute, at a gentle 
speed, to avoid air bubbles and the cell was left to settle for 60 seconds  
3. The cells were then centrifuged at 1100 rpm for 60 seconds and the supernatant 
discarded  
4. Cells were then resuspended in Primary astrocyte medium  
5. Suspended cells were counted, with the aid of Neubauer chamber and cells were 
plated at the density of 7,500 cells/cm2 in laminin-coated coverslips and grown 
for 6 DIVs and stained to assess the growth of astrocytes 
 
5.2.6. Enzymatic dissociation of mESCDA  
 
For enzymatic disassociations, cells were centrifuged, re-suspended in 1 mL enzymes 
(Accutase or Trypsin/EDTA - ThermoFisher, UK), and incubated at 37C in the water 
bath for time-points 15, 30 or 60 minutes. Cells were then centrifuged and re-suspended 
in astrocyte media and incubated at 37C in the water bath for 10 min. Half-way through 
both incubation periods, tubes were shaken lightly to re-suspend cells. Cells were then 
centrifuged and resuspended in 1 mL of astrocyte media and plated onto laminin-coated 
coverslips, as above.  
 
5.2.7. Mechanical dissociation  
 
To test the efficacy of enzymatic dissociation, mechanical dissociation was also 
performed. At DIV 28, mESCDA grown on laminin-coated coverslips were scraped using 
corning cell scraper (Sigma Aldrich, Poole, UK). Post scraping, cells were passed 
through a 70 µm cell strainer to derive a suspension of single cells and prevent embryoid 
bodies (EBs) to occur in culture. Cells were then triturated 2 or 3 times at 200 mL 
astrocyte media maintaining a consistent speed of approximately 3 times per 2 seconds. 
Large clusters were allowed to settle before 180 mL was transferred to a new tube. 
Another 200 mL DMEM was added and cells were again triturated, settled, and 
transferred. The process was repeated for a total of 10 or 15 trituration and a final volume 
of 1 mL.  
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4.2.8. Immunocytochemistry 
 
 
 
Table 8: Antibodies used for immunofluorescence  
 
 
Immunocytochemistry was performed with same methodology as in previous chapters 
(see chapter 2) with antibodies that are detailed in Table 8. Isolated mESCDA were fixed 
at DIV 2 and washed three times with PBS at fixed with 3.7% formaldehyde in PBS for 
30 minutes, and permeabilised with 0.02% Triton X-100 diluted in 10% goat serum for 
10 minutes. Nuclei were counterstained with H-33342 (Hoechst dye). Images were taken 
using an Axio Imager microscope (Zeiss, Germany).  
 
Separate digital images (red 568nm, green 468nm, blue 350nm - RGB) of astrocyte stains 
(green and red light) and DNA (Hoechst 33342) were captured with a ×20 objective 
(1040x1388 pixels). Focus was adjusted for each new field, but fluorescent illumination 
and exposure were kept constant to improve consistency during analysis. Scale bars were 
calibrated using AxioVision software (release 4.6.3; Carl Zeiss). Files were saved in 
tagged image file format (.tif) and JPEG (.jpeg).  
 
5.2.9. Calcium Imaging of isolated mESCDA and primary astrocytes 
 
Calcium imaging was performed as before (Chapter 3). Briefly, isolated, generated, and 
primary astrocytes were imaged using Fluo-4 acetoxymethyl ester dye at 2.5 µM in 
HEPES buffer same as above methods (see chapter 3).  Post loading, cells were then 
moved to the recording chamber and all fluorescence measurements were made at 37C 
(Warner Instruments) with no CO2 control for 5 minutes – 300 Seconds. Excitation and 
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emission wavelengths were 494 nm and 516 nm respectively. Changes in calcium were 
detected with an inverted Nikon Eclipse TE2000-S microscope (Nikon) equipped with a 
xenon arc lamp (Sutter Instruments). Imaging Workbench 6.0 (INDEC Bio- Systems) 
was used to control a Lambda 10-2 shutter system (Sutter Instruments). 
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5.3. Results  
 
Removal of EBs is essential to obtain a pure astrocyte rich culture for future studies. 
Additionally, creating a cell bank is also essential (Lange et al 2012, Waang et al 2012). 
This will allow a non-stop supply of cells, to allow future studies to be conducted and a 
cell line to be created (Altschuler et al 2010). Hence, removal of anchored cells to 
coverslips was examined via mechanical and enzymatic isolation techniques (Aronowitz 
et al 2015, Jager et al 2016). Generated DIV 28 mESCDA were incubated in enzymes 
Trypsin/EDTA and Accutase for 15, 30 and 60 minutes, and then re-plated onto laminin 
coated coverslips. Furthermore, to determine if enzymatic treatments is an ideal 
methodology for efficient cell removal, cells were also scraped using a cell scraper and 
re-plated laminin coated coverslips  (Aronowitz & Hakakian 2015). Using 
immunocytochemistry, cells were assessed for astrocytic markers, ALDH1L1 and GFAP 
to determine the effectiveness of treatment. 
 
5.3.1. Single cell dissociation with Trypsin/EDTA  
	
Treatment and incubation of DIV 28 mESCDA with Trypsin/EDTA, led to effective 
dissociation of the majority of the cells at all the time points – observed via brightfield 
images (Fig. 37). From the 15 minute period, the monolayer of cells were seen to be 
detached from the laminin coated coverslips, suggesting Trypsin/EDTA effectively 
detached anchor proteins such as integrins, leading to effective cell removal (Pan  
et al 2014). Nevertheless, Trypsin/EDTA also compromised the EBs integrity and 
detached cells within the EBs, subsequently suggesting the accumulation of debris (Fig. 
37B - arrow) (Huang et al 2010). 
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Figure 37: Brightfield micrographs of astrocytes incubated with (A) 15, (B) 30 and (C) 60 
minutes with Tryspin/EDTA. Arrows point to disintegrated EB. Image acquired a x20 
magnification. 
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Figure 38: Immunocytochemistry images of astrocytes incubated with (A) 15, (B) 30 and 
(C) 60 minutes with Tryspin/EDTA. Isolated mESCDA reliably labelling for GFAP 
(Red), and ALDH1L1 (Green) at DIV2 post isolation from Trypsin/EDTA. Cultures have 
been counterstained for cell nuclei marker H- 33342 (blue stain). Scale bar = 20µm. 
 
To effectively remove debris, cells were filtered through a 70um cell strainer and 
repeated onto laminin coated coverslips for 2 days. Assessment of re-plated cells onto 
laminin coated coverslips post incubation with Trypsin/EDTA was performed for 
astrocyte markers (Fig. 38). Assessment of GFAP positive cells revealed a stable 
expression of cells (>100 cells/mm2) at groups of cells obtained from 15 and 30 minutes 
(Fig. 38/Fig. 39). However, in comparison there was a significant increase at the group of 
cells plated from 60 minutes (273.3 cells/mm2 ± 40.24 n=3) when compared to both 15 
(>125.5 cells/mm2, ± 21.25 n=3) and 30 (144.7 cells/mm2, ± 20.16 n=3) minutes groups 
(Fig. 39A). Inspection of ALDH1L1 cells revealed a stable expression across all time-
points (Fig. 38B). There was a non-significant increase at 60 minutes group (955.80 
cells/mm2 ± 90.04 n=3), when compared to both 15 minutes (818.0 cells/mm2 ± 110.19 
n=3) and 30 minutes (655.80 cells/mm2 ± 310.24 n=3) respectively. Additionally, when 
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comparing the number of cells, there are significantly more ALDH1L1 positive cells 
(>900 cells/mm2) when compared to GFAP positive cells (>200 cells.mm2) (Fig. 39). 
The morphological assessment also revealed the GFAP positive cells displayed an 
enlarged cytoplasm, with protrusions extending from the cytoplasm (Fig. 36).  
 
 
Figure 39: Quantification of marker expression. (A) Number of GFAP positive cells per 
mm2. (B) Number of ALDH1L1 positive cells per mm2. All data are expressed as mean 
± SEM from three separate experiments, *P < 0.05, **P < 0.01, ***P < 0.001) Mann-
Whitney statistical tests 
 
Figure 40: Representative ATP evoked responses of isolated mESCDA with  
Trypsin/EDTA. Isolated mESCDA reveals purinergic response similar to generated 
mESCDA and revealed transients which are bi-phasic in nature (black arrow at DIV 7 
showing bi-phasic response). 
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Based on the immunocytochemical analysis, calcium assessment of 60 minute group was 
performed - as this group yielded the most number of astrocytes. Similar to previous 
experiments, Flou-4 loaded cells were stimulated with ATP, subsequently leading to 
intracellular calcium rise and a calcium response (Fig. 40). The 60 minute group provided 
a typical purinergic calcium response comparable to previous mESCDA calcium 
dynamics and displayed a clear rise and decay phase. Nevertheless, on closer inspection, 
there were clear dual peaks observed within the peak response of the curve (Fig. 40 -
arrow). The second peak occurred at a significantly later time point. This suggests 
changes in mechanisms of actions brought about by Trypsin/EDTA.  
 
5.3.2. Single cell dissociation with Accutase of mESCDA  
 
Similar to Trypsin/EDTA, DIV 28 mESCDA were also treated with Accutase (Bajpai et 
al 2008). Assessment of accurate displayed effective dissociation of cells at all the time 
points, similar to Trypsin/EDTA – observed via brightfield images (Fig. 41).  
 
Figure 41: Brightfield micrographs of astrocytes incubated with (A) 15, (B) 30 and (C) 60 
minutes with Accutase. Image acquired a x20 magnification. 
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Nevertheless, the EBs integrity was not compromised (Fig. 41). Inspection of all the 
groups (15-60 minutes) also displayed reduced removal of monolayer when compared to 
Trypsin/EDTA, suggesting Accutase does not effectively dissociate cells from laminin 
coated coverslips. Nevertheless, cells were still passed through a 70um cell strainer to 
remove debris. Similar to Trypsin/EDTA, assessment of re-plated cells onto laminin 
coated coverslips post incubation was performed for astrocyte markers (Fig. 42). 
 
 
Figure 42: Immunocytochemistry images of astrocytes incubated with (A) 15, (B) 30 and 
(C) 60 minutes with Accutase. Isolated mESCDA reliably labelling for GFAP (Red), and  
ALDH1L1 (Green) at DIV2 post isolation from Accutase. Cultures have been 
counterstained for cell nuclei marker H- 33342 (blue stain). Scale bar = 20µm. 
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Figure 43: Quantification of marker expression. (A) Number of GFAP positive cells per 
mm2. (B) Number of ALDH1L1 positive cells per mm2. All data are expressed as mean 
± SEM from three separate experiments, *P < 0.05, **P < 0.01, ***P < 0.001) from 
unpaired T-test.  
 
Assessment of GFAP positive cells revealed a stepwise increase in cell numbers (>100 
cells/mm2). Group comparison revealed a significant increase between 60 minutes (137.2 
cells/mm2 ± 8.11 n=3) when compared with 15 minutes (>100.5 cells/mm2, ± 11.15 n=3) 
(Fig. 42/43A). Inspection of ALDH1L1 cells revealed a stepwise by non-significant 
expression across all time-points (Fig. 43B). There was a non-significant increase at 60 
minutes group (230.8 cells/mm2 ± 121.04 n=3), when compared to both 15 minutes 
(153.0 cells/mm2 ± 66.91 n=3) and 30 minutes (168.80 cells/mm2 ± 84.24 n=3) 
respectively. Additionally, when comparing the number of cells, both markers display a 
similar number of cell expression with >100 cells/mm2. Similarly, in comparison to 
Trypsin/EDTA, morphological assessment of GFAP positive Accutase treated cells 
revealed morphology reduced cell size and less but elaborate protusions with high co-
localisation with ALDH1L1 (Fig. 42C), comparable to mESCDA at DIV 28 - see 
previous chapter.  
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Figure 44: Representative ATP evoked responses of isolated mESCDA with Accutase. 
Isolated mESCDA reveals purinergic response similar to generated mESCDA and 
revealed transients which are bi-phasic in nature – similar to Trypsin/EDTA (black arrow 
at DIV 7 showing bi-phasic response). 
 
Similar to Trypsin/EDTA, calcium assessment of 60 minutes group was performed. Cells 
were loaded with Flou-4 and stimulated with ATP. This led to an intracellular calcium 
rise and a calcium response (Fig. 44). The 60 minute group provided a typical purinergic 
calcium response comparable to previous mESCDA calcium dynamics (Fig. 24) and 
displayed a clear rise and decay phase. Nevertheless, on closer inspection, similar to 
Trypsin/EDTA, Accutase treated cells also displayed dual peaks (Fig. 42 - arrow).  
 
5.3.3. Mechanical isolation of mESCDA 
 
To solidify whether enzymatic treatments is truly necessary for effective removal and 
isolation of pure population of astrocytes, mechanical isolation was also performed 
(Beers et al 2012, Bellei et 2017) cells were scraped from the laminin coated coverslips 
using a cell scraper with 1.8cm blade, and cells were subsequently passed through a 70 
um cell strainer - to remove debris and attached EBs. Similar to enzymatic treatments, re-
plated cells were similarly assessed for astrocyte markers GFAP and ALDH1L1. There 
was a significant increase in ALDH1L1 (125.75 ± 25.24 n=3) positive cells when 
compared to GFAP positive cells (79.05 ± 45.15 n=3), with morphologies which 
resemble mESCDA - extensive cytoplasm with elaborate protrusions of GFAP positive 
cells (Fig. 45A/B).  
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Figure 45: Immunocytochemistry images of mechanically isolated astrocytes. (A) 
Isolated mESCDA reliably labelling for GFAP (Red), and ALDH1L1 (Green) at DIV2 
post isolation. (B) Quantification of marker expression. Number of GFAP and ALDH1L1 
positive cells per mm2. All data are expressed as mean ± SEM from three separate 
experiments, *P < 0.05, **P < 0.01, ***P < 0.001) Cultures have been counterstained for 
cell nuclei marker H- 33342 (blue stain). Scale bar = 20µm. 
 
Figure 46: Immunocytochemistry images of mechanically isolated astrocytes. Isolated 
mESCDA reliably labelling for GFAP (Red), and Vinculin (Green) at DIV2 post 
isolation. Cultures have been counterstained for cell nuclei marker H- 33342 (blue stain). 
Scale bar = 50µm. 
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Figure 47: Representative ATP evoked responses of mechanically isolated mESCDA. 
Isolated mESCDA reveals purinergic response similar to generated mESCDA and 
revealed transients which are mono-phasic in nature.  
 
Evidence dictates that significant force that is applied during mechanical isolation 
prevents focal adhesions, such as vinculin, to occur leading to significant cell loss 
(Grashoof et al 2010). To assess cellular ability to adhere to laminin coated coverslips, 
and to show mechanical isolation does not impair cell ability to anchor itself, vinculin 
staining was performed (Fig. 46). The staining revealed vinculin surrounding the 
cytoskeleton of re-plated astrocytes, further confirming the viability of isolated cells (Fig. 
47). Similar to enzymatic isolation, when observing the calcium dynamics of scraped 
cells, there was a clear rise and decay transient with no presence of dual peaks (Fig. 47). 
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5.3.4. Comparison of primary astrocytes with isolated mESCDA 
 
To confirm whether the isolated mESCDA cells are a viable tool for further research use, 
functional and morphological assessment of mESCDA and isolated mESCDA with 
primary cortical astrocytes was performed. 
 
Figure 48: Immunocytochemistry images of astrocytes. (A) DIV 28 generated mESCDA 
(B) Mechanically isolated mESCDA (C) Primary cortical astrocytes reliably labelling for 
GFAP (Green) and showing similar morphology. Cultures have been counterstained for 
cell nuclei marker H- 33342 (blue stain). Scale bar = 20µm. 
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As cells with mechanical isolation provided comparable immunocytochemistry and 
calcium dynamics with generated mESCDA, these isolated cells were compared with 
primary cortical astrocytes (Fig. 48). Immunocytochemistry analysis for astrocyte marker 
GFAP of DIV 28 mESCDA, isolated astrocytes, and primary astrocytes revealed 
comparable staining (Fig. 48). All of the groups (DIV 28 mESCDA, Isolated mESCDA, 
and primary astrocytes) morphologies were comparable to each other - where there were 
extensive protrusions.  
 
 
Figure 49: Comparative representative ATP evoked responses of astrocytes. (A) Biphasic 
responses of DIV 28 generated mESCDA (B) Mechanically isolated mESCDA (C) 
Primary cortical astrocytes reliably labelling showing similar calcium dynamics which 
are mono-phasic in nature. 
 
Similarly, ATP evoked calcium dynamics of all these groups were compared and showed 
similar calcium transients (Fig. 49). There were a clear rise and decay phases, and when 
comparing the rise time were similar of DIV 28 mESCDA (6.50 seconds, n=1), isolated 
mESCDA (6.86 seconds, n=1) with a reduction in primary astrocytes (5.68 seconds, n=1). 
Similarly, decay tau also revealed no difference between the groups, DIV 28 mESCDA 
(78.68 seconds, n=1), isolated mESCDA (68.51 seconds, n=1) primary astrocytes (74.20 
seconds, n=1), revealing the isolated and majority of generated mESCDA are comparable 
to their primary counterparts.  
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5.3.5. Neuron rich and isolated mESCDA ability to integrate  
 
Figure 50: Integration ability of mESCDA. (A) Example of neuron rich culture (B) 
Treatment of neuron rich cultures with Ara-C results in extensive neuronal and astrocytic 
loss. (C) Direct seeding of mechanically isolated mESCDA show integration and survival 
ability of mESCDA and growth of neuronal cultures.  Cells staining for b-Tubulin III 
(TUJ1) (Green) and GFAP (Red) counterstained for cell nuclei marker H- 33342 (blue 
stain). (A) Scale bar = 200µm, (B) Scale bar = 100µm, (C) Scale bar = 50µm 
 
Cytosine arabinoside (AraC) treatment and integration ability of isolated mESCDA 
Neuron rich cultures were developed by following Pjelto et al 2012 protocol (Fig. 49A) to 
test isolated mESCDA ability to integrate and enhance network growth (Pjelto et al 
2010). The neuron rich cultures were shown to contain astrocytes - observed by GFAP 
positive cells (Fig 50A). To selectively limit the number of natively produced astrocytes 
and limit further astrocyte division, anti-mitotic cytosine arabinoside (AraC) was used 
(Delivopoulos & Murray 2011). AraC was able to remove the majority of astrocytes (Fig. 
50B), with few neuronal clusters remaining alongside it. These few neural clusters are not 
able to form elaborate networks seen from non-treated group (Fig. 50B). Mechanically 
isolated mESCDA at a density of 100 cells/mm2 were seeded onto Ara-C treated 
cultures. Immunostaining revealed that isolated mESCDA were able to integrate into the 
network of surviving neurons and promoted axonal and dendritic growth (Fig. 50C).  
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5.4. Discussion  
 
Cell isolation and harvesting are principal techniques which are ubiquitously used in 
tissue culture research and cell biology studies to isolate populations of cells for future 
studies. In in vitro systems, trying to recapture what occurs in the brain is vital, therefore, 
isolation of one cell type and assessing their role is necessary to fully elucidate the 
function of that specific subtype of cell within the network (Altschuler & Wu 2010). A 
widespread of methodologies are employed for cell isolation, however, they can be 
usually broken down into two main groups, mechanical and enzymatic (Jager et al. 2016). 
Mechanical isolation has shown to be a harsh process which leads to accumulation of 
debris and has shown to have high contamination rates (Aronowitz & Hakakian 2015) 
therefore the widespread use of enzymes recently has been for isolating of cells over the 
years. Enzymatic methods have the advantages: they have been shown to be easy to use, 
provide reduced contamination with debris, and require no additional equipment (Beers et 
al. 2012). However, their mechanisms of action in dissociation and harvesting are not 
fully well understood. Moreover, there is the presence of a plethora of enzymes for 
enzymatic treatment, testing and identifying the optimal enzyme lead to increase time 
spent solidifying a protocol (Jager et a.l 2016). As a result, the choice of one technique 
over another is often subjective and it is based on past experiences and successes rather 
than on an understanding the method and what modifications could lead to even better 
results.  
 
While this study is not the first study to approach the subject of how to best isolate cells 
from cultures, it provides novelty in its comparison of time points and its comparison 
with mechanical isolation.  
 
5.4.1. Enzymatic treatment of mESCDA reveals presence of reactive astrocytes 
 
The process of enzymatic treatment with enzymes such as, accurate and Trypsin/EDTA, 
cleaves proteins (such as cadherins, integrins, and dystroglycan) which enable the cells to 
adhere to the surface (Pan et al. 2014; Fong et al. 2017). Cleavage of these proteins 
allows detachment of the adhered cells (Pan et al. 2014). Nevertheless, it is necessary to 
not allow cells to be exposed to enzymes for too long, as they may permeabilise the 
membrane and essentially lyse the cells (Huang et al. 2010). Therefore, within the 
cultures, it was essential to discover the optimal time to get the maximal amount of 
astrocytes from enzymatic treatment. There is sparse evidence of long term incubation of 
stem derived cells in Trypsin/EDTA or accutase and what their effects are on structural 
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and functional ability (Cowan et al 2004; Hui et al. 2015), especially stem cell derived 
astrocytes, therefore it was essential to test long term incubation of these cells and what it 
yields.  
 
Increased incubation led to increased removal and breakdown of cells (Fig. 37 - bright 
field). Immunocytochemical analysis of cells incubated with Trypsin/EDTA revealed the 
existence of astrocytes after trypsinisation - termed re-plated mESCDA. At different time 
points, there was reliable staining for ALDH1L1 and GFAP (Fig. 38). Analysis of GFAP 
positive cells revealed a significant increase in GFAP positive cells at the 60 minute 
group when compared to 15/30 minutes (Fig. 38). This was similarly observed by Hui et 
al 2015, they observed significantly more GFAP positive astrocytes derived from 
Sprague Dawley rats when cells were incubated for 40 minutes when compared to 20 
minutes. The significant increase in GFAP positive cells could provide evidence of 
inflammatory reactive astrocytes, as trypsinisation is a harsh process in itself and GFAP 
is the most frequently used marker for inflammatory activation of astrocytes in the brain 
(Walz & Lang 1998; Fereidoni et al. 2013). Additionally, observing the morphology of 
GFAP positive cells revealed evidence towards reactivity, as the sating revealed enlarged 
protrusions and aberrant enlarged cytoplasm, similar to observed in APPPS1 Alzheimer 
mice model (Delekate et al. 2014). Further evidence towards reactivity induced by 
Trypsin/EDTA is shown by Fereidoni et al 2013. They revealed a dose dependent manner 
increase in Trypsin/EDTA concentration led to increased production of nitric oxide in 
cultured rat astrocytes (Fereidoni et al. 2013). Post 24 hours treatment of astrocytes with 
Trypsin/EDTA led to increased NF-κB activation and nitric oxide gene activity causing 
the development of reactive astrocytes. This may be what is occurring here, although this 
is to be further tested, the presence of ALDH1L1 astrocytes alongside GFAP positive 
astrocytes rules out the significant presence of reactive astrocytes (Boisvert et al. 2018), 
however this remains to be further tested. Further analysis showed that there were 
significantly more ALDH1L1 positive astrocytes when compared to GFAP positive 
astrocytes (Fig. 38), with no significant differences across the treated groups (although 60 
minute group had a large variance). This suggests the presence of ALDH1L1 positive 
cells provides Trypsin/EDTA ability to filter out subtype of astrocytes - as there is 
heterogeneous population of astrocytes even at DIV 28 (see chapter 2). Furthermore, 
evidence dictates increased presence of anchor proteins in mature astrocytes (Hui et al 
2015), therefore increased presence of GFAP positive cells in 60 minute group could be 
due to an increased ability of Trypsin/EDTA to cleave more anchor proteins yielding 
more mature astrocyte subtype (Peng et al. 2008). However, as previously discussed 60 
minutes incubation is a long time for the cells to be exposed to trypsin, and the presence 
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of GFAP could be due to presence of reactive astrocytes (Boisvert et al. 2018). This could 
be further tested by performing genetic assessment to see which genes are up and 
downregulated to show the presence and absence of each subtype of astrocytes. 
 
The removed and re-plated Trypsin/EDTA isolated mESCDA were analysed for they 
functionality at the 60 minute marks as it yielded an increased number of astrocytes 
across all time-points. As with previous analysis on generated mESCDA (chapter 3), 
isolated mESCDA were loaded with Fluo-4-AM dye and tested for purinergic mediated 
calcium dynamics. Cells loaded with Fluo-4 cells exhibited astrocytic morphology seen 
in generated mESCDA (Fig - chapter 3). Application of ATP displayed clear transient 
from isolated mESCDA (Fig. 40). The transients had a rise phase, a peak response, and a 
decay phase. The responses were analogous to generated mESCDA and other stem cell 
derived astrocytes (Zhang et al. 2016) showing isolated mESCDA are functional and 
readily respond to their environment, with no compromise in their ability to be functional. 
Nevertheless, closer observation of calcium dynamics revealed the presence of dual 
peaks, where there was a clear second rise which was smaller than the first rise (Fig. 27). 
These dual peaks observed have shown to be related to astrocyte reactivity (Morita et al 
2003). For example, Morital et al 2003, using Wistar rats showed the presence of evoked 
dual peaks in the presence of pro-inflammatory cytokines TNF-a and IL-1a. This is 
further confirmed by Delekate et al 2014, as they observe increase hyperactivity and the 
presence of increased dual peaks when measuring calcium activity in APPPS1 
(Alzheimer’s) mice astrocyte mice. Additionally, uncharacteristic expression of 
purinoreceptors may also cause changes in calcium dynamics  (Franke et al. 2012). 
During severe neurodegeneration, reactive astrocytes display hyperactivity altered 
calcium dynamics which are mediated by purinergic receptors. For example, Reichenbach 
et al 2018 in mice which have a human KM67/671NL mutation for Alzheimer’s there are 
severe cases of increased dual peaks and frequency of spontaneous calcium events from 
astrocytes, similar to what is observed here. And blocking the P2YR1 normalised 
network dysfunction by normalising calcium dynamics (Reichenbach et al. 2018). This is 
what is observed here and shows that long incubation with Trypsin/EDTA leads to 
changes in receptor dynamics causing changes in calcium dynamics seen here. These 
changes in receptor dynamic can also be attributed to increase in GFAP positive staining, 
pointing towards the argument of presence of reactive astrocytes at 60 minutes. 
Nevertheless, this needs to be further tested, for example by performing genetic 
expression at all-time points or performing calcium analysis at earlier time-point to see at 
which time points the changes start to occur.  
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The evidence here shows, that the presence of Trypsin/EDTA for a prolonged period of 
time leads to changes in astrocyte behaviour causing them to become more reactive. 
Therefore, a gentler approach or removal of cells at an earlier time point is needed to 
procure cells which are functionally and genetically similar to their primary and stem cell 
derived counterparts. Accutase is an enzyme which contains a mixture of proteolytic, 
collagenolytic, and DNAse activities  (Bajpai et al. 2008). Evidence dictates accutase 
leads to better cell viability and cell yield compared to Trypsin/EDTA (Li et al 2015), and 
more recently stem cells are being treated with accutase rather than trypsin for passaging 
and efficient cell generation (TCW et al 2017). Therefore, to prevent the presence of 
reactive astrocytes caused by Trypsin/EDTA, accutase was used on DIV 28 mESCDA. 
Accutase displayed reduced compromising the EBs and prevented the accumulation of 
debris (Fig. 40). Therefore, confirming straightaway the gentler approach of accutase 
when compared to trypsin. Similarly, with accutase, there was reliable staining with 
GFAP and ALDH1L1, showing accutase reliably being able to interact with anchor 
proteins on the laminin coated coverslips to remove astrocytes (Fig. 42). There is a 
significant increase in GFAP positive cells in 60 minutes when compared to 15 minutes – 
similar to Trypsin/EDTA treatment, pointing towards the presence of reactive astrocytes 
(Fig. 43). Additionally, analysis of ALDH1L1 staining revealed no differences in the 
number of astrocytes, again similar to Trypsin/EDTA. However, here accutase removed 
less number of ALDH1L1 positive cells when comparing the number/mm2 (Fig. 43). 
These similarities in long term incubation reveal long term incubation with enzymes 
produces reactive astrocytes. Therefore, focus of towards isolating astrocytes should be 
short term incubation, where there were a reduced number of astrocytes. 
Morphologically, isolated mESCDA seem to be comparable to generated mESCDA – 
across all time points, where there were extended protrusions from the cytoplasm and 
similar cell size from all of the time points. The result here shows that accutase seems to 
be gentler to the cells and less destructive to the cell surface and membrane proteins, yet 
long term incubation is as harmful as Trypsin/EDTA. These effects of accutase in long 
term incubation on stem cell derived astrocyte have not been reported, thus providing 
novelty. Comparative analysis with Mesenchymal Stromal Cells from Salzig et al 2016 
shows 45 minute incubation leads to more viable cells when compared to other enzymatic 
treatment including Trypsin/EDTA, and this is represented by morphological differences 
observed – observed via GFAP positive staining (Salzig et al. 2016). Nonetheless, the 
number of cells from each treatment is the same, which what is observed here. 
Additionally, Bajpai et al 2008, report accutase prevents the ‘cellular crisis’ in human 
embryonic stem cells (hESC) and lead to high efficiency and cell numbers. Although 
there is reduced number of cells reported here when compared to trypsin/EDTA, the 
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maintenance of cellular integrity and similarity in numbers across the DIVs dictates usage 
of accutase compared to Trypsin/EDTA may be a better alternative.  
 
Similar to Trypsin/EDTA, the removed and re-plated accutase treated mESCDA were 
analysed for their functionality at the 60-minute mark to allow direct comparison with 
Trypsin/EDTA treatment. As with previous analysis isolated mESCDA were loaded with 
Fluo-4-AM dye and tested for purinergic mediated calcium dynamics. Loaded cells 
exhibited astrocytic morphology and application of ATP displayed clear transient from 
isolated mESCDA (Fig. 44). The transients had a rise phase, a peak response, and a decay 
phase. The responses were analogous to generated mESCDA and Trypsin/EDTA 
mESCDA. Calcium dynamics revealed a rise and decay phase, with the peak rise 
showing the presence of dual peaks, where there was a clear second rise which was 
smaller than the first rise, and occurred in a similar manner to Trypsin/EDTA. 
Nevertheless, the peak rise was noticeably smaller. This smaller rise could be due to 
reduced reactivity in astrocyte with accutase treatment, however this further needs to be 
tested. The novel evidence here displays long term incubation with enzymes should be 
avoided. However, the study could benefit from analysis of calcium dynamics from 
previous timepoints. However as there were not any significant changes in morphology 
and marker expression, analysis of earlier incubation period may not provide any 
beneficial outcomes. Hence, enzymatic treatment, therefore, may not be a suitable option 
when isolating mESCDA.  
 
5.4.2. Mechanical isolation yields healthier isolated mESCDA 
 
As an alternative to enzymatic treatment, mechanical isolation of cells was also 
performed (Aronowitz et al. 2015). There is also various method for mechanical isolation 
for cell harvestings such as prolonged incubation on a rotator – the McCarthy and 
deVellis method for isolating astrocytes from a substrate from primary tissue (McCarthy 
1980), isolation via cell scrapers (Beers et al. 2012), or heavy pipetting. Prior to 
enzymatic treatments, mechanical isolation was the standard technique utilised when 
isolating cells from a substrate (Jager et al. 2016). Additionally, assessment and 
comparison of mechanical and enzymatic treatments have been previously performed 
(Jager et al. 2016), however assessment on stem cell derived astrocytes and measurement 
of functionality via calcium dynamics is where the study provides novelty. 
 
Here, mechanical isolation of DIV 28 mESCDA led successful removal from the 
substrate and cells reliably labelled for astrocyte markers. Analysis showed significant 
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more ALDH1L1 positive cells compared to GFAP and closer inspection to the numbers 
revealed isolation resembling accutase treatment (~100 cells/mm2 for each staining). This 
result displayed accutase treatment to be as good as mechanical treatment when 
comparing the number of astrocyte positive staining. Additionally, the morphology of 
mechanically isolated astrocytes (observed via GFAP positive staining), was similar to 
accutase treated cells (extended protrusions from the cytoplasm and similar cell size from 
all of the timepoints and comparable cell size to generated mESCDA from DIV 28). 
Nevertheless, when observing calcium dynamics, the responses here differed (Fig. 47). 
Mechanically isolated mESCDA were subjected to similar ATP stimulation and provided 
a clear and robust calcium transient, confirming the presence of purinergic receptors (Fig. 
47). However, when comparing the calcium transient with mechanically isolated cells, 
there was a notable absence of dual peaks, which was similarly observed in generated 
mESCDA (Fig. 28). The lack of dual peaks observed shows mechanical isolation is better 
in maintaining cellular structural and functional integrity. Mechanical isolation of stem 
cell astrocytes has been performed previously by Santos et al 2017, where they use 
human iPSCs to derive astrocytes (See Table 1). However, the study does not measure 
the calcium dynamics of astrocytes. Therefore, the results obtained here are novel in 
terms of assessment of functional calcium aspects of enzymatic and mechanical 
disassociations.  
 
5.3.3. Isolated and generated mESCDA are similar to the primary astrocytes and 
can be used as a tool for co-culture studies  
 
Once the isolation methodology was established, the isolated cells were compared with 
their generated and primary cortical counterparts, to assess and confirm their ability to be 
utilised for future studies and create cell banks (Stacey 2012). The similar pattern of 
immunocytochemistry and functional analysis was used to provide comparative analysis 
(Fig. 48/49).  
 
Immunocytochemistry revealed a similar pattern of expression of GFAP when isolated, 
and generated mESCDA were compared to primary cortical astrocytes. GFAP was shown 
to label astrocytes which displayed similar morphologies across the groups (Fig. 48). This 
showed that generated and mechanically isolated mESCDA are similar in expression to 
primary astrocytes. This similarity in expression is observed by other stem cell derived 
astrocyte studies. For example, Kleiderman et al 2016 observed similar expression in 
mouse neural stem cell derived astrocytes when compared to primary astrocytes derived 
from P1 pups (Kleiderman 2016). However, this isolated expression has not been 
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observed previously. These multiple comparisons with three different groups is novel and 
provide mESCDA to be used as a tool for future studies in determining the roles of 
astrocytes.  
 
One of the fundamental roles of astrocytes is providing support and network integrity 
(Ullian et al. 2001; Perez-alvarez et al. 2010). Isolated mESCDA were assessed in their 
ability to support and rescue and improve altered neural network (Boehler et al. 2008). 
Neuron rich culture was grown by following Peljto et al protocol (Fig. 50) and the 
number of endogenous astrocytes was limited with anti-mitotic agent cytosine 
arabinoside (AraC) (Delivopoulos & Murray. 2011). The addition of AraC caused 
significant loss of neurons and endogenous astrocytes led to altered neural networks - 
observed via loss of neuronal clusters, reduction of TUJ1 and GFAP positive cells. This 
has been observed before, as Ahlemeyer et al 2003 have shown that AraC causes 
astrocytes to become reactive resulting in damage to neurons and astrocytes (Ahlemeyer 
et al. 2003; Delivopoulos & Murray 2011). Further evidence is shown by Geller et al 
2001, and show AraC kills postmitotic neurons by a mechanism similar to neurotrophic 
factor deprivation and TUJ positive images demonstrate that neurons in AraC treated 
cultures appear unhealthy when compared to untreated cultures, similar to what is 
observed here.  
 
Since the endogenous astrocytes were successfully removed (Fig. 49A), mechanically 
isolated mESCDA were directly plated onto the damaged neutron rich network (Fig. 
50B). The introduced mESCDA were able to show integration into cells that were left 
post AraC treatment, and showed to promote neural survival, shown by TUJ1 positive 
staining (Fig. 50C), similar to what is observed in vivo (Farhy-Tselnicker et al. 2018), and 
displayed by their primary counterparts (Boehler et al. 2007). Although rudimentary, this 
observation provided evidence of mESCDA possessing ability to integrate into the 
neuronal network, confirming the future potential usage of mESCDA as a tool to study 
neurodegenerative diseases. This observation is in close agreement with multiple stem 
cell derived astrocytes studies (See Table 1). For example, Keugler et al 2012, Shaltouki 
et al 2013, Santos et al 2017 were able to show that derived astrocytes were able to rescue 
damaged neurons - shown via increased TUJ1 string, and were able to promote new 
synapses and dendrites by inducing release of trophic factors and promote synaptogenesis 
(Shaltouki et al. 2013, TCW et al 2017).  
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5.3.4. Study improvements and future directions  
 
Although the study provides efficient method for isolation of mESCDA and their ability 
to integrate, improvements which time could not permit to perform, would enhance the 
results explained. For example, further improvements could be performed on isolated 
astrocytes. They could be tested for their expression for all of the relevant astrocyte 
markers that were used for generated mESCDA (see chapter 2 and 3). The expression of 
purinergic and some relevant astrocyte markers are present because isolated cells respond 
to ATP and exhibit expression of ALDH1L1, and GFAP, however a full characterisation 
would further solidify the results obtained. The study could benefit by initially providing 
calcium dynamics analysis from all of the time points for each enzymatic treatment. 
Although here providing calcium dynamics from Tryspin/EDTA would be not fully 
necessary, as immunocytochemistry has provided sufficient results that regardless of 
timepoint, the isolated cells have shown to be reactive - seen via morphology and 
expression via GFAP staining. Results for accutase could make accutase treatment the 
better candidate for isolating astrocytes, as earlier timepoints have shown to have reduced 
GFAP positive staining (Fig. 40). Furthermore, the dual peaks observed at 60 minutes 
mark are significantly attenuated when compared to Trypsin/EDTA (Fig. 42), thus do the 
dual peaks arise at earlier timepoints. Further to this, even though trypan blue analysis 
was performed before cell plating, cellular viability assays such as BrdU, MTT, and 
Live/Dead assays would further provide evidence on the effect of the enzyme on 
mESCDA.  
 
The integration ability of isolated mESCDA could also be tested even further. It is 
established that these mESCDA are able to integrate and rescue a neuron rich culture.  
Further studies could assess how mESCDA rescue a disrupted network. For example 
Farhy-Tselnicker et al. 2018 recently displayed stabilisation of pre and post synapses 
occurs due to expression of glypican (heparan sulfate proteoglycans) by astrocytes. 
Removal of astrocytes leads to disruption in synapse stabilisation and neuronal signalling 
(Ullian et al 2001). The study here could test the expression of glypican pre and post 
introduction of mESCDA, and could also test for synaptic integrity and synapse 
formation by staining for pre and post synapses (Ullian et al. 2001). Additionally, the 
disruption of network via electrophysiological studies could also be performed. Evidence 
has shown that a single astrocyte can come into contact with many synapses – 
subsequently forming a tripartite synapse (Araque et al. 1999), hence astrocytes can 
communicate between them and simultaneously effect neurons. This effect has been 
demonstrated in the hippocampus, where astrocyte calcium elevations release 
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gliotransmitters causing synchronous excitation of clusters of pyramidal neurons, 
indicating that astrocyte activity contributing towards neuronal synchronisation (Fellin 
2009). Neuronal network and mESCDA role in network activity could also be studied via 
tools such as multi electrode arrays (MEAs), and network level activity can be monitored. 
Furthermore, better analysis of the integration ability could be tested via performing co-
localisation analysis of staining. Additionally, increasing n numbers, or conditioned 
media and astrocyte suspension study could be tested on neuronal population could 
provide better insight onto mESCA ability to integrate and rescue the neuronal 
population. For example, Boehler et al 2008 were able to show that conditioned media 
from astrocytes was sufficient enough to rescue damaged neural activity shown via 
electrophysiological recordings  (Boehler et al 2008), and similar analysis could be 
performed here where before direct seeding, conditioned media or physical barrier studies 
could be performed to better understand integration ability of astrocytes.  
 
Nevertheless, the isolated and generated mESCDA showed they contain the ability to 
form a co-cultures of neurons. This opens up new possibilities of studying the interplay of 
neurons and astrocytes during development, the influence of astrocyte during 
neurodegenerative diseases and inflammation.  
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6. Conclusion 
	
A major breakthrough in the study of astrocytes was the description of a procedure to 
purify and culture astrocytes from neonatal rodent brains using serum-containing media 
(McCarthy and de Vellis, 1980). This protocol was used and modified for decades to 
culture not only rodent cells but also human astrocytes from foetal post-mortem tissue 
(Ennas et al., 1992; Lee et al., 1993). Recently, new methods of astrocyte purification 
using immunopanning combined with serum-free culture have been described for adult 
rodent and human brains (Zhang et al. 2016). However, these are invasive techniques. 
Thus, cellular models that rely on the differentiation of astrocytes from stem cells are the 
most accessible methods for in vitro disease modelling and can potentially allow for new 
discoveries and allow us to probe intricate function of astrocyte in different conditions.  
 
In this study, significant effort has been made to contribute towards a standardisation of 
protocols for in vitro astrocytogenesis and generate astrocytes from stem cells. Similar to 
in vivo astrocytogenesis, majority of in vitro protocol require a prolonged time-course to 
generate functional and morphologically relevant cells, which can be used to probe 
further questions. Here, the protocol was able to generate different subpopulations of 
astrocytes, which are heterogeneous in form and function, in a quick and efficient 
manner. To our knowledge, our method is distinct from others recently reported (see 
Table 4). Its major advantages are the ease by which mESCDA can be differentiated – via 
semi directed approach and with reduced use of morphogens, and how they follow the in 
vivo astrocytegenesis signature – seen via genetic and staining analysis. This allows 
future studies to be conducted at different timelines to further to assess the developmental 
role of astrocytes, and contribute towards studies examining the factors controlling 
astrocyte differentiation. Furthermore, the mESCDA can be expanded and cryopreserved, 
serving as a source of cells to support an array of experiments, such as performing co-
culture studies with neurons and other cell types.  
 
In summary, reduction of the timeframe, together with data on the phenotype and 
function of the resultant cells, suggests that generation of astrocytes from mouse 
embryonic stem cells (mESCDA) is a viable alternative to the preparation of primary 
astrocytes for biological, pharmacological and toxicological studies. The comparison of 
mESCDA and primary astrocytes performed here provided new insights into stem cell 
derived functionality. In the future, the generation of mESCDA with different genetic 
back grounds opens up new possibilities in patient-specific research.		
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7. Appendix 
	
	
A 
	
Figure 51A: Representative reverse transcriptase PCR image. (B) Expression of tested 
genes (Table 3). Each gene expression was compared against GAPDH to obtain absolute 
value via gel densitometry and ImageJ.  
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Figure 51B: Representative reverse transcriptase PCR image. Expression of tested genes 
(Table 3). Each gene expression was compared against GAPDH to obtain absolute value 
via gel densitometry and ImageJ.  
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Figure 52: (A) Representative image of a graph of absorbance from the 
spectrophotometer (Nanodrop). (B) The values obtained from the spectrophotometer to 
be used to determine the yield of mRNA and cDNA.  
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Figure 53: Image analysis. Each image was split into relevant channel and was analysed 
for its components. (A) Each image had a peak or optimal thresholding value seen. (B) 
Image was split into relevant channel, Green, Red, and Blue and was analysed for its 
components from the optimal value, further analysis was performed.  
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